ɟġ ‫ם‬ġ ໲ġġȆShimada H, Endo I, Shimada K, Matsuyama R, Kobayashi N, Kubota K : The current diagnosis
and treatment of benign biliary stricture. Surg Today,  ĩ12Ī : 1143-1153, 2012.
ȆKunisaki C, Makino H, Kosaka T, Oshima T, Fujii S, Takagawa R, Kimura J, Ono H, Akiyama
H, Taguri M, Morita S, Endo I : Surgical outcomes of laparoscopy-assisted gastrectomy versus
open gastrectomy for gastric cancer : a case-control study. Surg Endosc,  ĩ3Ī : 804-810,
2012 .
ȆKunisaki C, Takahashi M, Ono H, Oshima T, Takagawa R, Kimura J, Kosaka T, Makino H,
Akiyama H, Endo I : Inflammation-based prognostic score predicts survival in patientsadvanced gastric cancer receiving biweekly docetaxel and S-1 combination chemotherapy.
Oncology,  : 183-191, 2012.
ȆKunisaki C, Ono H, Oshima T, Makino H, Akiyama H, Endo I : Relevance of reduced-port
laparoscopic distal gastrectomy for gastric cancer : a pilot study. Dig Surg,  : 261-268, 2012.
ȆKunisaki C, Ono H, Hasegawa S, Oshima T, Fujii S, Tokuhisa M, Izumisawa Y, Takagawa R,
Kimura J, Kosaka T, Makino H, Akiyama H, Endo I : Low-dose docetaxel and cisplatin
combination chemotherapy for stage Ԇ/ԇ gastric cancer showing resistance to S-1 adjuvant
chemotherapy : a phase ԅ study. Journal of Chemotherapy.  ĩ6Ī : 364-368, 2012.
ȆIshikawa T, Shimizu D, Yamada A, Sasaki T, Morita S, Tanabe M, Kawachi K, Nozawa A,
Chishima T, Kimura M, Ichikawa Y, Endo I : Impacts and Predictors of Cytotoxic Anticancer
Agents in Different Breast Cancer Subtypes. Oncology Research,  : 71-79, 2012.
ȆFujii S, Watanabe K, Ota M, Watanabe J, Ichikawa Y, Yamagishi S, Tatsumi K, Suwa H,
Kunisaki C, Taguri M, Morita S, Endo I : Laparoscopic Colorectal Cancer Surgery by a Colon
Lifting-Up Technique That Dereases the Number of Access Ports : Comparison by Propensity
Scoring of Short-term and Long-term Outcomes With Standard Multiport Laparoscopic
Surgery. Surg Laparosc Endosc Percutan Tech,  ĩ1Ī : 38-45, 2012.
ȆFujii S, Watanabe K, Ota M, Watanabe J, Ichikawa Y, Yamagishi S, Tatsumi K, Suwa H,
Kunisaki C, Taguri M, Morita S, Endo I : Single-incision laparoscopic surgery using colon㧙95㧙

lifting technique for colorectal cancer : a matched case-control comparison with standard
multiport laparoscopic surgery in terms of short-term results and access instrument cost.
Surg Endosc,  : 1403-1411, 2012.
ȆFujii S, Yamamoto S, Ito M, Yamaguchi S, Sakamoto K, Kinugasa Y, Kokuba Y, Okuda J,
Yoshimura K, Watanabe M : Short-term outcomes of laparoscopic intersphincteric resection
from a phase II trial to evaluate laparoscopic surgery for stage 0/I rectal cancer : Japan Societyof Laparoscopic Colorectal Surgery Lap RC. Surg Endosc,  : 3067-3076, 2012.
ȆTanaka K, Kumamoto T, Nojiri K, Takeda K, Endo I : The effectiveness and appropriate
management of abdominal drains in patients undergoing elective liver resection : aretrospective analysis and prospective case series. Surg Today,  ĩ4Ī ; 372-380, 2012.
ȆTanaka K, Kumamoto T, Nojiri K, Takeda K, Ichikawa Y, Endo I : Timing of Two-stage Liver
Resection During Chemotherapy for Otherwise Unresectable Colorectal Metastases. World J
Surg,  ĩ8Ī : 1832-1841, 2012.
ȆTanaka K, Hiroshima Y, Nakagawa K, Kumamoto T, Nojiri K, Takeda K, Ota M, Ichikawa Y,
Endo I : Two-stage hepatectomy with effective perioperative chemotherapy does not induce
tumor growth or growth factor expression in liver metastases from colorectal cancer. Surgery, ĩ2Ī : 179-188, 2012.
ȆTakeda K, Tanaka K, Kumamoto T, Yamada A, Yamada M, Takakura H, Kubota K, Kobayashi
N, Lee J, Endo I : Severe outflow block syndrome caused by compression by the swollen
caudate lobe after living donor liver transplantation : report of a case. Surg Today,  ĩ2Ī : 177180, 2012.
ȆTakeda K, Tanaka K, Kumamoto T, Nojiri K, Mori R, Taniguchi K, Matsuyama R, Endo I :Emergency versus elective living-donor liver transplantation : a comparison of a single center
analysis. Surg Today.  ĩ5Ī : 453-439, 2012.
ȆTakeda K, Tanaka K, Kumamoto T, Nojiri K, Mori R, Taniguchi K, Matsuyama R, Endo I :Predictive

Factorsfor

Prolonged

Intubation

Following

Liver

Transplantation.

Hepatogastroenterology,  ĩ119Ī : 2276-2279, 2012.
ȆKumamoto T, Tanaka K, Takeda K, Nojiri K, Mori R, Taniguchi K, Matsuyama R, Ueda M,
Sugita M, Ichikawa Y, Nagashima Y, Endo I : Intrahepatic cholangiocarcinoma arising 28 years
after excision of a type Ԉ-A congenital choledochal cyst : report of a case. Surg Today, Doi
10.1007/s00595-012-0387-2, 2012.
ȆTanabe M, Endo I, Masunari H, Sugita M, Morioka D, Ishikawa T, Ichikawa Y, Shimada H : Islymph-node micrometastasis in gallbladder cancer a significant prognostic factor?
Hepatogastroenterology,  ĩ113Ī : 31-35, 2012.
㧙96㧙ȆMomiyama M, Zhao M, Kimura H, Tran B, Chishima T, Bouvet M, Endo I, Hoffman RM :Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium inan orthotopic nude-mouse model. Cell Cycle,  ĩ3Ī : 1-5, 2012.
ȆMomiyama M, Kumamoto T, Suetsugu A, Kishimoto H, Chishima T, Tanaka K, Akiyama H,
Ichikawa Y, Bouvet M, Endo I, Hoffman.R.M : Major liver resection stimulates stromal
recruitment and metastasis compared with repeated minor resection. Journal of surgicalResearch,  ĩ1Ī : 280-287, 2012.
ȆHiroshima Y, Nakamura F, Miyamoto H, Mori R, Taniguchi K, Matsuyama R, Akiyama H,
Tanaka K, Ichikawa Y, Kato S, Kobayashi N, Kubota K, Nagashima Y, Goshima Y, Endo I :Collapsin Response Mediator Protein 4 Expression is Associated with Liver Metastasis andPoor Survival in Pancreatic Cancer. Ann Surg Oncol, DOI 10.1245/s10434-012-2491-3, 2012.
ȆYamada A, Takabe K : Should we examine sentinel lymph nodes during the operation? GlandSurgery,  ĩ3Ī : 161-163, 2012.
ȆSawada Y, Yoshikawa T, Nobuoka D, Shirakawa H, Kuronuma T, Motomura Y, Mizuno S, Ishii
H, Nakachi K, Konishi M, Nakagohri T, Takahashi S, Gotohda N, Takayama T, Yamao K,
Uesaka K, Furuse J, Kinoshita T, Nakatsura T : Phase I trial of a glypican-3-derived peptide
vaccine for advanced hepatocellular carcinoma : immunologic evidence and potential for
improving overall survival. Clin Cancer Res, ĩ13Īġ: 3686-3696, 2012.
ȆNakayama G, Morioka D, Murakami T, Takakura H, Miura Y, Togo S : Chylous ascites
occurring after low anterior resection of the rectum successfully treated with an oral fat-freeelemental diet ĩElentalĪ. Clin J Gastroenterol,  : 216-219, 2012.
ȆNimura Y, Nagino M, Takao S, Takada T, Miyazaki K, Kawarada Y, Miyagawa S, Yamaguchi A,
Ishiyama S, Takeda Y, Sakoda K, Kinoshita T, Yasui K, Shimada H, Katoh H : Standard versus
extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of
the head of the pancreas. J Hepatobiliary Pancreat Sci,  : 230-241, 2012.
ȆBeppu T, Sakamoto Y, Hasegawa K, Honda G, Tanaka K, Kotera Y, Nitta H, Yoshidome H,
Hatano E, Ueno M, Takamura H, Baba H, Kosuge T, Kokubo N, Takahashi K, Endo I,
Wakabayashi G, Miyazaki M, Uemoto S, Ohta T, Kikuchi K, Yamaue H, Yamamoto M, Takada
T : A nomogram Predicting disease-free survival in patients with colorectal liver metastases
treated with hepatic resection : multicenter data collection as a Project Study for Hepatic
Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary
Pancreat Sci,  : 72-84, 2012.
ȆKobayashi N, Sugimori K, Simamura T, Hosono K, Watanabe S, Kato S, Ueda M, Endo I,
Inayama Y, Maeda S, Nakajima A, Kubota K : Endoscopic Ultrasonographic findings predict
㧙97㧙the risk of carcinoma in Branch Duct Intraductal Papillary Mucinous Neoplasms of the
Pancreas. Pancreatology.  ĩ2Ī : 141-145, 2012.
ȆNagahashi M, Ramachandran S, Kim EY, Allegood JC, Rashid OM, Yamada A, Zhao R, MilstienS, Zhou H, Spiegel S, Takabe K : Sphingosine-1-phosphate produced by sphingosine kinase 1
promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
Cancer Res,  ĩ3Ī : 726-35, 2012.
ȆStevenson CE, Nagahashi M, Ramachandran S, Yamada A, Bear HD, Takabe K : Bevacizumab
and breast cancer : what does the future hold? Future Oncol,  ĩ4Ī : 403-414, 2012.
ȆTakabe K, Yamada A, Rashid MO, Adams JB, Huang WC, Aoyagi T, Nagahashi M : Twofer antivascular therapy targeting sphingosine-1-phosphate for breast cancer. Gland Surgery,  ĩ2Ī :80-83, 2012.
ȆAoyagi T, Nagahashi M, Yamada A, Takabe K. The role of sphingosine-1-phosphate in breast
cancer tumor-induced lymphangiogenesis : Lymphat Res Biol. 2012;  ĩ3Ī : 97-106.
ȆRashid OM, Ku JK, Nagahashi M, Yamada A, Takabe K. Inverted Meckel's diverticulum as acause of occult lower gastrointestinal hemorrhage. World J Gastroenterol,  ĩ42Ī : 6155-6159,
2012.
ȆFujita S, Akasu T, Mizusawa J, Saito N, Kinugasa Y, Kanemitsu Y, Ohue M, Fujii S, Shiozawa
M, Yamaguchi T, Moriya Y : Lancet Oncol. Postoperative morbidity and mortality after
mesorectal excision with and without lateral lymph node dissection for clinical stage II or
stage III lower rectal cancer (JCOG0212) : results from a multicentre, randomised controlled,
non-inferiority trial. Lancet Oncol,  (6) : 616-621, 2012.

ɟġ გġ ໲ġȆ‫׿‬൥ġ ‫ڒ‬, ૩ၦఊ჊, ઐ५ၦ୆, ໌നგ‫ז‬, ଩ന࢕ၦ, നಎཆढȇ۴࿝໐౨‫ͅ܈ۯ‬చ̳ͥ۴ऒ२ߊ֖ȼ๶ેဩ୨ੰ, ࿝ྤȼ۴൲ྤࣣ໵୨ੰ੅. ક‫شٸܕا‬,  ĩ1Ī : 1-10, 2012.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇ౨ൽ̦ͭ੅ஜ‫ڠا‬ၷ༹ ਀੅̧̦̞́̈́͂૷౯̯̹ͦۛ৪̯ͭ͜ͅआহহၷ
͈‫خ‬ෝ଻ġ ੅ஜ‫ڠا‬ၷ༹ͤ͢ͅ౨ൽ̦͈ͭহၷ଼ୡ̦࢜ષ?!. ̦ͭ΍εȜΠ,  ĩ10Ī :50-54, 2012.
Ȇ‫׿‬൥ġ ‫ڒ‬, ઐ५ၦ୆, ౓࢛ࢼ֚, ૩ၦఊ჊, ଩ന࢕ၦ, നಎཆढȇಎ‫ئ‬໐౨‫ͅ܈ۯ‬చ̳ͥᦙ൮਱ඵঐಸ୨౯੅. ඾ུ౨ൽ‫ڠ‬ٛॠধ,  ĩ4Ī : 26-32, 2012.
Ȇኈॄ৽୕, ઀࿤ਜࣞ, ઀ाၦং, ཪ࿤ဢ౶, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇΑ΅σΑ֍‫͈܈‬হၷ
ĩ2Īġ ‫ڠا‬ၷ༹ a. ੅ஜȆ੅ࢃ༞੩‫ڠا‬ၷ༹. ႉ᛼ક‫ܕا‬ඤ‫ش‬,  ĩ9Ī : 1237-1241, 2012.
Ȇ୞୼ġ ࢣ, ঌ୼࿭ঃ, ఊന֘ঊ, ୄକఱ༟, ୷ോၦং, ‫׿‬൥ġ ‫ڒ‬ȇ඿‫ ܈‬ĩల 2ๅĪġ Ƚ‫ܖ‬ய͂
㧙98㧙ႉ઄͈ड૧ࡄ‫ݪ‬൲࢜Ƚԇ. ඿‫͈܈‬໦ঊ୆໤‫͂ڠ‬อ‫ܥ܈‬੬ อ‫۾ͅ܈‬Ⴒ̳ͥ֒ഥঊఉ߿. ඾ུႉ᛼,  ĩ7Ī : 101-109, 2012.
Ȇ໛ോ಑౳, ‫׿‬൥ġ ‫ڒ‬ȇྎઑ୓ྤႹ‫ږ‬༗. ક‫شٸܕا‬,  : 1517-1522, 2012.
Ȇനಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇഢ֊଻۴‫܈‬. ક‫ڠشٸܕا‬τΫνȜ2012, 85-93, 2012.
Ȇനಎཆढ, ઐུ୷೧, ߧུܽ໲, ࿤૜გങ, ౓࢛ࢼ֚, ໌നგ‫ז‬, ఱന࣓ဇ, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫܈‬۴ഢ֊͈۴୨ੰͬஜ೹̱̹͂੅ஜْ௨૷౯. ۴౨ᦙْ௨,  ĩ3Ī : 245-253,2012.
Ȇനಎཆढ, Ꭲോࢨ຃, ಎ୼გ࿟, ᩊ‫ئ‬ణࢤ, ࿤૜გങ, ߧུܽ໲, ౓࢛ࢼ֚, ള༏֚ܵ, ໌നგ‫ז‬, ఱന࣓ဇ, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫ࣞ܈‬ഽ۴ഢ֊ͅచْ̳ͥࠗഎඵ‫ܢ‬എ୨ੰ࣐͂ࠬठ࠺ฺ̠ͬ‫ڐ‬ఱ۴୨ੰ͈փ݅. ક‫شٸܕا‬,  ĩ9Ī : 1381-1392, 2012.
Ȇ୷ോၦং, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ඿‫܈‬۴ഢ֊͈ႉ઄എඅಭ. ඾ུႉ᛼,  ĩ7Īġ : 124-130,2012.
Ȇఱന࣓ဇ, ଋངဎၮ, ࡔനġ ֘, ५ུ૨࿟, ളᰧġ ੗, ള༏֚ܵ, നಎཆढ, ਝ५ࢼ၌, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇඅਬȇຈඋ ͼτ;Α͈૷౯̥ͣহၷ́͘ ԅ. ‫ܥ‬٫എͼτ
;Α 2. ໝॠ଻̹͉͘ࣆᑫ଻ͼτ;Α bĪġ ಸਹୟ. ႉ઄ॠধȶ‫شٸ‬ȷ,  ĩ3Ī : 255-260,2012.
Ȇఱന࣓ဇ, ५ུ૨࿟, ઀ᚧ૯ဇ๼, ളᰧġ ੗, ള༏֚ܵ, നಎཆढ, ൥֔ୃ֚, ঌ୼࿭ঃ,‫׿‬൥ġ ‫ڒ‬ȇ๧‫ٸئ‬ᥬ࿝‫گ‬࿩޼ςέΠȇIntersphincteric resection̤̫ͥͅ੅ࢃෳ༒‫ܥ‬ෝ٨஝ͬ࿒എ̱͂̀ັ‫੅਀ح‬. ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛॠধ,  ĩ5Ī : 294-296.
Ȇ໌നგ‫ז‬, നಎཆढ, ߧུܽ໲, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ૩‫ؖ‬ఱٚ, ‫۾‬࡫ġ ૾, ୔൥ġ ௛, ߦനࡋ༟, ፜ఆġ ࠲, ஜ୼ඵ჊, ൌനġ ࣅ, ‫׿‬൥ġ ‫ڒ‬ȇུ‫̫̤ͥͅڠ‬୆ఘ۴֊૒͈࡛‫ޙ‬. ‫؍‬ຩ֓‫ڠ‬,  ĩ1Ī : 1-6, 2012.
Ȇઐ५ၦ୆, ૩ၦఊ჊, ໌നგ‫ז‬, ષനႃຳ, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ੅ಎ૷౯̯̹ͦ
Incidental Gallbladder cancer͈হၷ༷ૻ. ۴౨ᦙ,  ĩ4Ī : 537-544, 2012.
Ȇઐ५ၦ୆, ‫׿‬൥ġ ‫ڒ‬ȇٜཎ୆ၑɕ৖ۛɕ੅৆ɕΉͺ ౨ෙ 3steṕζΑΗȜȊ. ક‫ٸܕا‬‫ش‬NURSING,  ĩ5Ī : 55-71, 2012.
Ȇઐ५ၦ୆, ఱനဢ໹, ུ‫ۼ‬ဈਏ, ౓࢛ࢼ֚, ૩ၦఊ჊, ࿤૜გങ, ߧུܽ໲, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, നಎཆढ, ஜ୼ඵ჊, ‫׿‬൥ġ ‫ڒ‬ȇ‫ޗ‬৒̤̫ͥͅ౨ൽ‫شٸ͈܈‬୨ੰ଼ୡ.
‫؍‬ຩ֓‫ڠ‬,  : 65-74, 2012.
Ȇઐ५ၦ୆, ૩ၦఊ჊, ໌നგ‫ז‬, നಎཆढ, ஜ୼ඵ჊, ‫׿‬൥ġ ‫ڒ‬ȇ۴࿝໐౨‫ͅ܈ۯ‬చ̳ͥ‫ڐ‬ఱ਀੅. ਀੅,  ĩ13Ī : 1831-1840, 2012.
Ȇ౓࢛ࢼ֚, ઐ५ၦ୆, ૩ၦఊ჊, ໌നგ‫ז‬, ࿤૜გങ, ߧུܽ໲, ષനႃຳ, ਝ५ࢼ၌, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇNCCN΄ͼΡρͼϋ̤̫ͥͅBorderline resectableᦙ‫ͅ܈‬చ̳ͥ੅ஜ‫ ڠا‬ĩ༶ৣ஌Īġ ၷ༹͈হၷ଼ୡ. ‫͈܈‬ႉ઄,  ĩ5Ī : 261-265, 2012.
㧙99㧙Ȇߧུܽ໲, ‫׿‬൥ġ ‫ڒ‬ȇ஻໐͂ΡτȜϋ‫ۯ‬ၑ. ક‫੅ شٸܕا‬ஜȆ੅ࢃ‫ۯ‬ၑຈࠈ, 35 ĩ5Ī :565-569, 2012.
Ȇߧུܽ໲, നಎཆढ, ໹౓ୄࢁ, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ໌നგ‫ז‬, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ‫ئ‬໐౨‫܈ۯ‬ਔ੅‫ͅܢ‬อછ̱̹ࢃഛ଻ࠬ࿻ພ͈ 1႕. ඾ུક‫ڠشٸܕا‬ٛॠধ,  ĩ11Ī : 1098-1104, 2012.
Ȇౌྜ࠲঎, ఱന࣓ဇ, ଋངࢤგ, ߧུܽ໲, ౓࢛ࢼ֚, ള༏֚ܵ, ५‫܅‬ġ ࿆, ಿനੇ֚, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇໜ࣌‫ئޢ‬୨ੰࢃͅ port site recurrencȩ̹̱̹ͬఱಸ‫͈܈‬
2႕. ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛॠধ,  ĩ1Ī : 31-37, 2012.
Ȇ૩ၦఊ჊, ષനႃຳ, ߧུܽ໲, ࿤૜გങ, ઐ५ၦ୆, ‫׿‬൥ġ ‫ڒ‬ȇౙࢢ৆ໜ࣌‫ئޢ‬౨ෙഊ੄੅͈੅ࢃគ೑ࠚࡘ࢘‫࠿̳ͥ۾ͅض‬൦. ౨ൽ,  ĩ5Ī : 739-744, 2012.
Ȇ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, നಎཆढ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ൚‫̫̤ͥͅش‬๱՛଻ᦙ৖ۛͅచ̳ͥ๶௰ᦙ୨ੰ੅ ໜ࣌‫ޢ‬਀੅͂‫ٳ‬ໜ਀੅͈๤‫࠿ڛ‬൦. ‫؍‬ຩ֓‫ڠ‬,  : 75-81, 2012.
Ȇ૩ၦఊ჊, ષനႃຳ, ଩૩֚ढ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇᦙςϋΩષ๧଻ෙ༾͈ 1 ୨ੰ႕.
඾ུ‫ࠏشٸ‬Ⴒࣣ‫ڠ‬ٛধ,  ĩ4Ī : 853-858, 2012.
Ȇ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ષനႃຳ, ‫׿‬൥ġ ‫ڒ‬ȇᦙક‫ۯا‬໧ࣣ੅ࢃ͈ᦙ‫׶‬. ક‫ܕا‬‫شٸ‬,  ĩ11Ī : 1625-1630, 2012.
Ȇ୞໐කআ, ఱന࣓ဇ, ౌྜ࠲঎, ଋངࢤგ, ള༏֚ܵ, ५‫܅‬ġ ࿆, ൥֔ୃ֚, ঌ୼࿭ঃ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇࣞႢ৪ఱಸ‫̵ͭࢃ੅܈‬࿇อ୆ထ௶̤̫ͥͅಿ౓୼৆۰օ౶ෝບ‫ث‬ΑΉȜσ͈ခဥ଻. ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛॠধ,  ĩ2Ī : 43-50, 2012.
Ȇ୞໐කআ, ५‫܅‬ġ ࿆, നġ ળۘ, ാ‫ؚ‬૝ࢩ, ऎ൥ġ ખ, നಎ࿹ै, ઐ๶࠲֚, Ⴎനࢫ֚჊,ಏ࿤ġ ྶȇ൚̤̫֭ͥͅໜ࣌‫ئޢ‬ఱಸ୨ੰછ႕͈࠿൦. ‫؍‬ຩ֓‫ڠ‬,  : 95-99, 2012.
Ȇ୞໐කআ, ५‫܅‬ġ ࿆, നġ ળۘ, ാ‫ؚ‬૝ࢩ, ऎ൥ġ ખ, നಎ࿹ै, ઐ๶࠲֚, Ⴎനࢫ֚჊,ಏ࿤ġ ྶȇඅอ଻ࠬ઀โࡘઁ଻টแພ໵ం S ેࠫಸ‫ͅ܈‬చ̱̀ໜ࣌‫ئޢ‬ఱಸ୨ੰͬঔ࣐
̱̹ 1႕. ‫؍‬ຩ֓‫ڠ‬,  : 107-112, 2012.
Ȇᚧനġ ဎ, ਝ५ࢼ၌, ઐ५ၦ୆, გന༸ঊ, ‫׿‬൥ġ ‫ڒ‬ȇ‫଻ݢ‬ಖ଒‫੅਀׶‬છ႕̤̫ͥͅSSI
͈࠿൦. ඾ུໜ໐‫ڠ֓ݢݣ‬ٛॠধ,  ĩ6Ī : 1027-1031, 2012.
Ȇಎ୼გ࿟, ૩ၦఊ჊, ષനႃຳ, ࿤૜გങ, ౓࢛ࢼ֚, ઐ५ၦ୆, ໌നგ‫ז‬, നಎཆढ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ੅ஜ૷౯̢̱̹۴࿝໐౨‫ޛۯ‬ॏͬ೮̳ͥؕ૗රٔਆ଻౨ෙ‫ ͈׶‬1႕.
඾ུક‫ڠشٸܕا‬ٛॠধ,  ĩ1Ī : 1083-1090, 2012.
Ȇႝ࿐૲ဈ, ࿐ఆ‫ྶם‬, ኈॄႚঊ, ‫׿‬൥ġ ‫ڒ‬ȇ੅ஜͅ૷౯̱ං̹Press Through Packageࢋ֩ͥٝ͢ͅಸஊ೒ͬြ̱̹Crohnພ͈ 1႕. ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛॠধ,  ĩ5Ī : 283-287, 2012.
Ȇളᰧ୍ఊ჊, ઀ႅܰੇ, ऎ൥ࣞ࢕, ൥֔ഔႿ, ‫ح‬൥૯ࢁ, ळ࿤ཆࢩ, ፜ఆġ ࠲, ஜനġ ᐤ,ಎോġ ੓, ‫׿‬൥ġ ‫ڒ‬, ߦനࡋ༟ȇMDCT͂ਆនζȜ΃Ȝͬঀဥ̱̹૧̱̞ᦙ‫͈܈‬൲ྤ૫
㧙100㧙੕Α΋ͺ͈೹մ. ᦙ௫,  ĩ3Ī : 398, 2012.

‫۾‬Ⴒພ֭ა໲อນġɃ࣭ၛພ֭‫؍‬ຩ֓ၷΓϋΗȜɄġȆാ‫ؚ‬૝ࢩ, ಿཱġ ࿹, ି࿤ฎ෗, ᠟൥࠲૽, ષ࢜૝ࢨ, ໹࿤ġ ૺȇ੅ஜͅ૷౯̢̱̹ᦏ᥻ΰσΣͺ͈ 2႕. ‫شٸ‬,  ĩ1Ī : 109-112, 2012.

ġɃ൥ాঌྦྷພ֭ɄġȆMatsuo K, Rocha F G, Ito K, D'Angelica M I, Allen P J, Fong Y, DeMatteo R P, Gonen M,
Endo I, Jarnagin W R : The Blumgart Preoperative Staging System for Hilar
Cholangiocarcinoma : Analysis of Resectability and Outcomes in 380 Patients. J Am Coll
Surg,  : 343-355, 2012.
ȆMomiyama M, Zhao M, Kimura H, Tran B, Chishima T, Bouvet M, Endo I, Hoffman RM :Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium inan orthotopic nude-mouse model. Cell Cycle. ĩ3Ī : 628-32, 2012.
ȆMomiyama M, Kumamoto T, Suetsugu A, Kishimoto H, Chishima T, Tanaka K, Akiyama H,
Ichikawa Y, Bouvet M, Endo I, Hoffman RM : Major liver resection stimulates stromal
recruitment and metastasis compared with repeated minor resection. J Surg Res,  ĩ1Ī :280-7, 2012.
ȆMomiyama M, Suetsugu A, Kimura H, Kishimoto H, Aki R, Yamada A, Sakurada H,
Chishima T, Bouvet M, Bulgakova NN, Endo I, Hoffman RM : Fluorescent proteins enhance
UVC PDT of cancer cells. Anticancer Res,  ĩ10Ī : 4327-4330, 2012.
Ȇಏ࿤ġ ྶ, ാ‫ؚ‬૝ࢩ, ५‫܅‬ġ ࿆, ୞໐කআ, ऎ൥ġ ખ, നಎ࿹ै, നġ ળۘ, ઐ๶࠻֚,ఱಸࠆ৒৖͈ۛ਀੅എহၷ. ֍͂ಸ,  ĩ7Ī : 1111-1117, 2012.
Ȇऎ൥ġ ખ, ५‫܅‬ġ ࿆, ੉നࢼ֚, ୞໐කআ, ઐ๶࠻֚, ಏ࿤ġ ྶȇठอ໾ङࢢΰσΣͺ
ͅచ̱̀Kugel Patchͬဥ̞̀ਘ໘̱̹ 1 ႕. ඾ུໜ໐‫ڠ֓ݢݣ‬ٛॠধ,  ĩ7Ī : 21631266, 2012.

Ƀ‫؍‬ຩႻबພ֭ɄġȆ୷ോၦং, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ඿‫܈‬۴ഢ֊͈ႉ઄എඅಭ. ඾ུႉ᛼,  ĩ7Ī : 124-130,
2012.
㧙101㧙

Ȇ୞୼ġ ࢣ, ঌ୼࿭ঃ, ఊന֘ঊ, ୄକఱ༟, ୷ോၦং, ‫׿‬൥ġ ‫ڒ‬ȇอ‫۾ͅ܈‬Ⴒ̳ͥ֒ഥ
ঊఉ߿. ඾ུႉ᛼,  ĩ7Ī : 101-109, 2012.

ġ ĩॠধȆ૧໳ĪȆ୷ോၦংȇ඿̦͈ͭྴ֓Ȇ඿̦ͭহၷ͈୺࿝֓ၷঔ୭. ੫଻Γήϋ ĩ઀‫܁ڠ‬ĪȄ
ĩ31Ī : 119, 2012.
Ȇ୷ോၦংȇඅਬ ̦ͭ࠿૷. ࢩ༭̭͉͘͢ࢽཤߊๅ,  : 2-3, 2012.
Ȇ୷ോၦংȇ඿ஏ୺࿝̦̞֓ͥພ֭ςΑΠ. ඿̦ͭ ड૧হၷ༹ ĩͼ΃υΑ੄ๅĪ, 139,2012.
Ȇ୷ോၦংȇ඿̦ͭచॐ͒ȶΙȜθ֓ၷȷ. ൐؈඾༭ ĩတ‫ۏ‬Ī,  : 3, 2012.

Ƀ‫؍‬ଌٖ‫ވ‬फພ֭ɄġȆධġ ဉఊ, ஐ֔ਜ୹, ଩ന࢕ၦ, ࣞ୼ġ ၮ, ଼֚֔ၦ, େന౶ࢨ, ໛ോ಑౳, ࿆‫ੇٗڈ‬,ಿ ཱ ġ ߰ ȇ ۖ ஠ ‫ ޢ‬ণ ‫ ئ‬۴ ୨ ੰ ͒ ࢜ ̫ ̹ ໜ ࣌ ‫ ޢ‬༞ ੩ ‫ ئ‬۴ ୨ ੰ ͈ ခ ဥ ଻ . Journal of
Microwave Surgery,  : 191-194, 2012.

Ƀ‫؍‬ຩ͙̈́͂୤਱লພ֭ɄġȆઐུਜ਼຃, ಿനੇ֚, ଫࢺ೭‫ހ‬, ಿ౓୼୍ং, ઀๶༿჊, Ւ໐ഓຳȇ૤෹வ୆ͤ͢ͅ֍
෫Ⴈ̧̹̱̹ͬ 1႕. ඾ུႉ઄‫ڠشٸ‬ٛধ, 336-339, 2012.
Ȇ‫ډ‬ഞġ ‫ڠ‬, ಿനੇ֚, ଫࢺ೭‫ހ‬, ಿ౓୼୍ং, ઀๶༿჊, Ւ໐ഓຳȇ‫ޢ‬ণ‫́੅਀ئ‬হၷ̱̹֍৊ෑഢฺ̠ͬ‫྄ڞ؍‬ႨࢢΰσΣͺ͈ 1႕. ඾ུႉ઄‫ڠشٸ‬ٛধ, 2515-2518, 2012.

Ƀ‫؍‬ຩ஑֥༗ࡏພ֭ɄġȆാ‫ؚ‬૝ࢩ, ಿཱġ ࿹, ି࿤ฎ෗, ᠟൥࠲૽, ષ࢜૝ࢨ, ໹࿤ġ ૺȇ੅ஜͅ૷౯̢̱̹ᦏ᥻ΰσΣͺ͈ 2႕. ‫شٸ‬,  : 109-112, 2012.

Ƀ࣭ၛ̦ͭࡄ‫ݪ‬ΓϋΗȜ൐ພ֭ġ ႉ઄‫ٳ‬อΓϋΗȜɄġȆSawada Y, Nakatsura T : Phase I trial of glypican-3-derived peptide vaccine for advanced
hepatocellular carcinoma showed immunological evidence and potential for improving
overall survival Clin. Cancer Res,  ĩ13Ī : 3686-3696, 2012.
ȆSawada Y, Nakatsura T : A glypican-3-derived peptide vaccine against hepatocellular
carcinoma. OncoImmunology,  ĩ8Ī : 1449-1451, 2012.
Ȇᚧനġ ဎ, ਝ५ࢼ၌, ઐ५ၦ୆, გന༸ঊ, ‫׿‬൥ġ ‫ڒ‬ȇ‫଻ݢ‬ಖ଒‫੅਀׶‬છ႕̤̫ͥͅ
SSI͈࠿൦. ඾ུໜ໐‫ڠ֓ݢݣ‬ٛॠধ,  ĩ6Ī : 1027-1031, 2012.
㧙102㧙

ġ

ġ
ġ
ġ
ġ
ġ
ɟ ࣭ष‫ڠ‬ٛȆFujii S, Yamamoto S, Ito M, Yamaguchi S, Sakamoto K, Kinugasa Y, Kokuba Y, Okuda J,
Yoshimura K, Watanabe M : Short-term outcomes of laparoscopic intersphincteric resection
from a phase II trial to evaluate laparoscopic surgery for stage 0/I rectal cancer : Japan Societyof Laparoscopic Colorectal Surgery Lap RC. SAGES2012. San Diego, 2012, 3.
ȆWatanabe K, Fujii S, Watanabe J, Godai T, Ota M, Kunisaki C, Ichikawa Y, Endo I :Laparoscopic right hemicolectomy with medially approached lymph node dissection along thesurgical trunk for T3 or T4 colon cancer. SAGES2012. San Diego, 2012, 3.
ȆFujii S, Yamamoto S, Ito M, Yamaguchi S, Sakamoto K, Saito S, Bando H, Okuda J, Yoshimura
K, Watanabe M : Short-term outcomes of laparoscopic intersphincteric resection from phaseԆ trial to evaluate laparoscopic surgery for stage 0/I rectal carcinoma : Japan society oflaparoscopic colorectal surgery lap rc ĩNCT00635466Ī. XIII World congress of endoscopic
surgery. Puerto vallarta, 2012, 4.
ȆIchikawa Y, Goto A, Shimamura T, Ishikawa T, Nojiri K, Kumamoto T, Watanabe J, Watanabe
K, Takeda K, Ota M, Fujii S, Akiyama H, Tanaka K, Endo I : Power of FOLFOXIRI+B-mab aspreoperative chemotherapy for multiple liver metastases of colorectal cancer-Relationshipbetween clinical response and pathological response-. AACR 103rd Annual meeting. Chicago,
2012, 4.
ȆIshikawa T, Ichikawa Y, Shimizu D, Yamada A, Tanabe M, Sasaki T, Kida K, Kimura M, Ota I,
Chishima T, Endo I : Aldehyde dehydrogenase 1 is useful for identifying some subtypes ofnon-basal triple negative breast cancer. AACR 103rd Annual meeting, Chicago, 2012, 4.
ȆMomiyama M, Hiroshima Y, Suetsugu A, Tome Y, Mii S, Yano S, Bouvet M, Chishima T, Endo
I, Hoffman RM : Fluorescence-guided navigation surgery for resection of human glioma in an
orthotopic model in nude mice. AACR 103rd Annual meeting. Chicago, 2012. 4.
ȆMomiyama M, Hiroshima Y, Suetsugu A, Tome Y, Mii S, Yano S, Bouvet M, Chishima T, Endo
I, Hoffman RM : Comparison of repeated minor liver resection and major resection on lungmetastasis growth in mice. AACR 103rd Annual meeting. Chicago, 2012, 4.
ȆMomiyama M, Hiroshima Y, Suetsugu A, Tome Y, Mii S, Yano S, Chishima T, Bouvet M, Endo

㧙104㧙I, Hoffman RM : UVC irradiation inhibits superficial tumor growth in the brain of nude mice.
AACR 103rd Annual meeting. Chicago, 2012, 4.
ȆMomiyama M, Zhao M, Hiroshima Y, Suetsugu A, Tome Y, Mii S, Yano S, Bouvet M, Chishima
T, Endo I, Hoffman RM : Monotherapy with a tumor-targeting mutant of Salmonella
typhimurium inhibits human glioma in an orthotopic model in nude mice. AACR 103rd Annual
meeting. Chicago, 2012, 4.
ȆHiroshima Y, Nakamura F, Miyamoto H, Mori R, Taniguchi K, Matsuyama R, Takeda K,
Akiyama H, Tanaka K, Ichikawa Y, Nagashima Y, Goshima Y, Endo I : Collapsin Response
Mediator Protein 4 Promotes Tumor Cell Invasion and Lethality of Pancreatic Cancer. AACR
103rd Annual meeting. Chicago, 2012, 4.
ȆYamada A, Nagahashi M, Ramachandran S, Kim EY, Allegood C.J, Rashid M.O, Milstien S,
Spiegel S, Takabe K : Activation of sphingosine kinase 1 is necessary angiopoietin 2-induced
hemangiogenesis and lymphangiogenesis. AACR 103rd Annual meeting. ĩPosterĪ, Chicago,
2012, 4.
ȆYamada A, Ishikawa T, Nagahashi M, Endo I, Takabe K : ATP-BINDING TRANSPORTERS,ABCC1 AND ABCG2 ARE EXPRESSED HIGHER IN TRIPLE NEGATIVE BREASTCANCER. 8th Annual Women’s Health Research Day at VCU, ĩPosterĪ, Richmond, 2012, 4.
ȆYamada A, Ishikawa T, Takabe K, Endo I : Both the level and frequency of high expression of
ATP-binding cassette transporter ABCC11 in the tumor are associated with aggressive
subtypes of breast cancer. VCU Massey Cancer Center Breast Cancer Research Interest
Group Conference, ĩOralĪ, Richmond, 2012, 5.
ȆMiyamoto H, Kunisaki C, Otsuka Y, Takahashi M, Takagawa R, Misuta K, Kameda K, Makino
H, Matsuda G, Yamaguchi N, Kamiya N, Murakami T, Akiyama H, Endo I : Prognostic factors
for recurrence free survival after resection of gastric gastrointestinal stromal tumor ĩGISTĪ.
The international college of surgeons The 58th annual congress of Japan section. Tokyo, 2012,6.
ȆFujii S, Watanabe K, Ota M, Watanabe J, Godai T, Kunisaki C, Endo I : Laparoscopic surgery
for advanced lower rectal cancer : Impact of laparoscopic lymphadenectomy of pelvic side wall
via small laparotomy ĩHybrid LapRCĪ. European Association for Endoscopic Surgery ĩEAESĪ.
Brussels, 2012, 6.
ȆIchikawa Y : Effect and safety of FOLFOXiRI+B-mab as preoperative chemotherapy for
multiple liver metastases of colorectal cancer. XXV International society of university colon &rectal surgeons biennial congress. Bologna, 2012, 6.
ȆFujii S, Watanabe K, Ota M, Watanabe J, Ishibe A, Godai T, Kunisaki C, Endo I, Ohki S :㧙105㧙Laparoscopic total mesorectal excision with lymphadenectomy of pelvic side wall via small
laparotomy for advanced lower rectal cancer ĩHybrid Lap RCĪ. XXV International society ofuniversity colon & rectal surgeons biennial congress. Bologna, 2012, 6.
ȆOta M : Randomized clinical trial of peritoneal lavage in elective colorectal surgery :prevention of surgical site infection. XXV International society of university colon & rectal
surgeons biennial congress. Bologna, 2012, 6.
ȆInoue E, Ichikawa Y, Goto A, Suwa Y, Watanabe K, Watanabe J, Ota M, Fujii S, Tanaka K,
Akiyama H, Endo I : Safety and efficacy analysis of anti-EGFR antibodies treatment foradvanced and recurrent colorectal cancer 3rd-line chemotherapy. XXV International society ofuniversity colon & rectal surgeons biennial congress. Bologna, 2012, 6.
ȆKosaka T, Kunisaki C, Ono H, Hasegawa S, Ohshima T, Fujii S, Makino H, Akiyama H, Endo
I : Application of laparoscopy-assisted distal gastrectomy for clinical T2 ĩMP/SSĪ gastriccancer. ACOS 2012. Seoul, 2012, 6.
ȆHoffman RM, Momiyama M, Suetsugu A, Kishimoto H, Chishima T, Bouvet M, Endo I : Effectof major liver resection on colon cancer metastasis in the lung and liver. American Society ofClinical Oncology ĩASCOĪ 48th Annual meeting, Chicago, 2012, 6.
ȆMomiyama M, Zhao M, Kimura H, Tran B, Chishima T, Bouvet M, Endo I, Hoffman RM : Useof tumor-targeting salmonella typhimurium to eradicate human glioma in an orthotopic modelin nude mice. American Society of Clinical Oncology ĩASCOĪ 48th Annual meeting, Chicago,
2012, 6.
ȆMomiyama M, Suetsugu A, Kishimoto H, Chishima T, Bouvet M, Endo I, Hoffman RM : Effectof major liver resection on colon cancer metastasis in the lung and liver. 2012 American
Society of Clinical Oncology, Poster, Chicago, 2012, 5-6.
ȆIwase H, Yamamoto Y, Ishikawa T, Hozumi Y, Ikeda M, Iwata H, Yamashita H, Toyama T,
Chishima T, Kimijima I, Ibusuki M, Saji S : Phase II randomized trial of toremifene 120 mg
compared with exemestane 25 mg after prior nonsteroidal aromatase inhibitor inpostmenopausal women with hormone receptor-positive breast cancer. American Society ofClinical Oncology ĩASCOĪ 2012 Breast Cancer Symposium, San Francisco, 2012, 6.
ȆTanaka K : Liver resection with preoperative chemotherapy for advanced or aggressive
colorectal cancer metastasis. 10th World Congress of the International Hepato-PancreatoBiliary Association. Paris, 2012, 7.
ȆTanaka K : Debate, No resection of previous sites. 10th World Congress of the International
Hepato-Pancreato-Biliary Association. Paris, 2012, 7.
ȆTanaka K, Nojiri K, Kumamoto T, Taniguchi K, Takeda K, Sugita M, Endo I : Complete
㧙106㧙

response by imaging to prehepatectomy chemotherapy in treating advanced liver metastases
from colorectal cancer. 10th World Congress of the International Hepato-Pancreato-Biliary
Association. Paris, 2012, 7.
ȆMatsuyama R, Taniguchi K, Mori R, Nojiri K, Kumamoto T, Takeda K, Tanaka K, Schenk A,
Peitgen H, Endo I : Impact of 3D-CT analysis in preoperative surgical planning for hilar
cholangiocarcinoma. 10th World Congress of the International Hepato-Pancreato-Biliary
Association. Paris, 2012, 7.
ȆNojiri K, Tanaka K, Sugita M, Takeda K, Ueda M, Matsuyama R, Taniguchi K, Kumamoto T,
Mori R, Watanabe J, Ota M, Ichikawa Y, Endo I : Timing of resection for synchronous liver
metastases from colorectal cancer. 10th World Congress of the International HepatoPancreato-Biliary Association. Paris, 2012, 7.
ȆNakagawa K, Tanaka K, Nojiri K, Sugita M, Takeda K, Ueda M, Kumamoto T, Endo I : Risk
factors for surgical site infection after liver resection. 10th World Congress of theInternational Hepato-Pancreato-Biliary Association. Paris, 2012, 7.
ȆTaniguchi K, Matsuyama R, Mori R, Takeda K, Kumamoto T, Nojiri K, Ueda M, Akiyama H,
Tanaka K, Endo I : Role of neoadjuvant chemo ĩradiationĪ therapy for patients with locallyadvanced pancreatic cancer. International Symposium on Pancreas Cancer 2012. Kyoto,
2012,10.
ȆMori R, Matsuyama R, Taniguchi K, Kumamoto T, Nojiri K, Ueda M, Takeda K, Tanaka K,
Endo I : The feature of pancreatic Fistula distal pancreatectomy according to the manner of
cutting. International Symposium on Pancreas Cancer 2012. Kyoto, 2012,10.
ȆHonma Y, Taniguchi K, Matsuyama R, Murakami T, Nakagawa K, Mori R, Nojiri K, Kumamoto
T, Ueda M, Takeda K, Ichikawa Y, Tanaka K, Endo I : Ⱥ Young investigator award Ȼ
Immunological Effect of Neoadjuvant Chemoradiotherapy on Tumor Microenvironment of
Pancreatic Cancer. International Symposium on Pancreas Cancer 2012. Kyoto, 2012,10.
ȆYamada A, Ishikawa T, Aoyagi T, Nagahashi M, Takabe K, Endo I : CLINICAL RELEVANCE
OF THE HIGH EXPRESSION OF ABC TRANSPORTER C11, IN THE LIGHT OF BREASTCANCER SUBTYPES. 2012 Cancer Research Retreat, Massey Cancer Center, ĩPosterĪ,Richmond, 2012, 10.
ȆYamada A, Ishikawa T, Ota I, Kimura M, Shimizu D, Tanabe M, Aoyagi T, Nagahashi M,
Chishima T, Sasaki T, Ichikawa Y, Endo I, Takabe K : The expression of ABC transporter C11
in aggressive breast cancer subtype is related with poor prognosis. Daniel T. Watts Research
Symposium. ĩPoster17Ī, Richmond, 2012, 10.

㧙107㧙ɟġ ࣭ඤ‫ڠ‬ٛġȆኈॄ৽୕, ઀࿤ਜࣞ, ಿ౓୼૥֚, ఱോġ ܲ, ൥֔ୃ֚, ஂᚧဈٚ, ඃ‫ࡓݛ‬຃, ࣞ୼ġ ၮ,࿐ఆġ ੔, ઀ाၦং, ཪ࿤ဢ౶, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇૺ࣐ठอ֍‫ͅ܈‬చ̳ͥ‫ڠا‬ၷ༹͈ுࢗ႕͈‫شٸ‬୨ੰ͈փ݅. ల84ٝ඾ུ֍‫ڠ܈‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ఱि, 2012, 2.
Ȇਝ५ࢼ၌, ઀ाၦং, ࣞ୼ġ ၮ, ઐ५ၦ୆, ఱന࣓ဇ, നಎཆढ, ঌ୼࿭ঃ, ઀࿤ਜࣞ, ཪ࿤ဢ౶, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ֍‫੅܈‬ஜ‫ڠا‬ၷ༹છ႕ͅచ̳ͥఱ൲ྤਔսςϋΩ୯‫ڜ‬ୄ͈਀੅਀ܿ. ల84ٝ඾ུ֍‫ڠ܈‬ٛ௙ٛ. χȜ·ΏοΛί, ఱि, 2012, 2.
ȆKosaka T, Akiyama H, Makino H, Watanabe J, Ota M, Ono H, Fujii S, Kunisaki C, Endo I :Application of laparoscopy-assisted distal gastrectomy for clinical T2 gastric cancer. ల84ٝ඾ུ֍‫ڠ܈‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ఱि, 2012, 2.
Ȇఆષġ ଢ, ኈॄ৽୕, ಿ౓୼૥֚, ઀࿤ਜࣞ, ఱോġ ܲ, ൥֔ୃ֚, ઀ाၦং, ਝ५ࢼ၌,‫׿‬൥ġ ‫ڒ‬ȇণ࿤‫ޛ‬ॏ́อછ̱̹Α΅σΑ֍‫܈‬ಹࠁࣸ൸ഢ֊͈ 1 ႕. ల84ٝ඾ུ֍‫ڠ܈‬ٛ
௙ٛ. εΑΗȜ, ఱि, 2012, 2.
Ȇऎ࿤ġ ખ, ኈॄ৽୕, ऎ൥ġ ߽, ఆષġ ଢ, ฒ֔ਜ਼࿟, ಿ౓୼૥֚, ઀࿤ਜࣞ, ఱോġ ܲ,൥֔ୃ֚, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇTS-1̦ࡔ֦͂ࣉ̢̹ͣͦ࿪स଻ٝಸྎ౤‫͈֚׶‬႕. ల84
ٝ඾ུ֍‫ڠ܈‬ٛ௙ٛ. εΑΗȜ, ఱि, 2012, 2.
Ȇ५ུकయঊ, ઀ाၦং, ࿝ாੇྶ, ളᰧġ ੗, ఱന࣓ဇ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇํս૷౯̦ࣾඳ̜̹́̽0-Ԇb߿਀̨̾̈́߿்‫͈֚܈֍ܢ‬႕. ඾ུક‫ܕا‬ພ‫ڠ‬ٛల318ٝ‫۾‬൐঑໐
႕ٛ. ๊֚‫׵‬ఴ, ൐‫ނ‬, 2012, 2.
Ȇऎ൥ġ ߽, ઀࿤ਜࣞ, ऎ࿤ġ ખ, ႝ࿐૲ဈ, ఱോġ ܲ, ൥֔ୃ֚, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ‫؍‬࣐ࠫಸ‫ࡔ྄ۼ‬อExtra-Gatrointestinal Stromal Tumor ĩEGISTĪġ ͈֚႕. ల133ٝ૰ජ୼ࡇႉ
઄‫ڠ֓شٸ‬ٛਬ౴ٛ. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 2.
Ȇോġ ਜ‫ו‬, ࿤૜გങ, ઐ५ၦ୆, ໌നგ‫ז‬, ఱന࣓ဇ, നಎཆढ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ‫ݢ‬଻౨ෙ‫ͅࢃ੅׶‬๱ۜஅ଻෹‫ฺ̠ͅ׶‬ਹછࡤ‫ݟ‬ະ஠ͬ໵อ̱̹ 1 ႕. ల133ٝ૰ජ୼ࡇႉ઄
‫ڠ֓شٸ‬ٛਬ౴ٛ. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 2.
Ȇኈॄ৽୕, ઀࿤ਜࣞ, ಿ౓୼૥֚, ఱോġ ܲ, ൥֔ୃ֚, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ୓ྤࠬ஀ण஀છ͈ထཡ༹. ల48ٝ඾ུໜ໐‫ڠ֓ݢݣ‬ٛ௙ٛ. χȜ·ΏοΛί, ߄ా, 2012, 3.
Ȇઐ५ၦ୆, ౓࢛ࢼ֚, ߧུܽ໲, ࿤૜გങ, ૩ၦఊ჊, ໌നგ‫ז‬, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇໜ࣌‫ئޢ‬౨ෙഊ੄੅শ͈౨ൽఅੱͅచ̳ͥহၷ. ల48ٝ඾ུໜ໐‫ڠ֓ݢݣ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ߄ా, 2012, 3.
Ȇ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ౨ൽ‫੅܈‬ஜ‫ڠا‬ၷ༹ಎ౨‫࠿͈׶ۯ‬൦. ల48ٝ඾ུໜ໐‫ڠ֓ݢݣ‬ٛ௙ٛ. εΑΗȜ, ߄ా,2012, 3.
Ȇളᰧġ ੗, ఱന࣓ဇ, ५ུ૨࿟, ള༏֚ܵ, നಎཆढ, ਝ५ࢼ၌, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬㧙108㧙൥ġ ‫ڒ‬ȇఱಸ‫ͼ܈‬τ;Αછ႕͈ಿ‫଼ܢ‬ୡͅ‫੅̳ͥ۾‬ஜಸ‫ࡘۯ‬գ͈փ݅. ల48ٝ඾ུໜ໐
‫ڠ֓ݢݣ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ߄ా, 2012, 3.
Ȇ໹౓ୄࢁ, ໌നგ‫ז‬, ߧུܽ໲, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇഢ֊଻۴‫ͅۯࠬူו͈܈‬୆̲̹۴ඤ൲ྤរ෫Ⴈͅచ̱൲ྤण஀ͥ͢ͅগࠬࢃȂඵ‫ܢ‬എͅ۴୨ੰͬঔ࣐̱̹ 1 ႕. ల48ٝ඾ུໜ໐‫ڠ֓ݢݣ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ߄ా, 2012,3.
Ȇఆષġ ଢ, ൥֔ୃ֚, ള༏֚ܵ, ࡼయഛռ, ളᰧġ ੗, ఱന࣓ဇ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫͍̤͢ݢ޽͈܈‬੔޽‫੅਀ݢ‬છ႕͈࿚ఴത. ల48ٝ඾ུໜ໐‫ڠ֓ݢݣ‬ٛ௙ٛ. ๊֚‫׵‬ఴ,߄ా, 2012, 3.
Ȇ֔ષ‫ם‬๼, ໌നგ‫ז‬, ࿦ᚧࠄ֚, ଋངဎၮ, ߧུܽ໲, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ୆ఘ۴֊૒ࢃͅ࿝ྤࠬ஀છฺ̹ͬ̽ક‫ۯا‬ஊࢢͬอછ̱
̹֚႕. ల48ٝ඾ུໜ໐‫ڠ֓ݢݣ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ߄ా, 2012, 3.
Ȇ‫ٳ‬ന᥽໹, ࿐ఆ‫ྶם‬, ‫׿‬൥ġ ‫ڒ‬ȇఉอ۴ෟនȂᦃෟនฺ̹ͬ̽ȂCrohnພࠫಸᦃឝ͈ 1႕.
ల48ٝ඾ུໜ໐‫ڠ֓ݢݣ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ߄ా, 2012, 3.
Ȇႝ࿐૲ဈ, ࿐ఆ‫ྶם‬, ‫׿‬൥ġ ‫ڒ‬ȇ੅ஜͅ૷౯̱ං̢̹Press Through Packageࢋ֩ͥ͢ͅ
ٝಸஊ೒ͬြ̱̹Crohnພ͈ 1 ႕. ల48ٝ඾ུໜ໐‫ڠ֓ݢݣ‬ٛ௙ٛ. εΑΗȜ, ߄ా,2012, 3.
Ȇ଩ଽජೋঊ, ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬, നಎཆढ,ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ‫́׶ᦙ଻ݢ‬อછ̱ੀ઀਀੅́୨ੰ̢̱̹ᦙ൮໐໦খ߿ IPMN͈1႕.
ల824ٝ‫شٸ‬ਬ౴ٛ. ๊֚‫׵‬ఴ, ൐‫ނ‬, 2012, 3.
Ȇ୞୼ġ ࢣ, ୄକఱ༟, ५നࡐ࢕, ऎș࿐‫ܧ‬, ന༏๼ਏঊ, ࿐ఆྔၖঊ, ୷ോၦং, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇ඿‫ ܈‬4 Տ߿༆͈ດ੔‫ڠش‬ၷ༹ͅచ̳ͥۜ਋଻ထ௶֦ঊ̞̾̀ͅ. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012, 4.
Ȇਝ५ࢼ၌, ࣞ୼ġ ၮ, ઀ाၦং, ཪ࿤ဢ౶, ఱന࣓ဇ, ઐ५ၦ୆, നಎཆढ, ൥֔ୃ֚, ኈॄ৽୕, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇआহ୨ੰະෝ֍‫ͅ܈‬చ̳ͥ‫شٸ‬হၷ͈փ݅. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. ๊֚‫׵‬ఴ, ୷ဩ, 2012, 4.
Ȇ൥֔ୃ֚, ള༏֚ܵ, ఱന࣓ဇ, ളᰧġ ੗, ଋངဎၮ, ५ུ૨࿟, ઀ᚧ૯ဇ๼, ࡼయഛռ,ఱോġ ܲ, ਝ५ࢼ၌, ঌ୼࿭ঃ, ኈॄ৽୕, നߪୃၦ, ૩ന౺ণ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫ͅ܈‬చ̳ͥհ஠̈́ౙࢢ৆ໜ࣌‫੅਀ئޢ‬. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ,2012, 4.
ȆTanaka K, Kumamoto T, Nojiri K, Endo I : Liver resection with preoperative chemotherapy
for advanced or aggressive colorectal cancer metastases. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬ
ٛ. Ώϋεΐ;θ, ୷ဩ, 2012, 4.
Ȇఱന࣓ဇ, ଋངဎၮ, ളᰧġ ੗, ള༏֚ܵ, നಎཆढ, ਝ५ࢼ၌, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬㧙109㧙൥ġ ‫ڒ‬ȇ‫ئ‬໐ೄಸ‫ͅ܈‬చ̳ͥ௰༷ΓϋΙΥσΩΥσ୯୆࠿ͬ໵ဥ̱̹ໜ࣌‫ئޢ‬௰༷‫ڜ‬ୄ͈਀ܿ. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. ΫΟ΂Ώϋε, ୷ဩ, 2012, 4.
Ȇ଩ന࢕ၦ, ષനႃຳ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ࿤૜გങ, ߧུܽ໲, ໌നგ‫ז‬, നಎཆढ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇMDCTͥ͢ͅᦙਆនςϋΩ୯૷౯ෝ͈࠿൦. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012, 4.
Ȇષനႃຳ, ଩ന࢕ၦ, ૩ၦఊ჊, ࿤૜გങ, ߧུܽ໲, ౓࢛ࢼ֚, ઐ५ၦ୆, ໌നგ‫ז‬, നಎཆढ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ൚‫̫̤ͥͅش‬ໜ࣌‫ ޢ‬ĩ༞੩Īġ ‫ᦙئ‬ఘ๶໐୨ੰ੅͈਀ܿ͂হ
ၷ଼ୡ. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. ΫΟ΂ΓΛΏοϋ, ୷ဩ, 2012, 4.
Ȇ໌നგ‫ז‬, നಎཆढ, ߧུܽ໲, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ‫׿‬൥ġ ‫ڒ‬ȇ୆ఘ۴֊૒ࢃ౨‫ޛۯ‬ॏ͈‫֦ࡏܓ‬ঊ͂হၷ୽ၞ. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012, 4.
Ȇઐ५ၦ୆, ౓࢛ࢼ֚, ఱനဢ໹, ུ‫ۼ‬ဈਏ, ࿤૜გങ, ߧུܽ໲, ૩ၦఊ჊, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ୨ੰࡠ‫ٮ‬ത̥͙̹ͣBismuthԈ߿۴࿝໐౨‫܈ۯ‬ͅచ̳ͥহၷ୽ၞ. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012, 4.
Ȇ઀࿤ਜࣞ, ኈॄ৽୕, ಿ౓୼૥֚, ఱോġ ܲ, ൥֔ୃ֚, ࣞ୼ġ ၮ, ࿐ఆġ ੔, ઀ाၦং,ཪ࿤ဢ౶, ਝ५ࢼ၌, ୔൥૯ၐ, ૩ന౺ণ, ‫׿‬൥ġ ‫ڒ‬ȇ໵ం৖ۛͬခ̳ͥૺ࣐֍‫ۛ܈‬৪̤̫ͥͅ੅ࢃࣣ໵છထ௶. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012, 4.
Ȇ౓࢛ࢼ֚, നಎཆढ, ઐ५ၦ୆, ૩ၦఊ჊, ໌നგ‫ז‬, ߧུܽ໲, ࿤૜გങ, ུ‫ۼ‬ဈਏ, ఱന ဢ ໹ , ષ ന ႃ ຳ , ଩ ന ࢕ ၦ , ਝ ५ ࢼ ၌ , ‫ ׿‬൥ ġ ‫ ڒ‬ȇNCCN ΄ ͼ Ρ ρ ͼ ϋ ͅ ̤ ̫ ͥ
Borderline resectableᦙ‫ͅ܈‬చ̳ͥ੅ஜ‫ ڠا‬ĩ༶ৣ஌Īġ ၷ༹͈হၷ଼ୡ. ల112ٝ඾ུ‫شٸ‬‫ڠ‬ٛ೰‫੅ڠܢ‬ਬٛ. ΩΥσΟͻΑ΃ΛΏοϋ, ୷ဩ, 2012, 4.
Ȇള༏֚ܵ, ൥֔ୃ֚, ളᰧġ ੗, ࡼయഛռ, ఱന࣓ဇ, ঌ୼࿭ঃ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇໜ࣌‫ޢ‬༞੩‫ࠫئ‬ಸ‫̫̤ͥͅ੅਀܈‬ঢഐஜੜ౾༹͈࠿൦ȽERAS൵ව̫࢜̀ͅȽ. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012,4.
Ȇߧུܽ໲, നಎཆढ, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇૺ࣐۴ळ༾‫ͅ܈‬చ̳ͥࡘၾ۴୨ੰ͂੅ࢃ IFN໵ဥ5-FU൲ಕ‫ڠا‬ၷ༹͈ခဥ଻. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012, 4.
Ȇ઀ाၦং, ਝ५ࢼ၌, ཪ࿤ဢ౶, ളᰧġ ੗, ఱന࣓ဇ, ઀࿤ਜࣞ, ൥֔ୃ֚, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ֍‫੅܈‬ஜ༞੩‫ڠا‬ၷ༹͈֍୨ੰ੅ͅဓ̢ͥ‫ޣג‬. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. ΍Ȝΐ΃σέ΁Ȝρθ, ୷ဩ, 2012, 4.
Ȇ࿤૜გങ, നಎཆढ, ໌നგ‫ז‬, ଩ന࢕ၦ, ષനႃຳ, ઐ५ၦ୆, ౓࢛ࢼ֚, ߧུܽ໲, ૩ၦఊ჊, ‫׿‬൥ġ ‫ڒ‬ȇ۴௫‫شٸ‬ਔ੅‫ۯܢ‬ၑ͈ࢥຳ. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012, 4.
Ȇ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, ന㧙110㧙ಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇอ୆໐պ༆͙̹ͅૺ࣐౨ൽ‫܈‬୨ੰࢃಿ‫ܢ‬୆ం႕͈අಭ. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012, 4.
Ȇളᰧġ ੗, ఱന࣓ဇ, ଋངဎၮ, ള༏֚ܵ, ୷ോၦং, നಎཆढ, ਝ५ࢼ၌, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇໜ࣌‫ܿ਀੅਀ޢ‬ਠං͈‫֗ޗ‬ΏΑΞθ͈‫ږ‬ၚͬ࿒ঐ̱̹৾ͤழ͙. ల
112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012, 4.
Ȇ઀ᚧ૯ဇ๼, ঌ୼࿭ঃ, ആġ ֢໲, ఱോġ ܲ, ‫؂‬ᚧġ ‫ڠ‬, ୤౻ġ ૞, ള༏֚ܵ, ൥֔ୃ֚,‫׿‬൥ġ ‫ڒ‬, ౓࢛‫ם‬ਏȇఱಸ‫ۚ܈̫̤ͥͅ܈‬ळ༾ζȜ΃Ȝอ࡛͈ထࢃܰ೰֦ঊ̱͈͂̀փ
݅. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. ΍Ȝΐ΃σέ΁Ȝρθ, ୷ဩ, 2012, 4.
Ȇུ‫ۼ‬ဈਏ, ౓࢛ࢼ֚, ઐ५ၦ୆, ૩ၦఊ჊, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, ਝ५ࢼ၌, ५ಎୃඵ, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇਆន‫۾‬ႲςϋΩ‫͈ݩ‬་‫ᦙ̹͙̥ͣا‬‫ͅ܈‬చ̳ͥ੅ஜ༶ৣ஌‫ڠا‬ၷ༹͈փ݅. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. ๊֚‫׵‬ఴ,୷ဩ, 2012, 4.
Ȇऎș࿐૯ၑ, ઐ५ၦ୆, ૩ၦఊ჊, ߧུܽ໲, ࿤૜გങ, ౓࢛ࢼ֚, ໌നგ‫ז‬, ଩ന࢕ၦ,ਝ५ࢼ၌, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇEndotoxin Activity Assay ĩEAAĪġ ͥۜ͢ͅஅછ͈ਹછ‫ا‬ထ௶͈࠿൦. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012, 4.
Ȇऎ൥ġ ߽, ઀࿤ਜࣞ, ऎ࿤ġ ખ, ಿ౓୼૥֚, ఱോġ ܲ, ଩ന࢕ၦ, ൥֔ୃ֚, ઀ाၦং,ਝ५ࢼ၌, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇClavien-Dindo໦႒ͬဥ̞̹૙ൽ‫ࣣࢃ੅܈‬໵છਹછഽບ
‫͂ث‬ထ௶֦ঊ͈࠿൦. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. ΍Ȝΐ΃σέ΁Ȝρθ, ୷ဩ,2012, 4.
Ȇᩊ‫ئ‬ణࢤ, നಎཆढ, ߧུܽ໲, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ໌നგ‫ז‬, ఱന࣓ဇ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ۴୨ੰࢃ͈Biloma͈อ୆֦ঊ͂ಿ‫ًࠐܢ‬. ల112ٝ඾ུ‫ٸ‬‫ڠش‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012,4.
Ȇऎ࿤ġ ખ, ኈॄ৽୕, ઀࿤ਜࣞ, ಿ౓୼૥֚, ఱോġ ܲ, ൥֔ୃ֚, ඃ‫ࡓݛ‬຃, ஂᚧဈٚ,ࣞ୼ġ ၮ, ࿐ఆġ ੔, ઀ाၦং, ཪ࿤ဢ౶, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇTS-1 ೷ࢯ଻ठอ֍‫ͅ܈‬
చ̳ͥDocetaxel/Cisplatinઁၾ໦‫ڬ‬໵ဥ‫ڠا‬ၷ༹ ĩలԅ௖দࡑĪ. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012, 4.
Ȇႝ࿐૲ဈ, ࿐ఆ‫ྶם‬, ࣭ॄႚঊ, ઀߄֚֔ၦ, ଩നġ ઎, ‫׿‬൥ġ ‫ڒ‬ȇ઀঱೟ន଻ఱಸ‫ͅ׶‬చ̳ͥ‫شٸ‬হၷ. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012, 4.
Ȇଋངဎၮ, ఱന࣓ဇ, ളᰧġ ੗, ള༏֚ܵ, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇೄಸ‫̤ͅ܈‬̫ͥ๷ၥঊ‫଻ڰ‬ౢͬဥ̞̹௰༷ςϋΩ୯͈ςϋΩၠ͂ഢ֊ု଻ςϋΩ୯͈࠿॑. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. ๊֚‫׵‬ఴ, ୷ဩ, 2012, 4.
Ȇ‫ٳ‬ന᥽໹, ള༏֚ܵ, ൥֔ୃ֚, ളᰧġ ੗, ࡼయഛռ, ఱന࣓ဇ, ঌ୼࿭ঃ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇࠫಸֲ฼୨ੰ੅̤̫ͥͅໜ࣌ඤΡτȜϋ͈ຈါ଻ͅ‫࠿̳ͥ۾‬൦. ల112ٝ඾ུ‫ٸ‬‫ڠش‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012, 4.
㧙111㧙Ȇࡔനġ ֘, ঌ୼࿭ঃ, ࢃ൥ġ ༜, ോఆġ ࠲, ܲോ૬ୱ, ߧུܽ໲, ࿤૜გങ, ఱന࣓ဇ, ਝ५ࢼ၌, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸఉอ۴ഢ֊છ႕ͅచ̳ͥ੅ஜ‫ڠا‬ၷ༹̱͈͂̀
FOLFOXIRI+bevacizumab͈࢘‫͂ض‬հ஠଻. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. ๊֚‫׵‬ఴ, ୷ဩ, 2012, 4.
Ȇგന༸ঊ, ઀࿤ਜࣞ, ‫ٳ‬ന᥽໹, ઀ाၦং, ಿ౓୼૥֚, ཪ࿤ဢ౶, ఱോġ ܲ, ൥֔ୃ֚,ਝ५ࢼ၌, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ֍‫܈‬୨ੰࢃ͈ಿ‫ܢ‬ထࢃ̤̫ͥͅBMI͈‫ޣג‬. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012, 4.
Ȇ‫ܔ‬ఉ‫ݛ‬๼ঊ, ୞୼ġ ࢣ, ५നࡐ࢕, ఊന֘ঊ, ୄକఱ༟, ࿐ඤࢨ෗੩, ന༏๼ਏঊ, ऎș࿐‫ܧ‬, ࿐ఆྔၖঊ, ୷ോၦং, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇ૗ள༹༞੩‫ ئ‬4Node΍ϋίςϋΈ̱̹ͬ͂͜ͅ‫ܖ‬யഎ̤͍͢ႉ઄എࡄ‫̥ͣݪ‬. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ,୷ဩ, 2012, 4.
Ȇ‫ܔ‬ఉ‫ݛ‬๼ঊ, ୞୼ġ ࢣ, ऎș࿐૯ၑ, ఊന֘ঊ, ୄକఱ༟, ࿐ඤࢨ෗੩, ന༏๼ਏঊ, ऎș࿐‫ܧ‬, ࿐ఆྔၖঊ, ୷ോၦং, ‫׿‬൥ġ ‫ڒ‬ȇ΍ήΗͼί༆͈඿‫࠿̹̱̰͛ͬ૷࠿܈‬൦. ల28
ٝ඾ུ඿ஏࢿેஏ಼‫إ‬෨݈ٛ. ๊֚‫׵‬ఴ, ‫ؖ‬५, 2012, 4.
Ȇ࿝ாੇྶ, ໌നგ‫ז‬, ߧུܽ໲, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ൳শ଻෹ഢ֊ฺ̠ͬ۴ळ༾‫ͅ܈‬చ̱̀୆ఘ۴֊૒ͬঔ࣐̱ಿ‫ܢ‬୆ంͬ෇̹͛1
႕. ల23ٝ૰ජ୼֊૒֓‫ڠ‬ٛ. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 5.
Ȇఆષġ ଢ, ષനႃຳ, ଩ന࢕ၦ, നᰦġ ರ, २ႊহ୆, ߄ঊġ స, ଩૩֚ढ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ਱ඵঐಸ౨୞ͼτ;Α͈ 1 ႕. ల319ٝ඾ུક‫ܕا‬ພ‫ڠ‬ٛ‫۾‬൐঑໐႕ٛ. ๊֚‫׵‬ఴ, ൐‫ނ‬, 2012, 5.
Ȇಎ࢛ဉో, ઀ाၦং, ࿝ாੇྶ, ളᰧġ ੗, ఱന࣓ဇ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇພၑٜཎͅ
ͤ͢૷౯̯̹ͦࣞഽૺ࣐਱ඵঐಸକ໹‫ݗ‬໐‫͈֚܈‬႕. ల319ٝ඾ུક‫ܕا‬ພ‫ڠ‬ٛ‫۾‬൐঑໐
႕ٛ. ࡄਘ֓ΓΛΏοϋ, ൐‫ނ‬, 2012, 5.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇ۴࿝໐౨‫ͅ܈ۯ‬చ̳ͥ๶ેဩ୨ੰȆ۴‫ٸ‬౨‫ۯ‬୨ੰฺ̠ͬऒ௰۴୨ੰ. ల24ٝ඾ུ۴౨ᦙ‫ڠشٸ‬ٛȆ‫੅ڠ‬ਬٛ. අ༆ْܑ, ఱि, 2012, 6.
Ȇനಎཆढ, ߧུܽ໲, ࿤૜გങ, ౓࢛ࢼ֚, ષനႃຳ, ໌നგ‫ז‬, ଩ന࢕ၦ, ఱന࣓ဇ, ‫׿‬൥ġ ‫ڒ‬ȇ஠๶ેဩ͂ࢃߊ֖͈֚‫گ‬୨ੰ̤̫ͥͅHanging maneuver͈ခဥ଻. ల24ٝ඾ུ۴౨ᦙ‫ڠشٸ‬ٛȆ‫੅ڠ‬ਬٛ. χȜ·ΏοΛί, ఱि, 2012, 6.
Ȇനಎཆढ, Ꭲോࢨ຃, ߧུܽ໲, ࿤૜გങ, ષനႃຳ, ໌നგ‫ז‬, ఱന࣓ဇ, ਝ५ࢼ၌, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇ୨ੰະෝ۴ഢ֊ͅచْ̳ͥࠗഎඵ‫ܢ‬എ୨ੰ੅͈ఏ൚଻. ల24ٝ඾ུ۴౨ᦙ‫ڠشٸ‬ٛȆ‫੅ڠ‬ਬٛ. Ώϋεΐ;θ, ఱि, 2012, 6.
Ȇ଩ന࢕ၦ, ષനႃຳ, ౓࢛ࢼ֚, ઐ५ၦ୆, ૩ၦఊ჊, ࿤૜გങ, ߧུܽ໲, ໌നგ‫ז‬, നಎཆढ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇह֭‫ۼܢ‬ౣੀͬ࿒ঐ̱̹ᦙ൮਱ඵঐಸ୨ੰ੅ࢃᦙߗಸ໧
ࣣ͈਀͈ܿࢥຳ. ల24ٝ඾ུ۴౨ᦙ‫ڠشٸ‬ٛȆ‫੅ڠ‬ਬٛ. εΑΗȜ, ఱि, 2012, 6.
㧙112㧙

Ȇ໌നგ‫ז‬, നಎཆढ, ߧུܽ໲, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ‫׿‬൥ġ ‫ڒ‬ȇ
Stroke volume variation ĩSVVĪ ͬဥ̞̹۴֊૒ೄࢃ͈੏۪ࠬ‫ס‬ၾ͈ບ‫͈ث‬ခဥ଻. ల24ٝ඾ུ۴౨ᦙ‫ڠشٸ‬ٛȆ‫੅ڠ‬ਬٛ. εΑΗȜ, ఱि, 2012, 6.
Ȇઐ५ၦ୆, ౓࢛ࢼ֚, ఱനဢ໹, ུ‫ۼ‬ဈਏ, ࿤૜გങ, ߧུܽ໲, ૩ၦఊ჊, ໌നგ‫ז‬, നಎཆढ, ೛ఆġ ࠲, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇGEM+S1໵ဥၷ༹ͅະ؊̹͂̈́̽୨ੰະෝૺ
࣐Ȇठอ౨ൽ‫ͅ܈‬చ̳ͥGEM+CDDP໵ဥၷ༹͈ခဥ଻͈࠿൦. ల24ٝ඾ུ۴౨ᦙ‫شٸ‬‫ڠ‬ٛȆ‫੅ڠ‬ਬٛ. χȜ·ΏοΛί, ఱि, 2012, 6.
Ȇ౓࢛ࢼ֚, നಎཆढ, ઐ५ၦ୆, ૩ၦఊ჊, ໌നგ‫ז‬, ߧུܽ໲, ࿤૜გങ, ଩ന࢕ၦ, ષനႃຳ, ུ‫ۼ‬ဈਏ, ఱനဢ໹, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇBorderline resectableᦙ‫ͅ܈‬చ̳ͥ੅ஜ‫ ڠا‬ĩ༶ৣ஌Īġ ၷ༹͈ခဥ଻. ల24ٝ඾ུ۴౨ᦙ‫ڠشٸ‬ٛȆ‫੅ڠ‬ਬٛ. εΑΗȜ, ఱि,2012, 6.
Ȇߧུܽ໲, നಎཆढ, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, ‫׿‬൥ġ ‫ڒ‬ȇठอ۴ळ༾‫ͅ܈‬చ̳ͥठ۴୨ੰ੅͈হၷ଼ୡ. ల24ٝ඾ུ۴౨ᦙ‫ٸ‬‫ڠش‬ٛȆ‫੅ڠ‬ਬٛ. εΑΗȜ, ఱि, 2012, 6.
Ȇ࿤૜გങ, നಎཆढ, ଩ന࢕ၦ, ષനႃຳ, ໌നგ‫ז‬, ઐ५ၦ୆, ౓࢛ࢼ֚, ߧུܽ໲, ૩ၦఊ჊, ‫׿‬൥ġ ‫ڒ‬ȇໜ࣌‫ئޢ‬۴୨ੰ੅͈হၷ଼ୡ͂ഐ؊‫ڐ‬ఱ͈͒৾ͤழ͙. ల24ٝ඾ུ۴౨ᦙ‫ڠشٸ‬ٛȆ‫੅ڠ‬ਬٛ. εΑΗȜ, ఱि, 2012, 6.
Ȇ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ఱനဢ໹, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ൚‫̫̤ࣞͥͅش‬ഽޫਫ਼ૺ࣐౨ෙ‫ͅ܈‬చ̳ͥ਀੅଼ୡ͂হ
ၷ୽ၞ. ల24ٝ඾ུ۴౨ᦙ‫ڠشٸ‬ٛȆ‫੅ڠ‬ਬٛ. Ώϋεΐ;θ, ఱि, 2012, 6.
Ȇષനႃຳ, ଩ന࢕ၦ, ૩ၦఊ჊, ࿤૜გങ, ߧུܽ໲, ౓࢛ࢼ֚, ઐ५ၦ୆, ໌നგ‫ז‬, നಎཆढ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇᦙఘ๶໐୨ੰ੅ࢃᦙ‫ס‬Ⴣ͈ਹඈ‫ا‬ါ֦͈࠿൦. ల24ٝ඾ུ۴౨ᦙ‫ڠشٸ‬ٛȆ‫੅ڠ‬ਬٛ. ηΣΏϋεΐ;θ, ఱि, 2012, 6.
Ȇ໹౓ୄࢁ, ઐ५ၦ୆, ౓࢛ࢼ֚, ૩ၦఊ჊, ࿤૜გങ, ߧུܽ໲, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ൚̤̫֭ͥͅ۴ඤ౨‫͈܈ۯ‬হၷ଼ୡ̤͍͢ထࢃ֦ঊ͈࠿
൦. ల24ٝ඾ུ۴౨ᦙ‫ڠشٸ‬ٛȆ‫੅ڠ‬ਬٛ. εΑΗȜ, ఱि, 2012, 6.
Ȇኈॄ৽୕, ઀࿤ਜࣞ, ಿ౓୼૥֚, ఱോ ܲ, ൥֔ୃ֚, ઀ाၦং, ཪ࿤ဢ౶, ਝ५ࢼ၌,‫׿‬൥ ‫ڒ‬ȇ૙ൽ‫ͅ܈‬చ̳ͥडၻ͈‫ޢ‬ণ‫੅਀ئ‬. ల66ٝ඾ུ૙ൽ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. εΑΗȜ,ࠚ֔ా, 2012, 6.
Ȇఆષġ ଢ, ኈॄ৽୕, ಿ౓୼૥֚, ઀࿤ਜࣞ, ఱോġ ܲ, ൥֔ୃ֚, ઀ाၦং, ཪ࿤ဢ౶,ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ૙ൽ‫ۜࢃ੅܈‬அછࣣ໵છ͉Ȃಿ‫଼ܢ‬ୡͅ‫̥̳͖ݞͬޣג‬ȉ. ల66
ٝ඾ུ૙ൽ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. εΑΗȜ, ࠚ֔ా, 2012, 6.
Ȇ઀࿤ਜࣞ, ኈॄ৽୕, ಿ౓୼૥֚, ఱോġ ܲ, ൥֔ୃ֚, ඃ‫ࡓݛ‬຃, ஂᚧဈٚ, ࣞ୼ġ ၮ,࿐ ఆ ġ ੔ , ઀ ा ၦ ং , ཪ ࿤ ဢ ౶ , ਝ ५ ࢼ ၌ , ‫ ׿‬൥ ‫ ڒ‬ȇ ֍ ‫ ͅ ܈‬చ ̳ ͥ Reduced-port
㧙113㧙

Laparoscopic Distal Gastrectomy ĩRPLDGĪ ͈ခဥ଻. ల37ٝ඾ུ‫ࠏشٸ‬Ⴒࣣ‫ڠ‬ٛ‫੅ڠ‬ਬ
ٛ. ΫΟ΂Ώϋε, ໛‫ؖ‬, 2012, 6.
Ȇఆષġ ଢ, ષനႃຳ, ଩ന࢕ၦ, ૩ၦఊ჊, ࿤૜გങ, ߧུܽ໲, ౓࢛ࢼ֚, ઐ५ၦ୆, ໌നგ‫ז‬, നಎཆढ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇᦙ൮਱ඵঐಸ୨ੰ੅ࢃ֍ߗಸ໧ࣣ໐೟នછ႕͈
࠿൦. ల37ٝ඾ུ‫ࠏشٸ‬Ⴒࣣ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. ๊֚‫׵‬ఴ, ໛‫ؖ‬, 2012, 6.
Ȇგന༸ঊ, ൥֔ୃ֚, ႝ࿐૲ဈ, ള༏ġ ੗, ള༏֚ܵ, ࡼయഛռ, ఱോġ ܲ, ఱന࣓ဇ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ୨ੰະෝठอఱಸ‫͈܈‬ಿ‫ܢ‬୆ం͈֚႕. ల37ٝ඾ུ‫ࠏشٸ‬Ⴒࣣ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. ๊֚‫׵‬ఴ, ໛‫ؖ‬, 2012, 6
Ȇ౓࢛ࢼ֚, ઐ५ၦ୆, ૩ၦఊ჊, ໌നგ‫ז‬, ߧུܽ໲, ࿤૜გങ, ུ‫ۼ‬ဈਏ, ఱനဢ໹, ષനႃຳ, ଩ന࢕ၦ, നಎཆढ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ৔੕଻ᦙ‫ͅ܈ۯ‬చ̳ͥহၷ୽ၞ. ల
43ٝ඾ུᦙ௫‫ڠ‬ٛ. ါབ‫׵‬ఴ, ५ࠁ, 2012, 6.
Ȇ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ࿤૜გങ, ߧུܽ໲, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇᦙ౯౤ੜၑ༹༷༆͈ᦙఘ๶୨ੰ੅ࢃᦙ‫ס‬ឝ͈࠿൦. ల43ٝ඾ུᦙ௫
‫ڠ‬ٛ. ါབ‫׵‬ఴ, ५ࠁ, 2012,6.
ȆIshikawa T, Shimizu D, Tanabe M, Sasaki T, Kida K, Chishima T, Kimura M, Ichikawa Y, Endo
I : ALDH-1 is useful for identifying some specific subtypes of triple negative cancer. ల20ٝ඾ུ඿‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ. ๊֚‫׵‬ఴ, ߧུ, 2012, 6.
Ȇ୷ോၦং, ऎș࿐‫ܧ‬, ࿐ఆྔၖঊ, ୄକఱ༟, ୞୼ġ ࢣ, ५ಎୃඵ, ֞५‫ྶد‬, ‫׿‬൥ġ ‫ڒ‬ȇ21-gene recurrence score assayͅ‫̹̞̿ܖ‬Ki67 Labeling Index͈ບ‫༹ث‬. ల20ٝ඾ུ඿‫܈‬‫ڠ‬ٛ‫੅ڠ‬௙ٛ, ๊֚া୰, ߧུ, 2012. 6.
Ȇୄକఱ༟, ऎ໌၌຃, ؕġ ୉᜶, ऎș࿐‫ܧ‬, ୷ോၦং, ୞୼ġ ࢣ, ‫׿‬൥ġ ‫ڒ‬ȇࢩไ̈́඿‫܈‬ͅచ̳ͥ඿པ‫أ‬ం਀੅ ĩ෸໐‫ޝ‬෸൲୓ྤஊ೒খ๧༕ͥ͢ͅठ࠺͈৘षĪȅల20ٝ඾ུ඿‫܈‬‫ڠ‬ٛ‫੅ڠ‬௙ٛ, ๊࢛֚‫׵‬, ߧུ, 2012. 6.
Ȇఊന֘ঊ, ୞୼ġ ࢣ, ୄକఱ༟, ࿐ఆྔၖঊ, ന༏๼ਏঊ, ऎș࿐‫ܧ‬, ୷ോၦং, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇDCIS̤̫ͥͅΓϋΙΥσςϋΩ୯୆࠿͈ഐ؊ͅ‫࠿̳ͥ۾‬൦. ల20ٝ඾ུ඿‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ. εΑΗȜ, ߧུ, 2012, 6.
Ȇऎș࿐૯ၑ, ୞୼ġ ࢣ, ୄକఱ༟, ‫ܔ‬ఉ‫ݛ‬๼ঊ, ୷ോၦং, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇ඿‫͈܈‬‫ڠا‬ၷ༹͈‫ޑ‬ഽ͂࢘‫࠿̳ͥ۾ͅض‬൦. ల20ٝ඾ུ඿‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ. ߧུ, 2012, 6.
Ȇ‫ܔ‬ఉ‫ݛ‬๼ঊ, ୞୼ġ ࢣ, ऎș࿐૯ၑ, ఊന֘ঊ, ୄକఱ༟, ࿐ඤࢨ෗੩, ന༏๼ਏঊ, ऎș࿐‫ܧ‬, ࿐ఆྔၖঊ, ୷ോၦং, ‫׿‬൥ġ ‫ڒ‬ȇ΍ήΗͼί༆͈඿‫࠿̹̱̰͛ͬ૷࠿܈‬൦. ๊֚‫׵‬ఴ, ల20ٝ඾ུ඿‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ. ߧུ, 2012, 6.
Ȇག௏঎෕, ࣞ‫ޘ‬࿹ၖ, ‫ح‬൥ࢬ๼, ୷ോၦংȇ൚֭֭ඤۛ৪ٛȶΧȜΠζϋζ͈ٛȷ͈४‫ح‬৪ͺϋΉȜΠ಺औ͂ࣽࢃ͈ജབ̞̾̀ͅ. ల20ٝ඾ུ඿‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ, e-poster, ߧུ,2012, 6.
㧙114㧙Ȇչ൥‫ܮ‬ঊ, ࣞ࿤ટঊ, ५ಎၦং, ࿐ఆྔၖঊ, ୷ോၦংȇೄ୪་༷۟৆FPD൏शζϋκΈρέͻ௡౾͈ज़‫࠿͈࠯ૄג‬൦. ల20ٝ඾ུ඿‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ, ๊֚া୰, ߧུ, 2012, 6.
Ȇ‫ؖ‬നંঊ, ୞୼ġ ࢣ, ‫ࢗ࡫ף‬຃, ୄକఱ༟, ‫ܔ‬ఉ‫ݛ‬๼ঊ, ୷ോၦং, ‫׿‬൥ġ ‫ڒ‬ȇTCၷً༹̤̫ͥͅຮછ͈࠿൦. ల20ٝ඾ུ඿‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ, ๊࢛֚‫׵‬, ߧུ, 2012, 6.
Ȇ࿦ᚧࠄ֚, ୷ോၦং, ଫࢺ೭‫ހ‬, ࿐ఆྔၖঊ, ঌ୼࿭ঃ, ୞୼ġ ࢣ, ‫׿‬൥ġ ‫ڒ‬ȇ੅ࢃ༶ৣ஌ચৣํսඤ͈ςϋΩ୯ͅठอ̱̹ΓϋΙΥσςϋΩ୯୆࠿֮଻඿‫͈֚܈‬႕. ల825ٝ‫ٸ‬‫ش‬ਬ౴ٛ. ๊֚‫׵‬ఴ, ൐‫ނ‬, 2012, 6.
Ȇऎ࿤ġ ખ, ઀࿤ਜࣞ, നఆਔ२, ಿ౓୼૥֚, ఱോġ ܲ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ੅ஜ༞੩‫ڠا‬ၷ༹ಎͅ֍‫܈‬ஊࢢͬြ̱̹ 1႕. ๊֚‫׵‬ఴ, ల825ٝ‫شٸ‬ਬ౴ٛ. ൐‫ނ‬, 2012, 6.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇಎ໐౨‫ͅ܈ۯ‬చ̳ͥ‫ڐ‬ఱ۴࿝໐౨‫ۯ‬୨ੰ+ᦙ൮਱ඵঐಸ୨ੰ+ֲ۴൲ྤࣣ໵
୨ੰठ࠺. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ΫΟ΂Ώϋε, ີ५, 2012, 7.
Ȇኈॄ৽୕, ઀࿤ਜࣞ, ಿ౓୼૥֚, ఱോġ ܲ, ൥֔ୃ֚, ઀ाၦং, ཪ࿤ဢ౶, ਝ५ࢼ၌,‫׿‬൥ġ ‫ڒ‬ȇ૙ൽ‫ͅ܈‬చ̳ͥऒ௰ٓպ‫ޢ‬ণ‫ࢥ͈੅਀ئ‬ຳ͂হၷ଼ୡ. ల67ٝ඾ུક‫ٸܕا‬‫ڠش‬ٛ௙ٛ. Ώϋεΐ;θ, ີ५, 2012, 7.
Ȇঌ୼࿭ঃ, ࢃ൥ġ ༜, ፜ఆġ ࠲, ളᰧġ ੗, ള༏֚ܵ, ఱന࣓ဇ, ൥֔ୃ֚, ਝ५ࢼ၌, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇFOLFOXIRI+bevacizumab͈ਆនੀ઀࢘‫ض‬. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇਝ५ࢼ၌, ࣞ୼ġ ၮ, ઀ाၦং, ཪ࿤ဢ౶, ఱന࣓ဇ, ঌ୼࿭ঃ, ઀࿤ਜࣞ, ኈॄ৽୕, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ๱হ࿴֦ঊͬခ̳ͥ֍‫ͅ܈‬చ̳ͥ‫شٸ‬হၷ͈փ݅. ల67ٝ඾ུક‫ا‬‫ڠشٸܕ‬ٛ௙ٛ. Ώϋεΐ;θ, ີ५, 2012, 7.
Ȇ൥֔ୃ֚, ള༏֚ܵ, ఱന࣓ဇ, ളᰧġ ੗, ࡼయഛռ, ఱോġ ܲ, ঌ୼࿭ঃ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫ͅ܈‬చ̳ͥহ࿴୨ੰ੅ࢃ༞੩‫ڠا‬ၷ༹͈হၷ଼ୡ. ల67ٝ඾ུક‫شٸܕا‬‫ڠ‬ٛ௙ٛ. χȜ·ΏοΛί, ີ५, 2012, 7.
Ȇനಎཆढ, Ꭲോࢨ຃, ߧུܽ໲, ࿤૜გങ, ષനႃຳ, ໌നგ‫ז‬, ଩ന࢕ၦ, ఱന࣓ဇ, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇ୨ੰະෝ۴ഢ֊ͅచ̳ͥਬ‫ڠ‬എহၷ̱͈͂̀੅ஜ‫ڠا‬ၷ༹໵ဥ‫́ئ‬͈࿝ྤण஀໵ဥ୨ੰْ̤͍ࠗ͢എඵ‫ܢ‬എ୨ੰ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. Ώϋεΐ;θ, ີ५, 2012, 7.
Ȇఱന࣓ဇ, ଋངဎၮ, ളᰧġ ੗, ള༏֚ܵ, നಎཆढ, ਝ५ࢼ၌, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇඤಸࣸࠬ‫ྎۯ‬ઑႀ֖͈ୈྟ̈́ςϋΩ୯‫ڜ‬ୄͬ‫خ‬ෝ̳ͥͅdirect approach༹ͥ͢ͅໜ࣌‫ئޢ‬௰༷‫ڜ‬ୄ͈਀ܿ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇ࿐ఆ‫ྶם‬, ‫ٳ‬ന᥽໹, ઀߄֚֔ၦ, ଩നġ ઎, ‫׿‬൥ġ ‫ڒ‬ȇ୆໤‫ڠ‬എୋस൵වࢃ͈·υȜϋພহၷ̤̫ͥͅ‫͈شٸ‬࿨‫ڬ‬. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇ଩ന࢕ၦ, ઐ५ၦ୆, ౓࢛ࢼ֚, ૩ၦఊ჊, ໌നგ‫ז‬, ષനႃຳ, നಎཆढ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ3D-CTͬဥ̞̹۴࿝໐౨‫੅͈܈ۯ‬ஜૺജഽ૷౯͂਀੅ΏνητȜΏοϋ͈ခဥ㧙115㧙

଻. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. χȜ·ΏοΛί, ີ५, 2012, 7.
Ȇ໌നგ‫ז‬, നಎཆढ, ߧུܽ໲, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ‫׿‬൥ġ ‫ڒ‬ȇ
Stroke volume variation ĩSVVĪġ ͬဥ̞̹۴֊૒ೄࢃ͈੏۪ࠬ‫ס‬ၾ͈ບ‫͈ث‬ခဥ଻. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇઐ५ၦ୆, ౓࢛ࢼ֚, ུ‫ۼ‬ဈਏ, ఱനဢ໹, ૩ၦఊ჊, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇထࢃ֦ঊ̥͙̹ͣ۴࿝໐౨‫̫̤ͥͅ܈ۯ‬borderline resectable. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇ઀࿤ਜࣞ, ኈॄ৽୕, ಿ౓୼૥֚, ఱോġ ܲ, ൥֔ୃ֚, ࿐ఆġ ੔, ઀ाၦং, ཪ࿤ဢ౶,ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇૺ࣐֍‫ۛ܈‬৪̤̫ͥͅ੅ࢃࣣ໵છထ௶֦ঊ͈࠿൦. ల67ٝ඾ུક
‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇള༏֚ܵ, ൥֔ୃ֚, ളᰧġ ੗, ࡼయഛռ, ఱന࣓ဇ, ঌ୼࿭ঃ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇໜ྄ഢ֊ု଻ఱಸ‫͈܈‬ळ໦႒͂হၷ୽ၞ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ΩΥσΟͻΑ
΃ΛΏοϋ, ີ५, 2012, 7.
Ȇ౓࢛ࢼ֚, നಎཆढ, ઐ५ၦ୆, ૩ၦఊ჊, ໌നგ‫ז‬, ߧུܽ໲, ષനႃຳ, ଩ന࢕ၦ, ‫׿‬൥ġ ‫ڒ‬ȇStageԈᦙ‫ͅ܈‬చ̳ͥਬ‫ڠ‬എহၷ̱͈͂̀੅ஜ‫ ڠا‬ĩ༶ৣ஌Īġ ၷ༹͂ࠬ‫ࣣۯ‬໵୨ੰ͈হၷ଼ୡ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇߧུܽ໲, നಎཆढ, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, ‫׿‬൥ġ ‫ڒ‬ȇठอ۴ळ༾‫ͅ܈‬చ̳ͥठ۴୨ੰ੅͈ခ࢘଻. ల67ٝ඾ུક‫شٸܕا‬‫ڠ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇ࿤૜გങ, നಎཆढ, ଩ന࢕ၦ, ષനႃຳ, ໌നგ‫ז‬, ઐ५ၦ୆, ౓࢛ࢼ֚, ߧུܽ໲, ૩ၦఊ჊, ‫׿‬൥ġ ‫ڒ‬ȇໜ࣌‫ئޢ‬۴୨ੰ੅͈হၷ଼ୡ͂ഐ؊‫ڐ‬ఱ͈͒৾ͤழ͙. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ.๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇ઀ाၦং, ਝ५ࢼ၌, ཪ࿤ဢ౶, ളᰧġ ੗, ఱന࣓ဇ, ઀࿤ਜࣞ, ঌ୼࿭ঃ, ࢃ൥ġ ༜, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ๱୨ੰૺ࣐Ȇठอ֍‫̫̤ͥͅ܈‬HER2͈อ࡛͂ႉ઄ພၑ‫ڠ‬എ࠿൦. ల
67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ఱനဢ໹, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬, ષനႃຳ, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ൚‫̫̤ͥͅش‬pT2౨ෙ‫ͅ܈‬చ̳ͥ਀੅଼ୡ͂হၷ୽ၞ. ల67ٝ඾ུક
‫ڠشٸܕا‬ٛ௙ٛ.ີ५, ๊֚‫׵‬ఴ, 2012, 7.
Ȇളᰧġ ੗, ఱന࣓ဇ, ୞໐කআ, ള༏֚ܵ, ५‫܅‬ġ ࿆, ਝ५ࢼ၌, ൥֔ୃ֚, ঌ୼࿭ঃ, ಏ࿤ġ ྶ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫ͼ܈‬τ;ᾼచ̳ͥ੅ஜಸ‫ࡘۯ‬գ͈փ݅. ల67ٝ඾ུક‫ٸܕا‬‫ڠش‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇളᰧġ ੗, ఱന࣓ဇ, ଋངဎၮ, ୞໐කআ, ള༏֚ܵ, ൥֔ୃ֚, བ࠮ࢫ‫ݛ‬, ஐ֔ਜ୹, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫̫̤ͥͅ੅਀܈‬๧‫ئ‬໾ङ৆‫֨ݟ‬ΡτȜϋ͈ခဥ଻ȨίυβϋΏΞͻΑ΋ͺζΛΙϋΈͬဥ̞̹࠿൦ȩ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. අ༆ΓΛΏοϋ,㧙116㧙

ີ५, 2012,7.
Ȇᖸ५੿আ, ߧུܽ໲, ୷ോၦং, ఱന࣓ဇ, നಎཆढ, ਝ५ࢼ၌, Hoffman R, ‫׿‬൥ġ ‫ڒ‬ȇ۴୨ੰ͂ਆន௩૓ͅ‫࠿̳ͥ۾‬൦. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012,7.
Ȇஂᚧဈٚ, ਝུგ࠻, ࣞ୼ġ ၮ, ઀ाၦং, ઀࿤ਜࣞ, ਝ५ࢼ၌, ঌ୼࿭ঃ, ఱ࿤࿆౳, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ֍‫܈‬ळ༾‫͈ڼ‬ζ;ΑਆនκΟσͬဥ̞̹ਆនࠁ଼̤̫ͥͅळ༾ޭ଻
ଷࢄ֦ঊaPKCȜ/Ț͈࿨‫ڬ‬ٜଢ଼. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇུ‫ۼ‬ဈਏ, ઐ५ၦ୆, ౓࢛ࢼ֚, ૩ၦఊ჊, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, ਝ५ࢼ၌, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ౨ෙ‫૷݃܈‬႕ͅచ̳ͥহၷ༷ૻ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇ५ུ૨࿟, ఱന࣓ဇ, ളᰧġ ੗, ള༏֚ܵ, നಎཆढ, ൥֔ୃ֚, ਝ५ࢼ၌, ঌ୼࿭ঃ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫੅਀܈‬শ͈੅ಎໜ࣌ඤ஄૆͂SSI อ୆ထཡ. ల67ٝ඾ུક‫ٸܕا‬‫ڠش‬ٛ௙ٛ. χȜ·ΏοΛί, ີ५, 2012, 7.
Ȇఱനဢ໹, ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ੅ࢃಿ‫ܢ‬ထࢃ̥͙̹ͣᦙ౨‫ࣣۯ‬ၠ։ુછͅచ̳ͥ੅৆஖఼. ల67ٝ඾ུક‫ܕا‬‫ڠشٸ‬ٛ௙ٛ. ΩΥσΟͻΑ΃ΛΏοϋ, ີ५, 2012, 7.
Ȇ‫ུݠ‬ġ ဢ, ਝ५ࢼ၌, ઀ाၦং, ઀࿤ਜࣞ, ୷ോၦং, ఱന࣓ဇ, നಎཆढ, ঌ୼࿭ঃ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇGISTͅచ̳ͥͼζΙΣήহၷ͈࠿൦. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙
ٛ. ါབ‫׵‬ఴ, ີ५, 2012, 7.
Ȇᩊ‫ئ‬ణࢤ, ઐ५ၦ୆, ૩ၦఊ჊, ߧུܽ໲, ࿤૜გങ, ౓࢛ࢼ֚, ໌നგ‫ז‬, നಎཆढ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ۴൲ྤȆ࿝ྤࣣ໵୨ੰ, ΈρέΠठ࠺ঔ࣐̱̹۴࿝໐౨‫܈ۯ‬. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ΫΟ΂ΓΛΏοϋ, ີ५, 2012, 7.
Ȇ࿝ாੇྶ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ໌നგ‫ז‬, ષനႃຳ, നಎཆढ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ൚‫̫̤ͥͅش‬PNET͈হၷ୽ၞ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ါབ‫׵‬ఴ, ີ
५, 2012, 7.
Ȇఆષġ ଢ, ൥֔ୃ֚, ఱന࣓ဇ, ള༏֚ܵ, ࡼయഛռ, ঌ୼࿭ঃ, ఱോġ ܲ, ఱ࿐้౳, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇࣞႢ৪ ĩ85पոષĪġ ఱಸ‫ͅ܈‬చ̳ͥ਀੅଼ୡ͈࠿൦଼͂ୡ࢜ષ͈̹
͈͛చॐ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. χȜ·ΏοΛί, ີ५, 2012, 7.
Ȇऎ൥ġ ߽, ଩ന࢕ၦ, ષനႃຳ, ൥֔ୃ֚, ኈॄ৽୕, २ႊহຳ, ߄ঊġ స, ଩૩֚ढ, ‫׿‬൥ġ ‫ڒ‬ȇ୨ੰະෝᦙȆ౨ൽ‫ͥ͢ͅ܈‬਱ඵঐಸ‫ޛ‬ॏͅచ̳ͥ֍ߗಸΨͼΩΑ੅͂਱ඵঐಸ
ΑΞϋΠၣ౾੅͈๤‫࠿ڛ‬൦. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇႝ࿐૲ဈ, ઀࿤ਜࣞ, ऎ࿤ġ ખ, ऎ൥ġ ߽, ઀ाၦং, ಿ౓୼૥֚, ఱോġ ܲ, ਝ५ࢼ၌,ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇջం৖̥͙̹ۛͣໜ࣌‫ئޢ‬࿽࿝௰֍୨ੰ੅ࢃࣣ໵છထཡॐ. ల67
ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
㧙117㧙

Ȇऎ࿤ġ ખ, ઀࿤ਜࣞ, ಿ౓୼૥֚, ఱോġ ܲ, ൥֔ୃ֚, ኈॄ৽୕, ઀ाၦং, ཪ࿤ဢ౶,ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ൚̤̫֭ͥͅໜ࣌‫֍ئޢ‬஠ഊ੄੅̤̫ͥͅठ࠺༹͈ࢥຳ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ΫΟ΂ΓΛΏοϋ, ີ५, 2012, 7.
Ȇଋངဎၮ, ఱന࣓ဇ, ࢃ൥ġ ༜, ളᰧġ ੗, ള༏֚ܵ, നಎཆढ, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇޫਫ਼ૺ࣐ೄಸ‫ͅ܈‬చ̳ͥTS-1/Irinotecan/Cetuximab໵ဥ੅ஜ‫ڠا‬༶ৣ஌ၷ༹͈
ႉ઄లԅ௖দࡑ଼͈ୡ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇ‫ٳ‬ന᥽໹, ࿐ఆ‫ྶם‬, ‫׿‬൥ġ ‫ڒ‬ȇࣞႢ৪೟ន଻ఱಸ‫੅̫̤ͥͅ׶‬৆஖఼͈࿚ఴത. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇ֔ષ‫ם‬๼, ఱന࣓ဇ, ଋངဎၮ, ളᰧġ ੗, ള༏֚ܵ, നಎཆढ, ൥֔ୃ֚, ਝ५ࢼ၌, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇໜ࣌‫಼ئޢ‬೩պஜ༷୨ੰ੅̤̫ͥͅᥬ࿝௰ಸ‫ْ͈ࠗۯ‬എ໦‫ڬ‬୨ੰ଼༹͈༷͂ୡ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ΫΟ΂ΓΛΏοϋ, ີ५, 2012, 7.
Ȇࡔനġ ֘, ఱന࣓ဇ, ളᰧġ ੗, ള༏֚ܵ, ൥֔ୃ֚, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇໜ࣌‫ࠫئޢ‬ಸ୨ੰ੅̤̫ͥͅ੅ஜVFA௶೰͈ခဥ଻. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ
५, 2012, 7.
Ȇგന༸ঊ, ኈॄ৽୕, ಿ౓୼૥֚, ઀࿤ਜࣞ, ఱോġ ܲ, ൥֔ୃ֚, ཪ࿤ဢ౶, ઀ाၦং,ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ֍‫܈‬হ࿴୨ੰ႕̤̫ͥͅS-1੅ࢃ༞੩‫ڠا‬ၷ༹ࢃ͈ठอςΑ·ͅ‫۾‬̳ͥ࠿൦. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇ଩ଽජೋঊ, ఱന࣓ဇ, ‫׿‬൥ġ ‫ڒ‬ȇ࿋ಸࡔอ MALTςϋΩਆ͈֚႕. ల67ٝ඾ུક‫ٸܕا‬‫ڠش‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇ፜ఆġ ࠲, ࢃ൥ġ ༜, ऎ൥ġ ၦ, ܲോ૬ୱ, ࿐ఆྔၖঊ, ୷ോၦং, ઀ႅܰੇ, ࣞ‫ࢤޘ‬გ,ߦനࡋ༟, ಎോġ ੓, ஜനġ ᐤ, ‫׿‬൥ġ ‫ڒ‬, ਝ५ࢼ၌, നಎཆढȇᦙ௫΄ΑΠςΦȜζ̀ͅȂDOTATOCၷ༹̦ခ̜̹࢘́̽છ႕̞̾̀ͅ. ల10ٝ඾ུႉ઄ਆន‫ڠ‬ٛ‫੅ڠ‬ਬٛ, εΑΗȜΓΛΏοϋ, ఱि, 2012, 7.
Ȇ‫ݛ‬༗ฎ֚, ఱോġ ܲ, ࡔന૯ࢁ, ാന౶ঃ, ઀࿤ਜࣞ, ൥֔ୃ֚, ໛ോ಑౳, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ֍‫଻بࢃ੅܈‬۴൲ྤរ෫Ⴈ͈ 1႕. ల826ٝ‫شٸ‬ਬ౬ٛ. ๊֚‫׵‬ఴ, ̩̾͊, 2012,9.
Ȇ२ၣġ ఽ, ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ऎ࿤ġ ખ, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬, നಎཆढ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇਆរࠁ଼Ȃ౨‫ۯ‬৔੕Ȃ౨‫ۯ‬ඤอ͈֗ 3߿̦ईह̱̹۴ඤ౨
‫ ͈܈ۯ‬1႕. ల826ٝ‫شٸ‬ਬ౴ٛ. ๊֚‫׵‬ఴ, ̩̾͊, 2012, 9.
ȆChishima T, Momiyama M, Zhao M, Hiroshima Y, Suetsugu A, Tome Y, Mii S, Yano S, Bouvet
M, Endo I, Hoffman RM : Treatment of human glioma with tumor-targeting geneticallyengineered Salmonella typhimurium in orthotopic mouse models. ల71ٝ඾ུ‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ, εΑΗȜ, ढ़ི, 2012, 9.
ȆHasegawa S, Momiyama M, Hiroshima Y, Suetsugu A, Tome Y, Mii S, Yano S, Chishima T,
㧙118㧙Bouvet M, Endo I, Hoffman RM : Treatment of brain tumors in nude mice with intra-cranial
UV irradiation. ల71ٝ඾ུ‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ, εΑΗȜ, ढ़ི, 2012. 9.
ȆMomiyama M, Hiroshima Y, Suetsugu A, Tome Y, Mii S, Yano S, Bouvet M, Chishima T, Endo
I, Hoffman RM : Highly-effective resection of orthotopic human glioma by fluorescenceguided surgery in nude mice. ల71ٝ඾ུ‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ, εΑΗȜ, ढ़ི, 2012, 9.
Ȇ‫ܔ‬ఉ‫ݛ‬๼ঊ, ୞୼ġ ࢣ, ൌനგฎ, ଼֚֔ၦ, ୄକఱ༟, ന༏๼ਏঊ, ऎș࿐‫ܧ‬, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇTriple negative ඿‫ڠا̫̤ͥͅ܈‬ၷ༹ఛ଻͂cancer stemcell ͅ‫ݪࡄ̳ͥ۾‬.
ల71ٝ඾ུ‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ. ๊֚‫׵‬ఴ, ढ़ི, 2012, 9.
Ȇ૩ၦఊ჊ȇ౨ൽ‫ͅ܈‬చ̳ͥ੅ஜ‫ڠا‬ၷ༹ͥ͢ͅ۴વ‫࠿͈ٺ‬൦. ల48ٝ඾ུ౨ൽ‫ڠ‬ٛ‫੅ڠ‬
ਬٛ. ๊֚‫׵‬ఴ, ൐‫ނ‬, 2012, 9.
Ȇ઀ाၦং, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ൚‫̫̤ͥͅش‬clinical T4 ĩAIĪġ ૙ൽ‫ͅ܈‬చ̳ͥহၷ଼ୡ.
ల84ٝ඾ུક‫ܕا‬ඤণ‫ڠޢ‬ٛ௙ٛ JDDW. εΑΗȜ, ૰࡫, 2012, 10.
Ȇനಎཆढ, ߧུܽ໲, ‫׿‬൥ġ ‫ڒ‬ȇ‫ݴ‬ఱ̜̞͉ͥ‫ئ‬ఱ୓ྤ୓ྤਆន஀ฺ̠ͬ۴ळ༾‫܈‬୨ੰ̤̫ͥͅ‫ࣸޝ‬ਸ୨‫ٳ‬Ȇ۴ષ໐‫ئ‬ఱ୓ྤ୶࣐ΞȜάϋΈ͈ခဥ଻. ల20ٝ඾ུક‫شٸܕا‬‫ڠ‬ٛఱٛ JDDW. Ώϋεΐ;θ, ૰࡫, 2012, 10.
Ȇఱന࣓ဇ, ൥֔ୃ֚, ‫׿‬൥ġ ‫ڒ‬ȇೄಸ‫܈‬௰༷ςϋΩ୯ഢ֊૷౯̤̫ͥͅMRI͈ခဥ଻͂
࿚ఴത. ల20ٝ඾ུક‫ڠشٸܕا‬ٛఱٛ JDDW. Ώϋεΐ;θ, ૰࡫, 2012, 10.
Ȇ࿐ఆ‫ྶם‬, ଩നġ ઎, ଋངࢤგ, ࣞ‫ޘ‬స঄, ള༏֚ܵ, ଫࢺ೭‫ހ‬, Ḷ൥ਘহ, ߦനġ ഔ, ઀߄֚֔ၦ, ൥֔ୃ֚, ఱന࣓ဇ, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇ‫ز‬௼଻ఱಸஏਆછͅచ̳ͥఱಸ୨
ੰࢃ͈ಿ‫ܢ‬ထࢃ. ల20ٝ඾ུક‫ڠشٸܕا‬ٛఱٛ JDDW. εΑΗȜ, ૰࡫, 2012, 10.
Ȇ໌നგ‫ז‬, നಎཆढ, ߧུܽ໲, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ‫׿‬൥ġ ‫ڒ‬ȇ൚͈֭́୆ఘ۴֊૒̤̫ͥͅᦃ௫ഊ੄ࢃ͈෹‫ࣣ׶‬໵ͅచ̳ͥ࠿൦. ల20ٝ඾ུક‫شٸܕا‬‫ڠ‬ٛఱٛ JDDW. εΑΗȜ, ૰࡫, 2012, 10.
Ȇઐ५ၦ୆, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ۴࿝໐౨‫̫̤ͥͅ੅਀܈ۯ‬3D-CT triadgraphyͬဥ̞̹਀੅ΏηντȜΏοϋ. ల20ٝ඾ུક‫ڠشٸܕا‬ٛఱٛ JDDW. Ώϋεΐ;θ, ૰࡫,2012, 10.
Ȇߧུܽ໲, നಎཆढ, ࿤૜გങ, ളᰧġ ੗, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, ఱന࣓ဇ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ۴ळ༾‫͈ࢃ੅܈‬༞੩‫ڠا‬ၷ༹̱͂̀
͈ͼϋΗȜέͿυϋ໵ဥ5FU൲ಕ‫ڠا‬ၷ༹͈ခဥ଻. ల20ٝ඾ུક‫ڠشٸܕا‬ٛఱٛ
JDDW. εΑΗȜ, ૰࡫, 2012, 10.
Ȇ࿤૜გങ, നಎཆढ, ५ུ૨࿟, Ꭲോࢨ຃, ಎ୼გ࿟, ᩊ‫ئ‬ణࢤ, ໌നგ‫ז‬, ߧུܽ໲, ଩ന࢕ၦ, ષനႃຳ, ઐ५ၦ୆, ౓࢛ࢼ֚, ૩ၦఊ჊, ളᰧġ ੗, ఱന࣓ဇ, ਝ५ࢼ၌, ‫׿‬൥ġ‫ڒ‬ȇ۴ळ༾‫܈‬୨ੰ႕͈੅ࢃໜକอ୆‫֦ࡏܓ‬ঊ̞͈̾̀ͅ࠿൦. ల20ٝ඾ུક‫ڠشٸܕا‬ٛఱٛ JDDW. εΑΗȜ, ૰࡫, 2012, 10.
㧙119㧙Ȇളᰧġ ੗, ఱന࣓ဇ, ‫׿‬൥ġ ‫ڒ‬ȇ੅ஜࠐ࢛‫ူו‬༞੩सൎဓ଼̤̫ͥͅ໦༆֍ෳᘩশ‫͈ۼ‬‫ܖ‬யഎ࠿൦. ల20ٝ඾ུક‫ڠشٸܕا‬ٛఱٛ JDDW. ΩΥσΟͻΑ΃ΛΏοϋ, ૰࡫,2012, 10.
Ȇ‫ུݠ‬ġ ဢ, ኈॄ৽୕, ఱ೓ဉ֚, ࣞ‫ୃޘ‬੗, ࣞ୼ġ ၮ, Ⴎനࢫ֚჊, ܹന‫૾ݛ‬჊, ཪ࿤ဢ౶, ઐനࢅ჊, ५࢛ೄࢣ, ૰౓‫ܮ‬෗, ఆષġ ଢ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇआহ୨ੰࢃ֍GIST͈ठอ‫֦ࡏܓ‬ঊ͈࠿൦. ల20ٝ඾ུક‫ڠشٸܕا‬ٛఱٛ JDDW. εΑΗȜ, ૰࡫, 2012, 10.
Ȇ໹౓ୄࢁ, ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ੅ஜ‫ڠا‬ၷ༹ಎͅಠྴ̈́ডཛ۴ͬ೮̱̹۴࿝໐౨‫ ͈܈ۯ‬1 ୨ੰ႕. ల20ٝ඾ུક‫ڠشٸܕا‬ٛఱٛ JDDW. εΑΗȜ, ૰࡫, 2012, 10.
Ȇଋངဎၮ, ఱന࣓ဇ, ളᰧġ ੗, ള༏֚ܵ, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇೄಸ‫੅܈‬ஜ͈‫ܥ‬٫എಸ‫ۯ‬ஜੜ౾͈࠿൦. ల20ٝ඾ུક‫ڠشٸܕا‬ٛఱٛ JDDW. εΑΗȜ, ૰࡫,2012, 10.
Ȇგന༸ঊ, ള༏֚ܵ, ളᰧġ ੗, ୞໐කআ, ࡼయഛռ, ఱോġ ܲ, ఱന࣓ဇ, ൥֔ୃ֚, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ୨ੰະෝૺ࣐Ȇठอఱಸ‫͈܈‬ထࢃ֦ঊ̥͙̹ͣহၷ୽ၞ. ల20ٝ඾ུક‫ڠشٸܕا‬ٛఱٛ JDDW. εΑΗȜ, ૰࡫, 2012, 10.
Ȇࡔനġ ֘, ࿤૜გങ, ߧུܽ໲, ໌നგ‫ז‬, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ۴ࡔอ૰ࠐඤ໦๥‫ ͈܈‬1 ႕. ల20ٝ඾ུક‫ڠشٸܕا‬ٛఱٛ JDDW. εΑΗȜ,૰࡫, 2012, 10.
Ȇ൥֔ୃ֚, ୞໐කআ, ള໐ġ ࡐ, ളᰧġ ੗, ള༏֚ܵ, ఱന࣓ဇ, ঌ୼࿭ঃ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ76पոષ಼ࣞႢ৪ stageIIIఱಸ‫ͅ܈‬చ̳ͥ੅ࢃ༞੩‫ڠا‬ၷ༹͈փ݅. ඾ུ‫܈‬হၷ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. εΑΗȜ, ‫؍‬ຩ, 2012, 10.
Ȇനಎཆढ, ࿤૜გങ, ᩊ‫ئ‬ణࢤ, ಎ୼გ࿟, ߧུܽ໲, ໌നგ‫ז‬, ఱന࣓ဇ, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇ୨ੰະෝఱಸ‫܈‬۴ഢ֊ͅచ̳ͥ‫ڠا‬ၷ༹‫͈́ئ‬۴୨ੰ୽ၞ. ల50ٝ඾ུ‫܈‬হၷ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. Ώϋεΐ;θ, ‫؍‬ຩ, 2012, 10.
Ȇ઀࿤ਜࣞ, ኈॄ৽୕, ಿ౓୼૥֚, ఱോġ ܲ, ൥֔ୃ֚, ࣞ୼ġ ၮ, ࿐ఆġ ੔, ઀ाၦং,ཪ࿤ဢ౶, ୔൥૯ၐ, ਝ५ࢼ၌, ૩ന౺ণ, ‫׿‬൥ġ ‫ڒ‬ȇໜ࣌‫ޢ‬༞੩‫֍ئ‬୨ੰ੅͈ಿ‫଼ܢ‬ୡ͈࠿൦. ల50ٝ඾ུ‫܈‬হၷ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. εΑΗȜ, ‫؍‬ຩ, 2012, 10.
Ȇ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ఱനဢ໹, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬, നಎཆढ, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇ୨ੰະෝૺ࣐Ȇठอ౨ൽ‫ͅ܈‬చ̳ͥS-1+irinotecan໵ဥၷ༹͈հ஠଻
͂ခ࢘଻ͅ‫࠿̳ͥ۾‬൦. ల50ٝ඾ུ‫܈‬হၷ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. εΑΗȜ, ‫؍‬ຩ, 2012, 10.
Ȇ୞໐කআ, ൥֔ୃ֚, ള໐ġ ࡐ, ളᰧġ ੗, ള༏֚ܵ, ఱന࣓ဇ, ࡼయഛռ, ఱോġ ܲ, ঌ୼࿭ঃ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ76पոષ಼ࣞႢ৪stageԇఱಸ‫ͅ܈‬చ̳ͥ੅ࢃ༞੩‫ڠا‬ၷ༹͈փ݅. ల50ٝ඾ུ‫܈‬হၷ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. εΑΗȜ, ‫؍‬ຩ, 2012, 10.
Ȇུ‫ۼ‬ဈਏ, ౓࢛ࢼ֚, ઐ५ၦ୆, ಎᚧୃා, ఆષġ ଢ, ૩ၦఊ჊, ߧུܽ໲, ࿤૜გങ, ໌㧙120㧙നგ‫ז‬, ષനႃຳ, ঌ୼࿭ঃ, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇᦙ‫ۛ܈‬৪̤̫ͥͅ‫ڠا‬ၷ༹ͥ͢ͅ྾
‫ע‬ෝ͈་‫ا‬. ల50ٝ඾ུ‫܈‬হၷ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. εΑΗȜ, ‫؍‬ຩ, 2012, 10.
Ȇ൥֔ୃ֚, ୞໐කআ, ള໐ġ ࡐ, ളᰧġ ੗, ള༏֚ܵ, ఱന࣓ဇ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬, ঌ୼࿭ঃ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇReduced port surgeryͥ͢ͅໜ࣌‫گئޢ‬࿩޼‫ۼ‬୨ੰ੅͈਀
ܿ. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. ๊֚‫׵‬ఴ, ໛‫ؖ‬, 2012, 11.
Ȇఱന࣓ဇ, ളᰧġ ੗, ൥֔ୃ֚, ଋངဎၮ, ୞໐කআ, ࿤૜გങ, നಎཆढ, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇඤಸࣸࠬ‫ྎۯ‬ઑႀ֖ͅೄ୪ͺίυȜΙ̳ͥໜ࣌‫ئޢ‬௰༷ςϋΩ୯‫ڜ‬ୄ༹͈༷.
ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. ๊֚‫׵‬ఴ, ໛‫ؖ‬, 2012, 11.
Ȇఱന࣓ဇ, ളᰧġ ੗, ൥֔ୃ֚, ଋངဎၮ, ୞໐කআ, ࿤૜გങ, നಎཆढ, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇISR̤̫ͥͅ੅ࢃෳ༒‫ܥ‬ෝ٨஝ͬ࿒എ̱̹͂ັ‫੅਀ح‬ȇ๧‫ٸئ‬ᥬ࿝‫گ‬࿩޼ςέΠ଼͈ୡ. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. ๊֚‫׵‬ఴ, ໛‫ؖ‬, 2012, 11.
Ȇള༏֚ܵ, ఱന࣓ဇ, ളᰧġ ੗, ୞໐කআ, നಎཆढ, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇૺ࣐‫ئ‬໐ೄಸȆᥬ࿝‫͈܈ۯ‬হၷ଼ୡ̥͙̹ͣ੅ஜ‫ڠا‬༶ৣ஌ၷ༹͈࡛ે͂‫ه‬ఴ. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. ๊֚‫׵‬ఴ, ໛‫ؖ‬, 2012, 11.
Ȇ࿤૜გങ, നಎཆढ, ఱന࣓ဇ, ໌നგ‫ז‬, ષനႃຳ, ઐ५ၦ୆, ౓࢛ࢼ֚, ߧུܽ໲, ૩ၦఊ჊, ള༏֚ܵ, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫܈‬۴ഢ֊ͅచ̳ͥহၷ୽ၞ. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. Ώϋεΐ;θ, ໛‫ؖ‬, 2012, 11.
Ȇളᰧġ ੗, ఱന࣓ဇ, ଋངဎၮ, ୞໐කআ, ള༏֚ܵ, നಎཆढ, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇໜ࣌‫ئޢ‬೩պஜ༷୨ੰ੅̤̫ͥͅ੅ஜໜ࣌ඤডཛ࿂ୟ௶೰͈ခဥ଻. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. ါབ‫׵‬ఴ, ໛‫ؖ‬, 2012, 11.
Ȇള໐ġ ࡐ, ൥֔ୃ֚, ߄ᚧġ ਔ, ୞໐කআ, ളᰧġ ੗, ള༏֚ܵ, ࡼయഛռ, ఱന࣓ဇ, ঌ୼࿭ঃ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇૺ࣐‫ئ‬໐ೄಸ‫ͅ܈‬చ̳ͥ઀‫ٳ‬ໜ͈́௰༷‫ڜ‬ୄͬဥ̞̹ໜ
࣌‫ޢ‬༞੩‫ئ‬ೄಸ́ೄಸ୨ੰ੆͈࠿൦. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. ๊֚‫׵‬ఴ, ໛‫ؖ‬, 2012, 11.
Ȇ࿝ாੇྶ, ঌ୼࿭ঃ, ള༏֚ܵ, ఱന࣓ဇ, നಎཆढ, ൥֔ୃ֚, ֞५‫ྶد‬, ‫׿‬൥ġ ‫ڒ‬ȇೄ
ಸMALTςϋΩਆ͈ 1႕. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ. εΑΗȜ, ໛‫ؖ‬, 2012, 11.
Ȇႝ࿐૲ဈ, ള༏֚ܵ, ࡼయഛռ, ളᰧġ ੗, ୞໐කআ, ఱന࣓ဇ, ൥֔ୃ֚, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇཌྷΑΠζΰσΣͺอછ̤̫ͥͅ‫֦ࡏܓ‬ঊ͈࠿൦. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫ڠ‬੅ਬٛ. εΑΗȜ, ໛‫ؖ‬, 2012, 11.
Ȇଫࢺ೭‫ހ‬, ୞୼ġ ࢣ, ‫ݛ‬༗ඤ࢕֚, ാ֔సঊ, ຒ‫ؚࣝ‬ຠ, ઐ‫ݠ‬આ຃, ส਱ോ࿷֚, ฒ֔ġં, ࿐ఆฎგ, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇ໹଼22ාഽ‫؍‬ຩঌ඿̦ͭ࠿૷͈࡛ે. ηΣΟͻΑ
΃ΛΏοϋ, ల22ٝ඾ུ඿‫ڠ૷࠿܈‬ٛ‫੅ڠ‬௙ٛ. ဓ࿤ს, 2012, 11.
Ȇ‫ܔ‬ఉ‫ݛ‬๼ঊ, ୞୼ġ ࢣ, ൌനგฎ, ଼֚֔ၦ, ୄକఱ༟, ന༏๼ਏঊ, ऎș࿐‫ܧ‬, ୷ോၦং, ‫׿‬൥ġ ‫ڒ‬ȇ඿‫܈‬΍ήΗͼί༆͈อࡉࠀ‫ْ͂ܥ‬௨ਫ਼ࡉ͈අಭ. ల22ٝ඾ུ඿‫ڠ૷࠿܈‬㧙121㧙

ٛ‫੅ڠ‬௙ٛ. ๊֚‫׵‬ఴ, ‫ؗ‬ථ, 2012, 11.
Ȇ൥֔ୃ֚, ୞໐කআ, ള໐ġ ࡐ, ളᰧġ ੗, ള༏֚ܵ, ఱന࣓ဇ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬, നߪୃၦ, ૩ന౺ণ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫ͅ܈‬చ̳ͥReduced port surgery ĩRPSĪġ ͈ౣ‫ܢ‬Ȇಿ‫ܢ‬଼ୡȇPropensity scoreͥ͢ͅColon lifting-up technique ĩCLTĪġ ͬဥ̞̹RPS͂ఉࢢ৆਀੅
‫͈ۼ‬Case-matched study. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. Ώϋεΐ;θ, ૧਽, 2012, 11.
Ȇനಎཆढ, ߧུܽ໲, ᩊ‫ئ‬ణࢤ, ಎ୼გ࿟, ࿤૜გങ, ౓࢛ࢼ֚, ໌നგ‫ז‬, ‫׿‬൥ġ ‫ڒ‬ȇૺ࣐۴ळ༾‫ͅ܈‬చ̳ͥ֒ॼພ௏͈͒ັ‫ح‬হၷͬஜ೹̱̹͂ࡘၾ۴୨ੰ͈փ݅. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. χȜ·ΏοΛί, ૧਽, 2012, 11.
Ȇനಎཆढ, ࿤૜გങ, ߧུܽ໲, ᩊ‫ئ‬ణࢤ, ಎ୼გ࿟, ౓࢛ࢼ֚, ໌നგ‫ז‬, ള༏֚ܵ, ఱന࣓ဇ, ‫׿‬൥ġ ‫ڒ‬ȇ۴໐‫ئ‬ఱ୓ྤࣣ໵୨ੰฺ̠ͬ஠๶ેဩ+ֲ۴֚‫̫̤ͥͅگ‬Hanging
maneuver͈ခဥ଻. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. ΫΟ΂Ώϋε, ૧਽, 2012, 11.
Ȇ໌നგ‫ז‬, നಎཆढ, ߧུܽ໲, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ‫׿‬൥ġ ‫ڒ‬, നಎ࿻‫ح‬, ఱ౲ਜਏȇ۴֊૒ࢃ͈΍ͼΠι΄υ;ͻσΑۜஅͅచ̱ȂςϋΩ‫ݩ‬ईࣣঁࠣদ
ࡑͬ‫̹͛܄‬ਬ‫ڠ‬എহၷ̦ு̱̹ࢗ 1 ႕. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ૧਽,2012, 11.
Ȇઐ५ၦ୆, ౓࢛ࢼ֚, ૩ၦఊ჊, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬, ષനႃຳ, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇထࢃ֦ঊ̥ͣࡉ̹۴࿝໐౨‫͈܈ۯ‬হၷ୽ၞ. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. Ώ
ϋεΐ;θ, ૧਽, 2012, 11.
Ȇ઀࿤ਜࣞ, ኈॄ৽୕, ാന౶ঃ, ఱോġ ܲ, ൥֔ୃ֚, ࣞ୼ġ ၮ, ࿐ఆġ ੔, ઀ाၦং, ཪ࿤ဢ౶, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇٝ໘֍୨ੰ̤̫ͥͅ੅ࢃࣣ໵છထ௶֦ঊ͈࠿൦. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. Ώϋεΐ;θ, ૧਽, 2012, 11.
Ȇ౓࢛ࢼ֚, ઐ५ၦ୆, ૩ၦఊ჊, ໌നგ‫ז‬, ߧུܽ໲, ࿤૜გങ, ષനႃຳ, ਝ५ࢼ၌, നಎཆढ, ஜ୼ඵ჊, ‫׿‬൥ġ ‫ڒ‬ȇޫਫ਼ૺ࣐ᦙ‫ͅ܈‬చ̳ͥ൲ྤࣣ໵୨ੰ͈হၷ଼ୡ. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ૧਽, 2012, 11.
Ȇള༏֚ܵ, ఱന࣓ဇ, ႝ࿐૲ဈ, ളᰧġ ੗, ୞໐කআ, നಎཆढ, ਝ५ࢼ၌, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇૺ࣐Raೄಸ‫ͅ܈‬చ̳ͥໜ࣌‫͈੅਀ئޢ‬ഐ؊. ๊֚‫׵‬ఴ, ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. ૧਽, 2012, 11.
Ȇߧུܽ໲, നಎཆढ, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ષനႃຳ, ໌നგ‫ז‬, ‫׿‬൥ġ ‫ڒ‬ȇ൚‫̫̤ͥͅش‬ໜ࣌‫ئޢ‬۴୨ੰ੅͈হၷ଼ୡ. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ૧਽, 2012, 11.
Ȇ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ऎș࿐૯ၑ, ఱനဢ໹, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬,നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇPET͈ခဥ଻͂࿚ఴത. ါབ‫׵‬ఴ, ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ.
૧਽, 2012, 11.
Ȇ଼֚֔ၦ, ୞୼ġ ࢣ, ୄକఱ༟, ൌനგฎ, ‫ܔ‬ఉ‫ݛ‬๼ঊ, ऎș࿐૯ၑ, ఊന֘ঊ, ࿐ඤࢨ෗㧙122㧙੩, ଫࢺ೭‫ހ‬, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇ඿‫܈‬๓‫ܢ‬ठอછ႕͈࠿൦Ƚ੅ࢃྫठอ‫ ۼܢ‬5 ාոષ͂ 5 ාྚྖ͈๤‫ڛ‬Ƚ. ΩΥσΟͻΑ΃ΛΏοϋ, ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. ૧਽,2012, 11.
Ȇ୞໐කআ, ൥֔ୃ֚, ള໐ġ ࡐ, ߄ᚧġ ਔ, ളᰧġ ੗, ള༏֚ܵ, ఱന࣓ဇ, ఱോġ ܲ, ໛ോ಑౳, ঌ୼࿭ঃ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇໜ࣌‫ئޢ‬ఱಸ୨ੰ੅͈੅ಎఈ௫‫ܕ‬૫੕฻ྶછ႕
͈࠿൦. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ૧਽, 2012, 11.
Ȇႝ࿐૲ဈ, ള༏֚ܵ, ളᰧġ ੗, ୞໐කআ, ఱന࣓ဇ, ൥֔ୃ֚, നಎཆढ, ਝ५ࢼ၌, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫੅܈‬ஜ͈૬໐୓ྤࠬ஀છΑ·ςȜΣϋΈ̤̫ͥͅDΘͼζȜ͈
փ݅. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ૧਽, 2012, 11.
Ȇ໹౓ୄࢁ, ઐ५ၦ୆, ౓࢛ࢼ֚, ૩ၦఊ჊, ࿤૜გങ, ߧུܽ໲, ໌നგ‫ז‬, ષനႃຳ, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇྎઑ߿۴ඤ౨‫͂܈ۯ‬۴࿝߿۴ඤ౨‫͈܈ۯ‬ႉ઄ພၑഎ։൳. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ૧਽, 2012, 11.
Ȇᩊ‫ئ‬ణࢤ, നಎཆढ, ࿤૜გങ, ߧུܽ໲, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ໌നგ‫ז‬, ఱന࣓ဇ, ਝ५ࢼ၌, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫܈‬۴ഢ֊ͅచ̳ͥ۴൲ಕ·υΦΓράȜ͈
଼ୡ. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ૧਽, 2012, 11.
Ȇ֔ષ‫ם‬๼, ઐ५ၦ୆, ࡔനġ ֘, ଋངဎၮ, ૩ၦఊ჊, ߧུܽ໲, ࿤૜გങ, ౓࢛ࢼ֚, ໌നგ‫ז‬, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ‫̈́ܭ‬౨ෙ‫ࣣۯ‬ၠအ৆ͬ੅ஜ૷౯̧̹́ 2 ႕. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ૧਽, 2012, 11.
Ȇࡔന૯ࢁ, ኈॄ৽୕, ‫ݛ‬༗ฎ֚, ാന౶ঃ, ઀࿤ਜࣞ, ఱോġ ܲ, ໛ോ಑౳, ൥֔ୃ֚, ‫׿‬൥ġ ‫ڒ‬ȇ֍‫ ࢃ੅܈‬5 ා࿒ͅࢩํս̈́ໜ༃ഢ֊ͬြ̹̱̹ 1 ႕. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ
௙ٛ. ๊֚‫׵‬ఴ, ૧਽, 2012, 11.
Ȇ‫ࢫࡔڦ‬໹, ઐ५ၦ୆, ໌നგ‫ז‬, ౓࢛ࢼ֚, ߧུܽ໲, ૩ၦఊ჊, ࿤૜გങ, നಎཆढ, ֞५‫ྶد‬, ‫׿‬൥ġ ‫ڒ‬ȇ۴ෟន́อછ̱۴࿝໐౨‫ۻ͈͂܈ۯ‬༆̦ࣾඳ̜̹́̽IgG4‫۾‬Ⴒࣁ‫ا‬଻౨‫ ͈׶ۯ‬1୨ੰ႕. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ૧਽, 2012, 11.
Ȇఱୌġ ಐ, ઀࿤ਜࣞ, ‫ݛ‬༗ฎ֚, ࡔന૯ࢁ, ఱ५ႃ౳, ാന౶ঃ, ఱോġ ܲ, ൥֔ୃ֚, ኈॄ৽୕, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇૺ࣐֍‫ͅ܈‬చ̳ͥໜ࣌‫֍ئޢ‬୨ੰ੅͈ခဥ଻. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. Ώϋεΐ;θ, ૧਽, 2012, 11.
Ȇള໐ġ ࡐ, ൥֔ୃ֚, ߄ᚧġ ਔ, ୞໐කআ, ളᰧġ ੗, ള༏֚ܵ, ࡼయഛռ, ఱന࣓ဇ, ঌ୼࿭ঃ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇໜ࣌‫ئޢ‬ऒ௰ࠫಸ‫܈‬Ȇષ໐ೄಸ‫̫̤ͥͅ੅਀܈‬ΡτȜϋၣ౾͈ຈါ଻͈࠿൦. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. εΑΗȜ, ૧਽, 2012, 11.
Ȇള༏֚ܵ, ఱന࣓ဇ, ႝ࿐૲ဈ, ളᰧġ ੗, ୞໐කআ, നಎཆढ, ਝ५ࢼ၌, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫੅܈‬ஜC.difficile toxinΑ·ςȜΣϋΈ͈փ݅. ల25ٝ඾ུ‫ۜشٸ‬அછ‫ڠ‬ٛ௙ٛ. ါབ‫׵‬ఴ, ୷ဩ, 2012, 11.
Ȇ࿝ாੇྶ, ઐ५ၦ୆, ऎș࿐૯ၑ, ૩ၦఊ჊, ߧུܽ໲, ࿤૜გങ, ౓࢛ࢼ֚, ໌നგ‫ז‬,
㧙123㧙നಎཆढ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇEndotoxin Activity Assay ĩEAAĪġ ͥۜ͢ͅஅછ͈ਹછ‫ا‬ထ௶͈࠿൦. ల25ٝ඾ུ‫ۜشٸ‬அછ‫ڠ‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ୷ဩ, 2012, 11.
Ȇ५ॄ‫ף‬య, ߧུܽ໲, നಎཆढ, ષനႃຳ, ໌നგ‫ז‬, ઐ५ၦ୆, ౓࢛ࢼ֚, ࿤૜გങ, ૩ၦఊ჊, ‫׿‬൥ġ ‫ڒ‬ȇ੅ஜ૷౯‫خ‬ෝ̜̹́̽΄ȜΔ΂Ȝζ͈ 1 ႕. ల135ٝ૰ජ୼ࡇႉ઄‫ٸ‬‫ڠ֓ش‬ٛਬ౴ٛ. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 12.
Ȇଫࢺ೭‫ހ‬, ୷ോၦং, ࿐ఆྔၖঊ, ऎș࿐૯ၑ, ‫ܔ‬ఉ‫ݛ‬๼ঊ, ൌനგฎ, ଼֚֔ၦ, ५ಎୃඵ, ֞५‫ྶد‬, ୞୼ġ ࢣ, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇ੅ࢃ 9 ා࿒ͅକଅછ́อછ̱̹ठอ඿‫܈‬͈ 1႕. ల 9ٝ඾ུ඿‫ڠ܈‬ٛ‫۾‬൐౷༷ٛ. ๊֚‫׵‬ఴ, ఱ‫ݠ‬, 2012, 12.
Ȇ൥֔ୃ֚, ୞໐කআ, ള໐ġ ࡐ, ളᰧġ ੗, ള༏֚ܵ, ఱന࣓ဇ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇࣞഽ๬ྖછ႕ ĩBMI>30Īġ ͈́ໜ࣌‫ئޢ‬ೄಸ਀੅͈ࢥຳȇHALS͈؊ဥ. ల25ٝ඾ུඤণ‫ޢ‬‫ڠشٸ‬ٛ௙ٛ. ါབ‫׵‬ఴ, ‫؍‬ຩ, 2012, 12.
Ȇളᰧġ ੗, ఱന࣓ဇ, ଋངဎၮ, ୞໐කআ, ള༏֚ܵ, നಎཆढ, ਝ५ࢼ၌, ൥֔ୃ֚, ஐ֔ਜ୹, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇౙࢢ৆ໜ࣌‫ئޢ‬ఱಸ‫͈ࠧ੅਀܈‬ത͈࣪໚͈দ͙. ల25ٝ඾ུඤণ‫ڠشٸޢ‬ٛ௙ٛ. ါབ‫׵‬ఴ, ‫؍‬ຩ, 2012, 12.
Ȇఱ५ႃ౳, ኈॄ৽୕, ‫ུ֚ܵޘ‬, ઀࿤ਜࣞ, ാന౶ঃ, ఱോġ ܲ, ൥֔ୃ֚, ໛ോ಑౳, ‫׿‬൥ġ ‫ڒ‬ȇ੅ஜͅໜ྄෥ਅ̹ͬ݃̽ࡔอ଻ߗಸ‫ ͈܈‬1 ႕. ల827ٝ‫شٸ‬ਬ౴ٛ. ๊֚‫׵‬ఴ,൐‫ނ‬, 2012, 12.
Ȇࢃ൥ࢴ‫ܮ‬, ઀ाၦং, ള༏֚ܵ, ఱന࣓ဇ, ঌ୼࿭ঃ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇWeekly
PTX+ΧȜΓίΙΰಿ‫ܢ‬୆ంͬං̹֍‫܈‬୨ੰࢃໜ྄෥ਅठอ͈ 1 ႕. ల827ٝ‫شٸ‬ਬ౴
ٛ. ๊֚‫׵‬ఴ, ൐‫ނ‬, 2012, 12.

ɟġ ࡄġ ‫ݪ‬ġ ٛġȆള༏֚ܵ, ൥֔ୃ֚, ള༏ġ ੗, ࡼయഛռ, ఱന࣓ဇ, ঌ୼࿭ঃ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇழ૕߿̥͙̹ͣໜ྄ഢ֊ု଻ఱಸ‫͈܈‬ႉ઄ພၑഎඅಭ. ల76ٝఱಸ‫ݪࡄ܈‬ٛ. ๊֚‫׵‬ఴ, ֳസ‫ݠ‬, 2012, 1.
Ȇളᰧġ ੗, ఱന࣓ဇ, ള༏֚ܵ, നಎཆढ, ਝ५ࢼ၌, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇೄಸ‫ޫ͈܈‬ਫ਼ठอ‫֦ࡏܓ‬ঊ̤͍͢ထࢃܰ೰֦ঊ̥͙̹ͣRbೄಸ̦͈ͭळ໦႒ͅ‫࠿̳ͥ۾‬൦. ల76ٝఱಸ‫ݪࡄ܈‬ٛ. εΑΗȜ, ֳസ‫ݠ‬, 2012, 1.
Ȇ౓࢛ࢼ֚ȇ൚̤̫֭ͥͅSMA໦খ୶࣐ੜၑ͈਀ܿ͂ࢥຳ. ల21ٝ૰ජ୼‫ࡄܿ਀੅਀شٸ‬‫ݪ‬ٛ. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 2.
Ȇ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ਱ඵঐಸ඿൮໐૰ࠐඤ໦๥ळ༾‫ ͈܈‬1႕. ల 7ٝNET Work Japan. εΑΗȜ, ൐‫ނ‬, 2012, 2.
Ȇ൥֔ୃ֚, ള༏֚ܵ, ఱന࣓ဇ, ളᰧġ ੗, ࡼయഛռ, ఱോġ ܲ, ঌ୼࿭ঃ, ኈॄ৽୕, ‫׿‬㧙124㧙൥ġ ‫ڒ‬ȇఱಸ‫̫̤ͥͅ੅਀܈‬ౙࢢ৆ໜ࣌‫͈੅਀ئޢ‬ഐ؊‫ڐ‬ఱ͈‫خ‬ෝ଻. ల 5 ٝౙࢢ৆ඤ
ণ‫ݪࡄ੅਀ޢ‬ٛ. ΫΟ΂Ώϋε, ࢩോ, 2012, 2.
Ȇ࿝ாੇྶ, ঌ୼࿭ঃ, ࢃ൥ġ ༜, ೛ఆġ ࠲, ఱന࣓ဇ, നಎཆढ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇೄ
ಸMALTςϋΩਆ͈ 1႕. ల35ٝ૰ජ୼ఱಸᥬ࿝৖ۛः౴ٛ. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 5.
Ȇ५ུ૨࿟, നಎཆढ, ࿤૜გങ, ߧུܽ໲, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ໌നგ‫ז‬, ఱന࣓ဇ, ୷ോၦং, ਝ५ࢼ၌, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫܈‬۴ഢ֊௏̤̫ͥͅCD133อ࡛͈փ݅. ల33ٝ‫܈‬྾‫ݪࡄشٸע‬ٛ. ါབ‫׵‬ఴ, ‫؍‬ຩ, 2012,5.
Ȇ໹౓ୄࢁȇ੅ஜ‫ڠا‬ၷ༹ͬঔ࣐̱̹ᦙਆន͈ 1 ႕. ల20ٝ21ଲ‫شٸܮ‬Γη΢Ȝ. ๊֚‫׵‬ఴ, ఱि, 2012, 5.
Ȇനಎཆढ, ᩊ‫ئ‬ణࢤ, ֔ષ‫ם‬๼, ಎ୼გ࿟, ࿤૜გങ, ߧུܽ໲, ໌നგ‫ז‬, ఱന࣓ဇ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫ࣞ܈‬ഽ۴ഢ֊ͅచ̳ͥ‫ڠا‬ၷ༹ࢃ۴୨ੰ͈਀଼ܿ͂ୡ. ల66ٝ਀੅਀ܿࡄ
‫ݪ‬ٛ. ါབ‫׵‬ఴ, ฎఉ, 2012, 5.
Ȇ઀࿤ਜࣞ, ኈॄ৽୕, ಿ౓୼૥֚, ఱോġ ܲ, ൥֔ୃ֚, ඃ‫ࡓݛ‬຃, ஂᚧဈٚ, ࣞ୼ġ ၮ,࿐ ఆ ġ ੔ , ઀ ा ၦ ং , ཪ ࿤ ဢ ౶ , ਝ ५ ࢼ ၌ , ‫ ׿‬൥ ġ ‫ ڒ‬ȇ ֍ ‫ ͅ ܈‬చ ̳ ͥ Reduced-port
Laparoscopic Distal Gastrectomy ĩRPLDGĪ ͈ခဥ଻. ల66ٝ਀੅਀ܿࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ,ฎఉ, 2012, 5.
Ȇఆષġ ଢ, ౓࢛ࢼ֚, ઐ५ၦ୆, ૩ၦఊ჊, ໌നგ‫ז‬, ߧུܽ໲, ࿤૜გങ, ષനႃຳ, നಎཆढ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇᦙ൮਱ඵঐಸ୨ੰࢃGrade B,Cᦙ‫ס‬Ⴣ͈ςΑ·έ͹·ΗȜ͂ΡτȜϋ‫ۯ‬ၑ. ల41ٝ૰ජ୼ࡇક‫ݪࡄشٸܕا‬ٛ. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 6.
Ȇ໌നგ‫ז‬, നಎཆढ, ߧུܽ໲, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ‫׿‬൥ġ ‫ڒ‬ȇ൚̤̫֭ͥͅ୆ఘ۴֊૒ࢃߊ֖ΈρέΠ͈ঀဥࠐࡑ. ల30ٝ඾ུ۴֊૒ࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ,໛‫ؖ‬, 2012, 6.
Ȇߧུܽ໲, ໌നგ‫ז‬, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ષനႃຳ, ଩ന࢕ၦ, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇࡔอ଻ࣁ‫଻ا‬౨‫׶ۯ‬۴֊૒ࢃȂ۴‫ܥ‬ෝ։ુ͈చੜͅߎၪ̱̞̀ͥ 1
႕. ల30ٝ඾ུ۴֊૒ࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ, ໛‫ؖ‬, 2012, 6.
Ȇߧུܽ໲, ઐ५ၦ୆, ౓࢛ࢼ֚, ઀ाၦং, ऎ࿤ġ ખ, ಎ५‫ڡ‬ၨ, ΏνητȜΗȜ́৘க΀΋Ȝ΄ͼΡ‫ئ‬ஊঁ. ࡄਘ͈̹͈֓͛࿶‫ס‬Γη΢Ȝ. ρ;ϋΡΓη΢ȜȄ‫؍‬ຩ, 2012, 6.
Ȇߧུܽ໲ȇ൚‫̫̤ͥͅش‬୆ఘ۴֊૒Ρ΢Ȝ਀੅͈հ஠଻. ‫؍‬ຩਔ੅‫ۯܢ‬ၑέ΁Ȝρθ
2012. ࡄ‫ݪ‬༭࣬, ‫؍‬ຩ, 2012, 6.
Ȇႝ࿐૲ဈȇ࿴಍ཡগέͻσθͥ͢ͅఱಸ‫܈‬࿴಍ཡগ࢘‫ض‬. ల 1ٝਔ੅‫ࣣܢ‬໵છࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 6.
Ȇਝ५ࢼ၌ȇ֍‫੅܈‬ஜ‫ڠا‬ၷ༹છ႕ͅచ̳ͥఱ൲ྤਔսςϋΩ୯‫ڜ‬ୄ. Yokohama Surgical
Oncology Forum. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 6.
Ȇऎ൥ġ ߽ȇᦙȆ౨ൽ‫ͥ͢ͅ܈‬਱ඵঐಸ‫ޛ‬ॏͅచ̳ͥ਱ඵঐಸΑΞϋΠ͈ഐ؊. ల34ٝ඾
㧙125㧙ུ‫ޫ܈‬ਫ਼ၷ༹ࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ, ໛ോ, 2012, 6.
Ȇఱ५ႃ౳, ఱୌġ ಐ, ‫ݛ‬༗ฎ֚, ࡔന૯ࢁ, ઀࿤ਜࣞ, ఱോġ ܲ, ൥֔ୃ֚, ໛ോ಑౳, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇS-1ౙसၷ༹ͤ͢ͅCRͬං̹ૺ࣐֍‫͈܈‬1႕. ల19ٝShin-yokohama
Digestive Disease Meeting. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 6.
Ȇஂᚧဈٚ, ਝུგ࠻, ࣞ୼ġ ၮ, ઀ाၦং, ઀࿤ਜࣞ, ਝ५ࢼ၌, ঌ୼࿭ঃ, ኈॄ৽୕, ఱ࿤࿆౳, ‫׿‬൥ġ ‫ڒ‬ȇ֍‫܈‬ळ༾‫͈ڼ‬ζ;ΑਆនκΟσͬဥ̞̹ਆនࠁ଼̤̫ͥͅޭ଻໦ঊ
aPKCȜ/Ț͈࿨‫ڬ‬ٜଢ଼. ల21ٝ඾ུ‫܈‬ພఠহၷࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ, ஜ‫ޘ‬, 2012, 7.
Ȇଋངဎၮȇ࿽࿝௰֍୨ੰࢃ்̤̫ͥͅ‫ܢ‬஠‫ۇ‬૙‫ٳ‬ই͈࠿൦. ల32ٝ૰ජ୼੅ࢃయ৫‫ူו‬ࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 7.
Ȇႝ࿐૲ဈȇERASͅ‫̹̞̿ܖ‬ఱಸ‫܈‬ਔ੅‫ۯܢ‬ၑ͈࡛ે଼͂ୡ. ల32ٝ૰ජ୼੅ࢃయ৫‫ူו‬ࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 7.
Ȇᩊ‫ئ‬ణࢤ, നಎཆढ, ࿤૜გങ, ߧུܽ໲, ૩ၦఊ჊, ౓࢛ࢼ֚, ള༏֚ܵ, ઐ५ၦ୆, ໌നგ‫ז‬, ఱന࣓ဇ, ਝ५ࢼ၌, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇ୨ੰະෝȆࣾඳ̈́ఱಸ‫܈‬۴ഢ֊ͅచ
̳ͥConversion therapy̤̫ͥͅ۴୨ੰ౯౤‫ݻ‬ၗ. ల77ٝఱಸ‫ݪࡄ܈‬ٛ. ๊֚‫׵‬ఴ, ൐‫ނ‬,
2012, 7.
Ȇ‫ݛ‬༗ฎ֚, ఱോġ ܲ, ಿ౓୼૥֚, ാന౶ঃ, ઀࿤ਜࣞ, ໛ോ಑౳, ൥֔ୃ֚, ኈॄ৽୕,‫׿‬൥ġ ‫ڒ‬ȇ֍‫੅܈‬ஜςϋΩ୯ഢ֊૷౯̤̫ͥͅFDG-PET/CT͈փ݅. ల42ٝ૰ජ୼֍‫܈‬হၷࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 7.
Ȇ౓࢛ࢼ֚, ઐ५ၦ୆, ૩ၦఊ჊, ໌നგ‫ז‬, ߧུܽ໲, ࿤૜გങ, ఆષġ ଢ, ષനႃຳ, നಎཆढ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇᦙ൮਱ඵঐಸ୨ੰ੅ࢃISGPF grade B, Cġ ᦙ‫ס‬Ⴣ͈ςΑ·έ͹·ΗȜ͂૧ܰΡτȜϋ‫ۯ‬ၑͅဥ̞֦ͥঊ͈࠿൦. ల39ٝ඾ུᦙ୨ࡄ‫ݪ‬ٛ. εΑΗȜ,൐‫ނ‬, 2012, 8.
Ȇ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ུ‫ۼ‬ဈਏ, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬, ષനႃຳ, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ൚‫ ̫̤ͥͅش‬ĩဥ਀༞੩Īġ ໜ࣌‫ئޢ‬๶௰ᦙ୨ੰ੅͈਀ܿ͂੅ࢃౣ‫ܢ‬
଼ୡ. ల39ٝ඾ུᦙ୨ࡄ‫ݪ‬ٛ. ါབ‫׵‬ఴ, ൐‫ނ‬, 2012, 8.
Ȇ൥֔ୃ֚, ୞໐කআ, ള໐ġ ࡐ, ളᰧġ ੗, ള༏֚ܵ, ఱന࣓ဇ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇReduced port surgeryͥ͢ͅໜ࣌‫گئޢ‬࿩޼‫ۼ‬୨ੰ੅. ౙࢢ৆ඤণ‫ݪࡄ੅਀ޢ‬ٛ. Ώϋεΐ;θ, ढ़ི, 2012, 8.
Ȇ໹౓ୄࢁ, ౓࢛ࢼ֚, ઐ५ၦ୆, ૩ၦఊ჊, ߧུܽ໲, ࿤૜გങ, ໌നგ‫ז‬, ષനႃຳ, നಎཆढ, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ࿝ྤ΄ΑࠬછȂಸ‫ۯ‬༃ඤ‫ܨ‬ਆͬ೮̱̹૯޿ۜஅͥ͢ͅ๱
໾ण଻ಸ‫ࠬݹۯ‬છ ĩNOMIĪġ ͈ 1 ႕. ల57ٝ඾ུક‫ْܕا‬௨૷౯ࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ, ઐോ,2012, 8.
Ȇఱന࣓ဇȇࠫಸ‫ࢃ੅܈‬༞੩‫ڠا‬ၷ༹͈૧ܰႉ઄দࡑ̞̾̀ͅ. ક‫܈ܕا‬ႉ઄ࡄ‫΃ݪ‬ϋέ͹τϋΑ. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 9.
㧙126㧙Ȇള༏֚ܵȇ৹਀֓ޫ֥͈̹͈͛ႉ઄দࡑͅ‫̳ͥ۾‬ႃၑঐૻ̞̾̀ͅ. ક‫܈ܕا‬ႉ઄ࡄ‫ݪ‬΃ϋέ͹τϋΑ. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 9.
Ȇఱനဢ໹, ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ષനႃຳ, ໌നგ‫ז‬, നಎཆढ, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇᦙ౨‫ࣣۯ‬ၠ։ુ̤̫ͥͅอ‫܈‬ςΑ·͈໦ঊ୆໤‫ڠ‬എ࠿൦. ల35ٝ඾ུᦙȆ౨‫ۯ‬ࣣၠ։ુࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ, ൐‫ނ‬, 2012, 9.
Ȇ‫ࢫࡔڦ‬໹, ࿤૜გങ, ໌നგ‫ז‬, ઐ५ၦ୆, ౓࢛ࢼ֚, ߧུܽ໲, ૩ၦఊ჊, ఱന࣓ဇ, ਝ५ࢼ၌, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ୶ഛ଻࿝ྤࠧఅછࣣͅ໵̱̹۴ਆន͈୨ੰࠐࡑ. ల16ٝႉ઄ٜཎࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ, ྴࡣ‫ؚ‬, 2012, 9.
Ȇߧུܽ໲ȇ‫؍‬ຩঌఱ̤̫ͥͅ୆ఘ۴֊૒͈࡛‫ޙ‬. ‫؍‬ຩ۴֊૒Γη΢Ȝ2012. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 10.
Ȇఆષġ ଢ, ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ષനႃຳ, ໌നგ‫ז‬, നಎཆढ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ‫ޗ‬৒̤̫ͥͅໜ࣌‫ޢ‬༞੩‫ᦙئ‬൮਱ඵঐಸ୨ੰ੅͈൵ව͂ࢥຳ. ల 4 ٝᦙ௫ඤণ
‫ݪࡄشٸޢ‬ٛ. ΫΟ΂ΓΛΏοϋ, ૧਽, 2012, 11.
Ȇఱ५ႃ౳, ઀࿤ਜࣞ, ఱୌġ ಐ, ‫ݛ‬༗ฎ֚, ࡔന૯ࢁ, ാന౶ঃ, ఱോġ ܲ, ൥֔ୃ֚, ໛ോ಑౳, ኈॄ৽୕, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇໜ࣌‫ޢ‬༞੩‫֍ئ‬஠ഊ੄੅̤̫ͥͅOrVilͬဥ̞̹hemi-double stapling technique͈ठ࠺਀͈ܿεͼϋΠ̷͈͂հ஠଻. ల 4 ٝᦙ௫ඤণ‫ޢ‬‫ݪࡄشٸ‬ٛ. ๊֚‫׵‬ఴ, ૧਽, 2012, 11.
Ȇ‫ݛ‬༗ฎ֚, ఱോġ ܲ, ಿ౓୼૥֚, ࡔന૯ࢁ, ാനგঃ, ઀࿤ਜࣞ, ൥֔ୃ֚, ໛ോ಑౳,ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ֍‫੅܈‬ஜςϋΩ୯ഢ֊૷౯̤̫ͥͅFDG-PET/CT͈փ݅. ల 4ٝᦙ௫ඤণ‫ݪࡄشٸޢ‬ٛ. ါབ‫׵‬ఴ, ૧਽, 2012, 11.
Ȇఱୌġ ಐ, ષനႃຳ, ࡔന૯ࢁ, ໛ോ಑౳, ൥֔ୃ֚, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇᦙਆន͈͂
‫ۻ‬༆̦ࣾඳ̜̹́̽Schwannoma 1 ႕. ૰ජ୼ࡇક‫ܕا‬ພ֓‫ڠ‬ٛ, ๊֚‫׵‬ఴ, ૧‫؍‬ຩ, 2012,10.
Ȇࡔന૯ࢁ, ఱോġ ܲ, ‫ݛ‬༗ฎ֚, ാന౶ঃ, ઀࿤ਜࣞ, ໛ോ಑౳, ൥֔ୃ֚, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇఱ൲ྤਔսςϋΩ୯Ȇᴢ໐ςϋΩ୯ഢ֊ͬ෇̹͛ૺ࣐֍‫ͅ܈‬చ̱̀
Docetaxel+S-1ၷ༹̦ಠ̱̹࢘ 1 ႕. ల42ٝ֍‫شٸ‬Ȇ੅ࢃવ‫ݪࡄٺ‬ٛ. ๊֚‫׵‬ఴ, ૧਽,2012, 11.
Ȇႝ࿐૲ဈ, ള༏֚ܵ, ଋངဎၮ, ളᰧġ ੗, ୞໐කআ, ఱന࣓ဇ, ൥֔ୃ֚, ਝ५ࢼ၌, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇΑΠȜζ౎੄ͅచ̱ςΣͺΑΞȜίρȜͬဥ̞ࠁ଼੅ͬঔ࣐̱̹ 3
႕. ૰ජ୼ΑΠζࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 12.
Ȇ࿝ாੇྶ, ઐ५ၦ୆, ऎș࿐૯ၑ, ߧུܽ໲, ࿤૜გങ, ૩ၦఊ჊, ౓࢛ࢼ֚, ໌നგ‫ז‬,ਝ५ࢼ၌, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ‫ۜشٸ‬அછ̤̫ͥͅEndotoxin Activity Assay ĩEAAĪ ͥ͢ͅਹછ‫ا‬ထ௶͈࠿൦. ల19ٝ‫شٸ‬૟ਥ͂΍ͼΠ΃ͼϋࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ, ૰࡫, 2012,
12.
㧙127㧙

Ȇ‫ࢫࡔڦ‬໹, ႝ࿐૲ဈ, ള༏֚ܵ, ࡼయഛռ, ള༏ġ ੗, ୞໐කআ, ఱന࣓ဇ, ൥֔ୃ֚, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇཌྷΑΠζΰσΣͺอછ̤̫ͥͅ‫֦ࡏܓ‬ঊ͈࠿൦. ల 4ٝ૰ජ୼ΰσΣͺࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ, ૧‫؍‬ຩ, 2012, 12ȅɟġ ࣒‫׵‬ȆρϋΙοϋΓη΢ȜȆͼήΣϋΈΓη΢ȜġȆ୞୼ġ ࢣȇ඿̦͈ͭহၷ͉ࣽ. ల 4 ̦ٝͭίυέͿΛΏο΢σူ଼ίρϋঌྦྷ࢖‫ٳ‬Γη΢Ȝ. ࣒‫׵‬ȆρϋΙοϋ, ‫؍‬ຩ, 2012, 1.
Ȇനಎཆढȇ۴୨ၗࢃ౨ਵឝ͈อ୆ထ௶̷͈͂చॐ. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ.
࣒‫׵‬ȆͼήΣϋΈ, ୷ဩ, 2012, 4.
Ȇനಎཆढȇ۴௫‫ڠا̹͙̥ͣشٸ‬ၷ༹໵ဥ‫͈́ئ‬ఱಸ‫ࣞ܈‬ഽ۴ഢ֊ͅచ̳ͥ୨ੰ୽ၞȽ
໦ঊດഎহၷ࿪͈͒‫ܢ‬ఞȽ. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. ࣒‫׵‬ȆρϋΙοϋ, ୷
ဩ, 2012, 4.
Ȇ൥֔ୃ֚ȇఱಸ‫شٸ‬হၷ͈up to date͂Clinical Question. ల49ٝ߇ਗ‫ڠشٸ‬ٛ. ࣒‫׵‬ȆρϋΙοϋ, ऎٖ, 2012, 5.
Ȇനಎཆढȇ۴௫‫̢ͥࣉ̦֓شٸ‬໦ঊດഎ࿪ͬဥ̞̹হၷ୽ၞġ ȡਆនੀ઀͈ພၑ‫ڠ‬എ࠿൦ȡ. ల77ٝఱಸ‫ݪࡄ܈‬ٛ. ࣒‫׵‬ȆρϋΙοϋ, ൐‫ނ‬, 2012, 7.
Ȇ൥֔ୃ֚ȇఱಸ‫ͅ܈‬చ̳ͥໜ࣌‫ ͈੅਀ئޢ‬up-to-date͂΀ΫΟϋΑ. ల25ٝ඾ུඤণ‫ٸޢ‬‫ڠش‬ٛ௙ٛ. ࣒‫׵‬ȆρϋΙοϋ, ‫؍‬ຩ, 2012, 12.

ɟġ जಿȆংٛȆ΋ιϋΞȜΗȜġȆ‫׿‬൥ġ ‫ڒ‬ȇ඿̦͈ͭহၷ͉ࣽ. ల 4 ̦ٝͭίυέͿΛΏο΢σူ଼ίρϋঌྦྷ࢖‫ٳ‬Γη΢Ȝ. जಿȆংٛ, ‫؍‬ຩ, 2012, 1.
Ȇኈॄ৽୕ȇ֍ġ ‫ޢ‬ণ‫ئ‬Ƚ3. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. जಿȆংٛ, ୷ဩ, 2012,4.
Ȇ଩ന࢕ၦȇల31ٝ૰ජ୼੅ࢃయ৫‫ݪࡄူו‬ٛ. जಿȆংٛ, ‫؍‬ຩ, 2012, 1.
Ȇ୷ോၦংȇ‫ٸ‬ြ‫ڠا‬ၷ༹͈໗ैဥ‫ۯ‬ၑ. ‫؍‬ຩ΂ϋ΋υΐȜ΢ȜΑΓη΢Ȝ, जಿ, ‫؍‬ຩ,2012, 2.
Ȇ଩ന࢕ၦȇ൚ঔ୭̤̫ͥͅᦙ൮਱ඵঐಸ୨ੰ੅͈ࢥຳ. ల21ٝ૰ජ୼‫ݪࡄܿ਀੅਀شٸ‬ٛ. जಿȆংٛ. ‫؍‬ຩ, 2012, 2.
Ȇ൥֔ୃ֚ȇ‫ੱٸ‬Ȇᦙ. ඾ུໜ໐‫ڠ֓ݢݣ‬ٛ௙ٛ. जಿȆংٛ, ߄ా, 2012, 3.
Ȇਝ५ࢼ၌ȇಸ‫ࠬݹۯ‬છ. ඾ུໜ໐‫ڠ֓ݢݣ‬ٛ௙ٛ. जಿȆংٛ, ߄ా, 2012, 3.
Ȇ୷ോၦংȇࢹಃ͈၄ͦ͂ພၑ૷౯. ల 7ٝ‫؍‬ຩ඿ஏພၑ૷౯ࡄ‫ݪ‬ٛ, जಿ, ‫؍‬ຩ, 2012, 3.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇ੅ஜ‫ڠا‬ၷ༹ͬঔ࣐̱̹ᦙਆន͈ 1႕. ల20ٝ21ଲ‫شٸܮ‬Γη΢Ȝ. जಿȆংٛ, ఱि, 2012, 5.
㧙128㧙

Ȇ‫׿‬൥ġ ‫ڒ‬ȇ৖ۛ༆͙̹ͅᦙ୨ੰ੅৆͈஖఼͂੅ࢃࣣ໵છచॐ. ల41ٝ૰ජ୼ࡇક‫ٸܕا‬‫ݪࡄش‬ٛ. जಿȆংٛ, ‫؍‬ຩ, 2012, 6.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇల 1ٝਔ੅‫ࣣܢ‬໵છࡄ‫ݪ‬ٛ. जಿȆংٛ, ‫؍‬ຩ, 2012, 6.
Ȇኈॄ৽୕ȇల 1ٝਔ੅‫ࣣܢ‬໵છࡄ‫ݪ‬ٛ. जಿȆংٛ, ‫؍‬ຩ, 2012, 6.
Ȇനಎཆढȇ۴ 2. ഢ֊଻۴‫܈‬. ల24ٝ඾ུ۴౨ᦙ‫ڠشٸ‬ٛȆ‫੅ڠ‬ਬٛ. जಿȆংٛ, ఱि,2012, 6.
Ȇ୷ോၦংȇা୰27ȇΓϋΙΥσ 3. ల20ٝ඾ུ඿‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ, जಿ, ߧུ, 2012, 6.
Ȇ౓࢛ࢼ֚ȇల43ٝ඾ུᦙ௫‫ڠ‬ٛ. εΑΗȜजಿ, ५ࠁ, 2012, 6.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇૺ࣐ᦙ‫ͅ܈‬చ̳ͥਬ‫ڠ‬എহၷ୽ၞ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. जಿȆংٛ, ີ५, 2012, 7.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇMore PN is more toxic? Ƚਹછۛ৪ͅచ்̳ͥ‫͈ူוྤ୓ܢ‬ଵ๱, ̷͈૯௖Ƚ.
ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. जಿȆংٛ, ີ५, 2012, 7.
Ȇ൥֔ୃ֚ȇఱಸࣞႢ৪ 2. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. जಿȆংٛ, ີ५, 2012, 7.
Ȇനಎཆढȇ۴ْ௨૷౯. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. जಿȆংٛ, ີ५, 2012, 7.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇల32ٝ૰ජ୼੅ࢃయ৫‫ݪࡄူו‬ٛ. जಿȆংٛ, ‫؍‬ຩ, 2012, 7.
Ȇ൥֔ୃ֚, ৽ఴԅࣞႢ৪ఱಸ‫ ܈‬ĩ76पոષĪġ ͈‫ڠا‬ၷ༹ġ P-ԅ-5. ల77ٝఱಸ‫ݪࡄ܈‬ٛ.
जಿȆংٛ, ൐‫ނ‬, 2012, 7.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇક‫܈ܕا‬ႉ઄ࡄ‫΃ݪ‬ϋέ͹τϋΑ. जಿȆংٛ, ‫؍‬ຩ, 2012, 9.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇඅ༆࣒‫׵‬ȺजಿȻ‫؍‬ຩ۴֊૒Γη΢Ȝ2012. जಿȆংٛ, ‫؍‬ຩ, 2012, 10.
Ȇ໌നგ‫ז‬ȇংٛ ‫؍‬ຩ۴֊૒Γη΢Ȝ2012. जಿȆংٛ, ‫؍‬ຩ, 2012, 10.
Ȇ൥֔ୃ֚ȇ‫ڠا‬ၷ༹ࣣ໵છ. ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛजಿȆংٛ, ໛‫ؖ‬, 2012, 11.
Ȇ൥֔ୃ֚ȇஊࢢȆ։໤. ల25ٝ඾ུඤণ‫ڠشٸޢ‬ٛ௙ٛ. जಿȆংٛ, ‫؍‬ຩ, 2012, 12.

ɟġ ̷͈ఈġȆ‫׿‬൥ġ ‫ڒ‬ȇĩ‫ٳ‬͈ٛৃĪ ల31ٝ૰ජ୼੅ࢃయ৫‫ݪࡄူו‬ٛ. ̷͈ఈ, ‫؍‬ຩ, 2012, 1.
Ȇ࿤૜გങȇYokohama Clinical Oncology group ĩYCOGĪ ͈ૺೃે‫͈ޙ‬༭࣬. ల31ٝ૰ජ୼੅
ࢃయ৫‫ݪࡄူו‬ٛ. ̷͈ఈ, ‫؍‬ຩ, 2012, 1.
Ȇኈॄ৽୕ȇĩ໾͈ٛৃĪ ల31ٝ૰ජ୼੅ࢃయ৫‫ݪࡄူו‬ٛ. ̷͈ఈ, ‫؍‬ຩ, 2012, 1.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇĩ‫ٳ‬͈ٛৃĪ ‫؍‬ຩક‫ܕا‬Ȇਆន‫شٸ‬έ΁Ȝρθ. ̷͈ఈ, ‫؍‬ຩ, 2012, 2.
Ȇঌ୼࿭ঃȇࡄ‫ݪ‬༭࣬. ‫؍‬ຩક‫ܕا‬Ȇਆន‫شٸ‬έ΁Ȝρθ. ̷͈ఈ, ‫؍‬ຩ, 2012, 2.
Ȇኈॄ৽୕ȇĩ໾͈ٛৃĪ ‫؍‬ຩક‫ܕا‬Ȇਆន‫شٸ‬έ΁Ȝρθ. ̷͈ఈ, ‫؍‬ຩ, 2012, 2.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇȺΞτΫ੄‫׵‬ȻΞȜζȇᦙ௫̦ͭĩ1Īĩ2Īġ ༶௣඾ 4 ࠮ 6 ඾Ȇ13඾. ΞτΫ૰ජ୼ȸ࠲ࢫडஜ஌ȹ
. ̷͈ఈ, 2012, 4.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇĩ‫ٳ‬͈ٛৃĪ ల41ٝ૰ජ୼ࡇક‫ݪࡄشٸܕا‬ٛ. ̷͈ఈ, ‫؍‬ຩ, 2012, 6.
㧙129㧙Ȇ‫׿‬൥ġ ‫ڒ‬ȇĩ‫ٳ‬͈ٛৃĪ Yokohama Surgical Oncology Forum. ̷͈ఈ, ‫؍‬ຩ, 2012, 6.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇĩ‫ٳ‬͈ٛৃĪ ల32ٝ૰ජ୼੅ࢃయ৫‫ݪࡄူו‬ٛ. ̷͈ఈ, ‫؍‬ຩ, 2012, 7.
Ȇኈॄ৽୕ȇĩ໾͈ٛৃĪ ల32ٝ૰ජ୼੅ࢃయ৫‫ݪࡄူו‬ٛ. ̷͈ఈ, ‫؍‬ຩ, 2012, 7.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇĩ‫ٳ‬͈ٛৃĪ ల10ٝ૰ජ୼౨ᦙ‫ݪࡄ܈‬ٛȡFinal Circularȡ. ̷͈ఈ, ‫؍‬ຩ, 2012,7.
Ȇኈॄ৽୕ȇĩ໾͈ٛৃĪ ల32ٝ૰ජ୼੅ࢃయ৫‫ݪࡄူו‬ٛ. ̷͈ఈ, ‫؍‬ຩ, 2012, 7.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇĩ‫ٳ‬͈ٛৃĪ ల10ٝ૰ජ୼౨ᦙ‫ݪࡄ܈‬ٛȡFinal Circularȡ. ̷͈ఈ, ‫؍‬ຩ, 2012,7.
Ȇ‫׿‬൥ġ ‫ڒ‬ȇĩ‫ٳ‬͈ٛৃĪ ક‫܈ܕا‬ႉ઄ࡄ‫΃ݪ‬ϋέ͹τϋΑ. ̷͈ఈ, ‫؍‬ຩ, 2012, 9.

ġġġ‫۾‬Ⴒພ֭‫ڠ‬ٛอນġġɃ࣭ၛພ֭‫؍‬ຩ֓ၷΓϋΗȜɄġȆനġ ળۘ, ५‫܅‬ġ ࿆, ऎ൥ġ ખ, ാ‫ؚ‬૝ࢩ, നಎ࿹ै, ୞໐කআ, ઐ๶࠻֚, Ⴎനࢫ֚჊,ಏ࿤ġ ྶȇ൚̤̫֭ͥͅఱಸ‫ ࢃ੅܈‬Surgical site infection ĩSSIĪġ ͈࡛ે. ల112ٝ඾ུ‫ٸ‬‫ڠش‬ٛ೰‫੅ڠܢ‬ਬٛ, εΑΗȜ, ୷ဩ, 2012, 4.
Ȇ२఺ࡊఊ჊, ஐ֔ਜ୹, ୼࢛ఱ༟, չ൥૥ࢁ, ࣞ୼ġ ၮ, ධġ ဉఊ, ଼֚֔ၦ, େന౶ࢨ,໛ോ಑౳, ࿆‫ੇٗڈ‬, ಿཱġ ߰ȇ੅ஜ૷౯̦ࣾඳ̜̹́̽۴๭྄‫ئ‬ਆរ͈֚႕. ۴౨ᦙ‫ٸ‬‫ڠش‬ٛ, ๊֚‫׵‬ఴ, ఱि, 2012, 5.
Ȇ२఺ࡊఊ჊, ࣞ୼ġ ၮ, ධġ ဉఊ, ଼֚֔ၦ, େന౶ࢨ, ໛ോ಑౳, ࿆‫ੇٗڈ‬, ஐ֔ਜ୹,ಿཱġ ߰ȇ࿽࿝௰֍୨ੰࢃ்̤̫ͥͅ‫ܢ‬஠‫ۇ‬૙‫ٳ‬ই͈ခဥ଻. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ, ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇാ‫ؚ‬૝ࢩ, ५‫܅‬ġ ࿆, നġ ળۘ, ੉നࢼ֚, നಎ࿹ै, ऎ൥ġ ખ, ୞໐කআ, ઐ๶࠻֚, Ⴎനࢫ֚჊, ಏ࿤ġ ྶȇ൚̤̫֭ͥͅૺ࣐ठอఱಸ‫ͅ܈‬చ̳ͥUGT1A1 *28ȟ*6֒ഥঊఉ߿
͂‫ͼॸ؂‬ςΦΞ΃ϋ͈໗ैဥͅ‫࠿̳ͥ۾‬൦. ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ, εΑΗȜ, ໛‫ؖ‬, 2012,11.
Ȇ२఺ࡊఊ჊, ࣞ୼ġ ၮ, ଋངဎၮ, ઀ୌၦ࣐, ུ‫ۼ‬ဈਏ, ളᰧġ ੗, ධġ ဉఊ, େന౶ࢨ,࿆‫ੇٗڈ‬, ஐ֔ਜ୹ȇ࿽࿝௰֍୨ੰࢃ்̤̫ͥͅ‫ܢ‬஠‫ٳۇ‬ইΩΑ͈ခဥ଻. ల13ٝ·ςΣ΃σΩΑ‫ڠ‬ٛ, ๊֚‫׵‬ఴ, ‫ؖ‬५, 2012, 12.

㧙130㧙ĩࡄ‫ݪ‬ٛ൝ĪġȆ२఺ࡊఊ჊, ‫࡫۾‬ġ ૾, ؋ġ ୃඃ, ઀༥ġ ࿾, നġ ળۘ, ാ‫ؚ‬૝ࢩ, ୄକഓ࿟, ઐനࢅ჊ȇ൚̤̫֭ͥͅ Reduced Port Laparoscopic Cholecystectomy. ల 6ٝౙࢢ৆਀੅਀ܿࡄ‫ݪ‬ٛ.
๊֚‫׵‬ఴ, ढ़ི, 2012, 8.

Ƀ‫؍‬ຩঌྦྷພ֭ɄġȆ໛ന౶ࢩ, ઀߄֚֔ၦ, ౌྜ࠲঎, ඵ࿐ġ ၭ, ५ඤ๼฿ঊ, ଩നġ ઎, ܸ൮໲຃ȇ·υȜϋພ͈઀ಸພ་̥ͣ ೄಸ୨౯ࢃ͈֮ٛ஻ͅឝࢢͬࠁ଼̱̹ 1 ႕. ల318ٝક‫ܕا‬ພ‫ڠ‬ٛ‫۾‬൐঑໐႕ٛ. ࢛‫׵‬, ൐‫ނ‬, 2012, 2.
Ȇౌྜ࠲঎, ଩നġ ઎, ಎ๶৩ဇ๼, ‫ࠐུؖ‬ঊ, ࣱ࿐ฎٚ, ඵ࿐ġ ၭ, ५ന‫ޕ‬ঊ, ࿐ఆ‫ྶם‬,࣏֔ੳ຃, ઀߄֚֔ၦ, ܸ൮໲຃, ໛ോࢭ౳ȇ઀঱೟ន଻ఱಸ‫੅਀׶‬႕͈਀੅ഐ؊͂੅ࢃ
ࠐً͈࠿൦. ඾ུ‫ڠشٸ‬ٛ, ΍Ȝΐ΃σέ΁Ȝρθ, ྃಫ, 2012, 4.
Ȇౌྜ࠲঎, ଩നġ ઎, ಎ๶৩ဇ๼, ‫ࠐུؖ‬ঊ, ࣱ࿐ฎٚ, ඵ࿐ġ ၭ, ५ന‫ޕ‬ঊ, ࿐ఆ‫ྶם‬,࣏֔ੳ຃, ઀߄֚֔ၦ, ܸ൮໲຃, ႅġ ࢤ࣐, ໛ോࢭ౳ȇఱಸ‫ࣣ܈‬໵೟ន଻ఱಸ‫੅਀׶‬છ႕͈ᥬ࿝‫྄ුۯ‬า‫ݲ‬໐̤̫ͥͅdysplasiaอ୆ၚ. ඾ུક‫ܕا‬ພ‫ڠ‬ٛ, ࢛‫׵‬, ൐‫ނ‬, 2012, 4.
Ȇനಎৄၑ, ౌྜ࠲঎, ඵ࿐ġ ၭ, ࣱ࿐ฎٚ, ઀߄֚֔ၦ, ଩നġ ઎, ܸ൮໲຃ȇ·υȜϋພ͈઀ಸພ་̥ͣ ಸࣴ޼ෟន̱ͬٚ̀ᦏ᥻ͅឝࢢͬࠁ଼̱̹ 1 ႕. ల319ٝક‫ܕا‬ພ‫ڠ‬ٛ‫۾‬൐঑໐႕ٛ. ࢛‫׵‬, ൐‫ނ‬, 2012, 5.
Ȇ୞५ġ ީ, ܸ൮ႛঊ, ୷ဩణ຃ȇ൚‫̫̤ͥͅش‬ΓϋΙΥσςϋΩ୯୆࠿଼͈ୡ. ల20ٝ඾ུ඿‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ. εΑΗȜ. ߧུ, 2012, 6.
Ȇ୷ဩణ຃, ୞५ ީ, ܸ൮ႛঊ, ܸ൮໲຃ȇఉ૖ਅΙȜθͥ͢ͅ඿‫ࢃ੅܈‬ςϋΩ຾ਆ͈ထཡȆ்‫ܢ‬อࡉ̞̾̀ͅ. ඾ུ඿‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ, εΑΗȜ, ߧུ, 2012, 6.
Ȇౌྜ࠲঎, ଩നġ ઎, ಎ๶৩ဇ๼, ࣱ࿐ฎٚ, ඵ࿐ġ ၭ, ५ന‫ޕ‬ঊ, ࿐ఆ‫ྶם‬, ࣏֔ੳ຃,઀߄֚֔ၦ, ܸ൮໲຃, ໛ോࢭ౳ȇ೟ន଻ఱಸ‫ࢃ੅׶‬ಸ໾णͅచ̱̀਀੅ͬຈါ̱̹͂
છ႕͈ႉ઄എඅಭ. ඾ུક‫ڠشٸܕا‬ٛ, ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇౌྜ࠲঎ȇఱಸ II. ల320ٝક‫ܕا‬ພ‫ڠ‬ٛ‫۾‬൐঑໐႕ٛ, जಿ, ൐‫ނ‬, 2012, 7.
Ȇ୞֔ဢٚ, ઀߄֚֔ၦ, ౌྜ࠲঎, ඵ࿐ġ ၭ, ࣱ࿐ฎٚ, ଩നġ ઎, ܸ൮໲຃ȇαȜΙͿΛΠພٝಸஊࢢ੅ࢃ10ා࿒ٝͅಸ໧ࣣ໐ឝࢢ̥ͣ୆̲̹ࢃໜ྄ෟនͥ͢ͅ๧ໂឝȆᦏ᥻ឝͅచ̱਀੅̦ு̱̹֚ࢗ႕. ల320ٝક‫ܕا‬ພ‫ڠ‬ٛ‫۾‬൐঑໐႕ٛ, ࢛‫׵‬, ൐‫ނ‬,
2012, 7.
Ȇౌྜ࠲঎, ଩നġ ઎, ઀߄֚֔ၦȇCrohnພ઀ಸພ་ͅచ̳ͥ઀ಸ௮‫༹͈ג‬ခဥ଻. ల20
ٝક‫ڠشٸܕا‬ٛJDDW. χȜ·ΏοΛί, ૰࡫, 2012, 10.
Ȇ୞५ġ ީ, ܸ൮ႛঊ, ୷ဩణ຃ȇ඿̦ͭྫၳ·Ȝεϋͥ͢ͅ࠿૷৪ତ͈࡛ે. ల22ٝ඾ུ඿‫ڠ૷࠿܈‬ٛ‫੅ڠ‬௙ٛ. ࢛‫׵‬, ‫ؗ‬ථ, 2012, 11.
㧙131㧙Ȇౌྜ࠲঎, ଩നġ ઎, ಎ๶৩ဇ๼, ࣱ࿐ฎٚ, ඵ࿐ġ ၭ, ५ന‫ޕ‬ঊ, ࿐ఆ‫ྶם‬, ࣏֔ੳ຃,઀߄֚֔ၦ, ܸ൮໲຃, ໛ോࢭ౳ȇఱಸ‫ࣣ܈‬໵೟ន଻ఱಸ‫੅਀׶‬છ႕͈ᥬ࿝‫྄ුۯ‬า‫ݲ‬໐̤̫ͥͅdysplasiaอ୆ၚ. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ, ΩΥσΟͻΑ΃ΛΏοϋ, ໛‫ؖ‬, 2012, 11.
Ȇౌྜ࠲঎, ଩നġ ઎, ઀߄֚֔ၦ, ୞֔ဢٚ, ಎ๶৩ဇ๼, ࣱ࿐ฎٚ, ඵ࿐ġ ၭ, ५ന‫ޕ‬ঊ, ࿐ఆ‫ྶם‬, ࣏֔ੳ຃, ܸ൮໲຃, ໛ോࢭ౳ȇ೟ន଻ఱಸ‫͈ࢃ੅׶‬ಸ໾ण਀੅႕͈ႉ઄
എඅಭ. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ, ๊֚‫׵‬ఴ, ૧਽, 2012, 12.

ĩࡄ‫ݪ‬ٛ൝ĪȆౌྜ࠲঎ȇ"૙ൽ‫ۯܨ‬ឝ໵อಸ‫ۯ‬αȜΙͿΛΠພ". ల38ٝ IBD Club Jr. ࡄ‫ݪ‬ٛ. ΋ιϋΞȜΗȜ, ൐‫ނ‬, 2012, 6.
Ȇ୼࢛ఱ༟, བ࠮ࢫ‫ݛ‬ȇᦙ՛଻ਆន਀੅̤̫ͥͅহၷ଼ୡࣣ͂໵છ͈࠿൦. ల57ٝ૰ජ୼ࡇક‫ݪࡄܕا‬ٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 9.
Ȇౌྜ࠲঎, ଩നġ ઎, ઀߄֚֔ၦ, ಎ๶৩ဇ๼, ࣱ࿐ฎٚ, ඵ࿐ġ ၭ, ܸ൮໲຃, ໛ോࢭ౳ȇ઀঱೟ន଻ఱಸ‫੅਀׶‬႕͈਀੅ഐ؊͂੅ࢃࠐً͈࠿൦. ల19ٝ૰ජ୼IBDࡄ‫ݪ‬ٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 11.

Ƀ൥ాঌྦྷພ֭ɄġȆYamagishi S, Ishibe A, Nakano A, Matsuo K, Den K, Tsuchiya N, Sato S, Tanaka Y : Prognostic
Factors for Patients with Peritoneal Metastasis from Colorectal Cancer. XXV ISUCRS Biennial
Congress, εΑΗȜ, Bologna, 2012, 6.
Ȇ५‫܅‬ġ ࿆, ୞໐කআ, നġ ળۘ, ऎ൥ġ ખ, ാ‫ؚ‬૝ࢩ, ੉നࢼ֚, നಎ࿹ै, ઐ๶࠻֚, Ⴎനࢫ֚჊, ಏ࿤ġ ྶȇໜ࣌‫ئޢ‬ऒ௰ఱಸ‫ ̫̤ͥͅ੅਀܈‬J ߿ಸ‫·ۯ‬ρϋίᱛঊͬဥ̞̹
ಸ‫ۯ‬஄૆୨ၗ༹. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ. εΑΗȜ, ୷ဩ, 2012, 4.
Ȇ੉നࢼ֚, ઐ๶࠻֚, നġ ળۘ, ാ‫ؚ‬૝ࢩ, നಎ࿹ै, ऎ൥ġ ખ, ୞໐කআ, ५‫܅‬ġ ࿆, Ⴎനࢫ֚჊, ಏ࿤ġ ྶȇ൚̤̫֭ͥͅ‫଻ੱٸ‬۴అੱ͈࠿൦. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫੅ڠܢ‬ਬٛ, εΑΗȜ, ୷ဩ, 2012, 4.
Ȇઐ๶࠻֚, ಏ࿤ġ ྶȇၑমْܑٛ 2 ྚြͬఽ̩අ೰ۭࢌ঍ ĩ‫ب‬ઠĪġ ުྩদ࣐মު̥ͣࡉ
̢̧̹͈̀͜. ల21ٝ඾ུ஻ੱȆ΂ΑΠηȜȆ৐޺‫ۯ‬ၑ‫ڠ‬ٛ, ̷͈ఈ, ૰࡫, 2012, 5.
Ȇઐ๶࠻֚, Ⴎനࢫ֚჊, നġ ળۘ, ੉നࢼ֚, ാ‫ؚ‬૝ࢩ, നಎ࿹ै, ऎ൥ġ ખ, ୞໐කআ,५‫܅‬ġ ࿆, ࡀ൥ੇ֚, ಏ࿤ġ ྶȇ౨‫ۯ‬ෙ༾ஏ‫ ͈܈‬3 ୨ੰ႕. ల24ٝ඾ུ۴౨ᦙ‫ڠشٸ‬ٛȆ‫੅ڠ‬ਬٛ, εΑΗȜ, ఱि, 2012, 6.
Ȇგന༸ঊ, ൥֔ୃ֚, ള༏֚ܵ, ࡼయഛռ, ႝ࿐૲ဈ, ള༏ġ ੗, ఱോġ ܲ, ఱന࣓ဇ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇ୨ੰະෝठอఱಸ‫͈܈‬ಿ‫ܢ‬୆ం͈֚႕, ల37ٝ‫ࠏشٸ‬Ⴒࣣ‫ڠ‬ٛ, εΑ㧙132㧙ΗȜ, ໛‫ؖ‬, 2012, 6.
Ȇઐ๶࠻֚, Ⴎനࢫ֚჊, നಎ࿹ै, നġ ળۘ, ੉നࢼ֚, ാ‫ؚ‬૝ࢩ, ऎ൥ġ ખ, ୞໐කআ,५‫܅‬ġ ࿆, ಏ࿤ġ ྶȇޫਫ਼ૺ࣐ᦙఘ໐‫ͅ܈‬చ̳ͥໜ࣌൲ྤࣣ໵୨ੰฺ̠ͬ๶௰ᦙ୨ੰ͈
2႕. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ, ါབ‫׵‬ఴ, ີ५, 2012, 7.
Ȇ५‫܅‬ġ ࿆, ୞໐කআ, നġ ળۘ, ऎ൥ġ ખ, ാ‫ؚ‬૝ࢩ, ੉നࢼ֚, നಎ࿹ै, ઐ๶࠻֚, Ⴎനࢫ֚჊, ಏ࿤ġ ྶȇໜ࣌‫ޢ‬༞੩‫ئ‬೩պஜ༷୨ੰ੅̤̫ͥͅ J ߿ಸ‫·ۯ‬ρϋίᱛঊͬဥ̞̹ಸ‫ۯ‬஄૆୨ၗ༹. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ, ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇᖸ५੿আ, ߧུܽ໲, ୷ോၦং, നಎཆढ, ਝ५ࢼ၌, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇ۴୨ੰ͂ਆ
ន௩૓ͅ‫࠿̳ͥ۾‬൦. ల67ٝક‫ڠشٸܕا‬ٛ௙ٛ, εΑΗȜ, ີ५, 2012, 7.
Ȇஂᚧဈٚ, ਝུგ࠻, ࣞ୼ġ ၮ, ઀ाၦং, ઀࿤ਜࣞ, ਝ५ࢼ၌, ঌ୼࿭ঃ, ኈॄ৽୕, ఱ࿤࿆౳, ‫׿‬൥ġ ‫ڒ‬ȇ֍‫܈‬ळ༾‫͈ڼ‬ζ;ΑਆនκΟσͬဥ̞̹ਆនࠁ଼̤̫ͥͅޭ଻໦ঊ
aPKCȜ/Ț͈࿨‫ڬ‬ٜଢ଼. ඾ུક‫ڠشٸܕا‬ٛ‫੅ڠ‬ਬٛ, ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇऎ൥ġ ખ, ५‫܅‬ġ ࿆, ௷ၛટঊ, ུઃ࿹֏, ੉നࢼ֚, გന༸ঊ, ஂᚧဈٚ, ᖸ५੿আ, ઐ๶࠻֚, ಏ࿤ġ ྶȇ൚̤̫֭ͥͅດ੔എໜ࣌‫ޢ‬༞੩‫ئ‬ऒ௰‫࣐ࠫ؍‬ಸ୨ੰ੅. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ, εΑΗȜ, ີ५, 2012, 7.
Ȇგന༸ঊ, ኈॄ৽୕, ಿ౓୼૥֚, നఆਔ२, ઀࿤ਜࣞ, ఱോġ ܲ, ൥֔ୃ֚, ཪ࿤ဢგ,઀ाၦং, ਝ५ࢼ၌, ‫׿‬൥ġ ‫ڒ‬ȇ֍‫܈‬হ࿴୨ੰ႕̤̫ͥͅS-1੅ࢃ༞੩‫ڠا‬ၷ༹ࢃ͈ठอ
ςΑ·ͅ‫࠿̳ͥ۾‬൦. ક‫ڠشٸܕا‬ٛ, εΑΗȜ, ີ५, 2012, 7.
Ȇ੉നࢼ֚, ઐ๶࠻֚, നġ ળۘ, ാ‫ؚ‬૝ࢩ, നಎ࿹ै, ऎ൥ġ ખ, ୞໐කআ, ५‫܅‬ġ ࿆, Ⴎനࢫ֚჊, ಏ࿤ġ ྶȇ൚̤̫֭ͥͅ‫଻ੱٸ‬۴అੱ͈࠿൦. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ, ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇऎ൥ġ ખ, ௷ၛટঊ, ੉നࢼ֚, ࣞ‫ޘ‬ೄ࣐, გന༸ঊ, ஂᚧဈٚ, ᖸ५੿আ, ५‫܅‬ġ ࿆, ઐ๶࠻֚, ಏ࿤ġ ྶȇ‫ئ‬໐ક‫ۯا‬ஊࢢͥ͢ͅ‫଻ݢ‬ไอ଻ໜ྄‫׶‬છ႕̤̫ͥͅNPWT͈ခဥ
଻. ల 4ٝ඾ུ஻ੱ‫ڠشٸ‬ٛ, ΩΥσΟͻΑ΃ΛΏοϋ, ໛‫ؖ‬, 2012, 7.
Ȇઐ๶࠻֚, നġ ળۘ, ੉നࢼ֚, ാ‫ؚ‬૝ࢩ, നಎ࿹ै, ऎ൥ġ ખ, ୞໐කআ, ५‫܅‬ġ ࿆, Ⴎനࢫ֚჊, ಏ࿤ġ ྶȇুட෫Ⴈ́อછ̱̹۴ඤ౨‫ྚۯ‬໦‫ ͈܈ا‬1႕. ల48ٝ඾ུ౨ൽ‫ڠ‬ٛ‫੅ڠ‬ਬٛ, εΑΗȜ, ൐‫ނ‬, 2012, 9.
Ȇઐ๶࠻֚ȇల134ٝ૰ජ୼ࡇႉ઄‫ڠ֓شٸ‬ٛਬ౴ٛ. जಿȆংٛ, ‫؍‬ຩ, 2012, 9.
Ȇࣞ‫ ܧࢬޘ‬ĩࡄਘ֓Ī, ᖸ५੿আ, ५‫܅‬ġ ࿆, ௷ၛટঊ, ུઃ࿹֏, ੉നࢼ֚, ࣞ‫ޘ‬ೄ࣐, გന༸ঊ, ऎ൥ġ ખ, ஂᚧဈٚ, ઐ๶࠻֚, ಏ࿤ġ ྶȇഢുͬ‫ܥ‬ഢ̱̹͂ஹࠂΰσΣͺྱඤ઀ಸஊࢢ͈֚႕. ల134ٝ૰ජ୼ࡇႉ઄‫ڠ֓شٸ‬ٛਬ౴ٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 9.
Ȇ५‫܅‬ġ ࿆, ᖸ५੿আ, გന༸ঊ, ऎ൥ġ ખ, ઐ๶࠻֚, ಏ࿤ġ ྶȇໜ࣌‫ئޢ‬ೄಸ‫ͅ੅਀܈‬̤̫ͥ J ߿ಸ‫·ۯ‬ρϋίᱛঊͬဥ̞̹ಸ‫ۯ‬஄૆୨ၗ༹. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬
ਬٛ. ๊֚‫׵‬ఴ, ໛‫ؖ‬, 2012, 11.
㧙133㧙

Ȇᖸ५੿আ, ५‫܅‬ġ ࿆, გന༸ঊ, ऎ൥ġ ખ, ઐ๶࠻֚, ಏ࿤ġ ྶȇࣞႢ৪ఱಸ‫܈‬છ႕ͅచ̳ͥໜ࣌‫̫̤ͥͅ੅਀ޢ‬ఏ൚଻͈࠿൦. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ, ๊֚‫׵‬ఴ,໛‫ؖ‬, 2012, 11.
Ȇऎ൥ġ ખ, ५‫܅‬ġ ࿆, გന༸ঊ, ᖸ५੿আ, ઐ๶࠻֚, ಏ࿤ġ ྶȇఱಸ‫ͼ܈‬τ;Αછ႕̤̫ͥͅͼτ;ΑΙνȜῄͥ͢ಸ‫ࡘۯ‬գ͈փ݅. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ,ါབ‫׵‬ఴ, ໛‫ؖ‬, 2012, 11.
Ȇಏ࿤ġ ྶȇల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ, जಿȆংٛ, ൐‫ނ‬, 2012, 11.
Ȇ५‫܅‬ġ ࿆, ᖸ५੿আ, გന༸ঊ, ऎ൥ġ ખ, ઐ๶࠻֚, ௷ၛટঊ, ུઃ࿹֏, ੉നࢼ֚, ஂᚧဈٚ, ಏ࿤ġ ྶȇໜ࣌‫ئޢ‬ஜ༷୨ੰ੅̤̫ͥͅণ࿤ജ‫ ͂ٳ‬J ߿ಸ‫·ۯ‬ρϋίᱛঊͬဥ̞̹ಸ‫ۯ‬஄૆୨ၗ͈ࢥຳ. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ, ါབ‫׵‬ఴ, ൐‫ނ‬, 2012, 12.
Ȇᖸ५੿আ, ५‫܅‬ġ ࿆, ௷ၛટঊ, ུઃ࿹֏, ੉നࢼ֚, ࣞ‫ޘ‬ೄ࣐, გന༸ঊ, ऎ൥ġ ખ, ஂᚧဈٚ, ઐ๶࠻֚, ಏ࿤ġ ྶȇࣞႢ৪ͅచ̳ͥ‫ڠا‬ၷ༹͈࡛ે. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ, εΑΗȜ, ൐‫ނ‬, 2012, 11.
Ȇऎ൥ġ ખ, ५‫܅‬ġ ࿆, ᖸ५੿আ, ௷ၛટঊ, ੉നࢼ֚, ࣞ‫ޘ‬ೄ࣐, გന༸ঊ, ஂᚧဈٚ, ઐ๶࠻֚, ಏ࿤ġ ྶȇ‫ئ‬໐ક‫ۯا‬ஊࢢͥ͢ͅ‫଻ݢ‬ไอ଻ໜ྄‫׶‬છ႕̤̫ͥͅNPWT͈ခဥ଻. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ, ̷͈ఈ, ൐‫ނ‬, 2012, 11.
Ȇ੉നࢼ֚, ઐ๶࠻֚, ௷ၛટঊ, ུઃ࿹֏, ࣞ‫ޘ‬ೄ࣐, გന༸ঊ, ऎ൥ġ ખ, ஂᚧဈٚ, ᖸ५੿আ, ५‫܅‬ġ ࿆, ಏ࿤ġ ྶȇ֍਱ඵঐಸ೟នஊࢢͅచ̳ͥ਀੅ഐ؊฻౯̤̫ͥͅCTΑ΋ͺςϋΈ͈ခဥ଻. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ, ါབ‫׵‬ఴ, ൐‫ނ‬, 2012, 11.
Ȇ५‫܅‬ġ ࿆, ᖸ५੿আ, გന༸ঊ, ऎ൥ġ ખ, ઐ๶࠻֚, ௷ၛટঊ, ུઃ࿹֏, ੉നࢼ֚, ஂᚧဈٚ, ಏ࿤ġ ྶȇࣞഽࡤ‫ܥݟ‬ෝવ‫ٺ‬છ႕ͅచ̳ͥໜ࣌‫ئޢ‬ఱಸ‫࠿͈੅਀܈‬൦. ల25ٝ඾ུඤণ‫ڠشٸޢ‬ٛ௙ٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 12.
Ȇ५‫܅‬ġ ࿆ȇ๊֚‫׵‬ఴġ ఱಸᥬ࿝՛଻ġ ༽ࣣະ஠. ల25ٝ඾ུඤণ‫ڠشٸޢ‬ٛ௙ٛ, जಿȆংٛ, ‫؍‬ຩ, 2012, 12.
Ȇᖸ५੿আ, ५‫܅‬ġ ࿆, ௷ၛટঊ, ུઃ࿹֏, ੉നࢼ֚, ࣞ‫ޘ‬ೄ࣐, გന༸ঊ, ऎ൥ġ ખ, ஂᚧဈٚ, ઐ๶࠻֚, ಏ࿤ġ ྶȇ൚̤̫֭ͥͅໜ࣌‫ئޢ‬ఱಸ୨ੰછ႕͈࠿൦. ల25ٝ඾ུඤণ‫ڠشٸޢ‬ٛ௙ٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 12.
Ȇஃ࿤࿻๼ ĩࡄਘ֓Ī, ᖸ५੿আ, ५‫܅‬ġ ࿆, ௷ၛટঊ, ུઃ࿹֏, ੉നࢼ֚, ࣞ‫ޘ‬ೄ࣐, გന༸ঊ, ऎ൥ġ ખ, ஂᚧဈٚ, ઐ๶࠻֚, ಏ࿤ġ ྶȇ՛଻஌֋଻ழ૕‫ݩ‬ਆ͈઀ಸഢ֊͢ͅ
ͥಸਹୣ͈֚႕. ల135ٝ૰ජ୼ࡇႉ઄‫ڠ֓شٸ‬ٛਬ౴ٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 12.

ĩࡄ‫ݪ‬ٛ൝ĪȆ५‫܅‬ġ ࿆, ാ‫ؚ‬૝ࢩ, നġ ળۘ, ऎ൥ġ ખ, നಎ࿹ै, ୞໐කআ, ઐ๶࠻֚, Ⴎനࢫ֚჊,ಏ࿤ġ ྶȇ๊֚ພ̤̫֭ͥͅఱಸ‫ࡢ܈‬༆‫ا‬হၷ͈࡛ે. Yokohama Personalized therapy
㧙134㧙

Meeting, ࣒‫׵‬ȆρϋΙοϋ, ‫؍‬ຩ, 2012, 2.
Ȇ५‫܅‬ġ ࿆, ಏ࿤ġ ྶȇໜ࣌‫̦੅਀ޢ‬ષ਀̩̹̞̈́ͤ૽͈̹͛ͅ. ల 3ٝ‫؍‬ຩໜ࣌‫਀੅਀ޢ‬ܿࡄ‫ݪ‬ٛ. ࣒‫׵‬ȆρϋΙοϋ, ‫؍‬ຩ, 2012, 4.
Ȇઐ๶࠻֚, Ⴎനࢫ֚჊, ௷ၛટঊ, ུઃ࿹֏, ੉നࢼ֚,‫ޘ‬ೄ࣐, გന༸ঊ, ऎ൥ġ ખ,ஂᚧဈٚ, ᖸ५੿আ, ५‫܅‬ġ ࿆, ಏ࿤ġ ྶȇޫਫ਼ૺ࣐ᦙఘ໐‫ͅ܈‬చ̳ͥໜ࣌൲ྤࣣ໵୨ੰ
ฺ̠ͬ๶௰ᦙ୨ੰ ĩDP-CARĪġ ͈ 2 ႕. ల41ٝ૰ජ୼ક‫ݪࡄشٸܕا‬ٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ,2012, 6.
Ȇ५‫܅‬ġ ࿆, ᖸ५੿আ, გന༸ঊ, ऎ൥ġ ખ, ઐ๶࠻֚, ௷ၛટঊ, ུઃ࿹֏, ੉നࢼ֚, ஂᚧဈٚ, ಏ࿤ġ ྶȇഩ‫ܨ‬ιΑ͈ঀ̞༷. LOOK and LEARN, ‫؍‬ຩ, 2012, 9.
Ȇऎ൥ġ ખ, ५‫܅‬ġ ࿆, ௷ၛટঊ, ུઃ࿹֏, ੉നࢼ֚, ࣞ‫ޘ‬ೄ࣐, გന༸ঊ, ஂᚧဈٚ, ᖸ५੿আ, ઐ๶࠻֚, ಏ࿤ġ ྶȇठอ໾ङࢢΰσΣͺͅచ̱̀ Kugel Patchͬဥ̞̀ਘ໘̱
̹ 1႕. ల 4ٝ૰ජ୼ΰσΣͺࡄ‫ݪ‬ٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 12.

Ƀ‫؍‬ຩႻबພ֭ɄġȆIwase H, Yamamoto Y, Ishikawa T, Hozumi Y, Ikeda M, Iwata H, Yamashita H, Toyama T,
Chishima T, Kimijima I, Ibusuki M, Saji S : Phase II randomized trial of toremifene 120 mg
compared with exemestane 25 mg after prior nonsteroidal aromatase inhibitor inpostmenopausal women with hormone receptor-positive breast cancer. American Society ofClinical Oncology ĩASCOĪ 2012 Breast Cancer Symposium. San Francisco, CA. 2012, 6.
Ȇ୷ോၦং, ऎș࿐‫ܧ‬, ࿐ఆྔၖঊ, ୄକఱ༟, ୞୼ġ ࢣ, ५ಎୃඵ, ֞५‫ྶد‬, ‫׿‬൥ġ ‫ڒ‬ȇ21-gene recurrence score assayͅ‫̹̞̿ܖ‬Ki67 Labeling Index͈ບ‫༹ث‬. ల20ٝ඾ུ඿‫܈‬‫ڠ‬ٛ‫੅ڠ‬௙ٛ, ๊֚া୰, ߧུ, 2012, 6.
Ȇ୷ോၦংȇা୰27ȇΓϋΙΥσ 3. ల20ٝ඾ུ඿‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ, जಿ, ߧུ, 2012, 6.
Ȇ५ུ૨࿟, ఱന࣓ဇ, ളᰦġ ੗, നಎཆढ, ൥֔ୃ֚, ਝ५ࢼ၌, ঌ୼࿭ঃ, ኈॄ৽୕, ૩ന౺ণ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫੅਀܈‬শ͈੅ಎໜ࣌ඤ஄૆͂SSI อ୆ထཡ. ల67ٝ඾ུક‫ٸܕا‬‫ڠش‬ٛ௙ٛ. χȜ·ΏοΛί, ີ५, 2012, 7.
ȆChishima T, Momiyama M, Zhao M, Hiroshima Y, Suetsugu A, Tome Y, Mii S, Yano S, Bouvet
M, Endo I, Hoffman RM : Treatment of human glioma with tumor-targeting geneticallyengineered Salmonella typhimurium in orthotopic mouse models. ల71ٝ඾ུ‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ, εΑΗȜΓΛΏοϋ, ढ़ི, 2012, 9.
Ȇଫࢺ೭‫ހ‬, ୷ോၦং, ࿐ఆྔၖঊ, ऎș࿐૯ၑ, ‫ܔ‬ఉ‫ݛ‬๼ঊ, ൌനგฎ, ଼֚֔ၦ, ५ಎୃඵ, ֞५‫ྶد‬, ୞୼ġ ࢣ, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇ੅ࢃ 9 ා࿒ͅକଅછ́อછ̱̹ठอ඿‫܈‬͈ 1႕. ల 9ٝ඾ུ඿‫ڠ܈‬ٛ‫۾‬൐౷༷ٛ, ๊࢛֚‫׵‬, ఱ‫ݠ‬, 2012, 12.
Ȇ୷ോၦংȇ๊֚‫׵‬ఴ D. ల 9ٝ඾ུ඿‫ڠ܈‬ٛ‫۾‬൐౷༷ٛ, जಿ, ఱ‫ݠ‬, 2012, 12.
㧙135㧙ĩࡄ‫ݪ‬ٛȆ࣒‫׵‬൝ĪȆ୷ോၦংȇΗ΅΍ϋࠏࢯ‫܈‬स͈໗ैဥచॐ̞̾̀ͅ. ‫؍‬ຩ΂ϋ΋υΐȜ΢ȜΑΓη΢Ȝ,ΩΥσΟͻΑ΃ΛΏοϋ, ‫؍‬ຩ, 2012, 2.
Ȇ५ུ૨࿟, നಎཆढ, ࿤૜გങ, ߧུܽ໲, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ໌നგ‫ז‬, ఱന࣓ဇ, ୷ോၦং, ਝ५ࢼ၌, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫܈‬۴ഢ֊௏̤̫ͥͅCD133อ࡛͈փ݅. ల33ٝ‫܈‬྾‫ݪࡄشٸע‬ٛ, ๊֚‫׵‬ఴ, ૧‫؍‬ຩ, 2012, 5.
Ȇ୷ോၦংȇ඿̦̹̠̳͈ͭ̈́̽ͣ̓ͥͅȉ੫଻̱͂̀Ȃ‫ز‬௼̱͂̀౶̧̤̹̞̽̀ȶ඿̦ͭȷ̞̠͂ພ‫ܨ‬Ƚ༦͈඾ΑβΏλσȽ. ‫؍‬ຩཤ໐֓ၷ࠷ల 4 ٝঌྦྷ࢖‫࣒ٳ‬ज, ࣒‫׵‬, ‫؍‬ຩ, 2012, 5.
Ȇ୷ോၦংḙ̥͈̑ͦͣ඿ஏ‫̳̰̦֓͛شٸ‬ၷ. ల 9ٝ‫؍‬ຩঌཤ໐ഴ჏͈֓ٛ, ࣒‫׵‬, ‫؍‬ຩ,2012, 6.
Ȇ୷ോၦংȇSession 2 ൚̤̫֭ͥͅLapatinibൎဓછ႕̞̾̀ͅ. Tykerb Conference in
Kanagawa 2012, जಿ, ‫؍‬ຩ, 2012, 7.
Ȇ୷ോၦংȇ඿̦ͭ࠿૷࣐̭̠͒Ȋ ‫؍‬ຩঌཤ໐֓ၷ࠷άϋ·ςδϋίυΐͿ·Π2012, ࣒‫׵‬, ‫؍‬ຩ, 2012, 9.
Ȇ୷ോၦংȇ඿̦ͭਔ੅‫̫̤ۛͥͅܢ‬৪΍εȜΠ ĩ੅ࢃςϋΩ຾ਆ͈ထཡ͂হၷĪ. ‫؍‬ຩঌཤ໐֓ၷ࠷άϋ·ςδϋίυΐͿ·Π2012, ࣒‫׵‬, ‫؍‬ຩ, 2012, 9.
Ȇ୷ോၦংȇΙȜθ́঑̢ͥ඿̦ͭ૷ၷ. Breast Cancer Seminar in AomoriȄ࣒‫׵‬, ୒૩,2012, 9.
Ȇ୷ോၦংȇΙȜθ֓ၷ࡛ͬાͅ୆̥̳և͈৾ͤழ͙ȡພ֭໓ാ̞̥ͬͅ་̢̥ͥȡ.
Breast Cancer Seminar in Aomori, ΩΥσΟͻΑ΃ΛΏοϋ, ୒૩, 2012, 9.
Ȇ୷ോၦংȇ඿‫ܖ͈܈‬ய౶ে͂ड૧হၷȅ୒૩άϋ·ςδϋίυΐͿ·Π2012, ࣒‫׵‬, ୒
૩, 2012, 9.
Ȇ୷ോၦংȇ඿̦ͭ࣬౶ฺ̠ͅιϋΗσΉͺ. ୒૩άϋ·ςδϋίυΐͿ·Π2012, ࣒‫׵‬,୒૩, 2012, 9.
Ȇ୷ോၦংȇ඿‫͈܈‬ഢ֊Ȇठอ. ల11ٝ With You Tokyo ȡ̜̹̈́͂ήτΑΠΉͺͬࣉ̢ͥٛȡ, έ͹ΏςΞȜΗȜ, ൐‫ނ‬, 2012, 10.
Ȇ୷ോၦংȇ̦ͭ૷ၷ̤̫ͥͅΙȜθ֓ၷ. ల 4 ٝႻ൱৪࠲ࢫ໛ছ‫ࢊ࡞ࢹܥ‬ಶ‫ژ‬আȆMSWࡄਘٛ, ࣒‫׵‬, ୼ॄ, 2012, 11.
Ȇ୷ോၦংȇ඿̦ͭͅ‫̳ͥ۾‬ड૧ૂ༭. ໹଼24ාഽ߄ాߊ౷֖࿪মႲࠈ‫݈ފ‬ٛ, ࣒‫׵‬, ‫؍‬ຩ, 2012, 11.
Ȇ୷ോၦংȇ਀੅̺̫̲̞̈́͝Ȋ඿̦͈ͭड૧হၷ. ‫؍‬ຩঌႂߊ‫ފ‬൱মުΙλτϋΐȶ̜̹͉̺̈́ͦͬ঑̢̳̥͘ȷ, ࣒‫׵‬, ‫؍‬ຩ, 2012, 11.
Ȇ୷ോၦংȇΙȜθ֓ၷ࡛ͬાͅ୆̥̳̹͈͛৾ͤழ͙Ȇఉ૖ਅͬచય̱̹͂ΙȜθ֓ၷ
㧙136㧙

࣒ज. ల 2ٝ Kanagawa Breast Cancer Oncology GroupίυΠ΋Ȝσ࠿൦ٛ, ࣒‫׵‬, ‫؍‬ຩ,2012, 11.
Ȇ୷ോၦংȇ౶̧̤̹̞̽̀඿̦͈ͭड૧হၷȅల 7 ٝ΋Ȝί͈̦ͭΓη΢Ȝ, ࣒‫׵‬, ‫؍‬ຩ, 2012, 11.

Ƀ‫؍‬ଌٖ‫ވ‬फພ֭ɄġȆMinami Y, Masui H, Takagawa R, Narui K, Morita T, Fukushima T, Mogaki M, Nagahori K :Efficacy of laparoscopy-assisted hepatectomy. 10th World Congress of the International
Hepato-Pancreato-Biliary Association, εΑΗȜ, Paris, 2012, 7.
Ȇࣞ୼ġ ၮ, ࿆‫ੇٗڈ‬, ධġ ဉఊ, ଼֚֔ၦ, େന౶ࢨ, ໛ോ಑౳, ஐ֔ਜ୹, ಿཱġ ߰ȇ൚̤̫֭ͥͅໜ࣌‫ޢ‬༞੩‫ئ‬࿽࿝௰֍୨ੰ੅͈਀੅਀͈ܿࢥຳ࡛͂ે. ల83ٝ඾ུ֍‫ڠ܈‬ٛ,ΫΟ΂ΓΛΏοϋ, ఱि, 2012, 2.
Ȇളᰧġ ੗, ఱന࣓ဇ, ५ུ૨࿟, ള༏֚ܵ, നಎཆढ, ਝ५ࢼ၌, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫ͼ܈‬τ;Αછ႕͈ಿ‫଼ܢ‬ୡͅ‫੅̳ͥ۾‬ஜಸ‫ࡘۯ‬գ͈փ݅. ల48ٝ඾ུໜ໐
‫ڠ֓ݢݣ‬ٛ௙ٛ, ๊֚‫׵‬ఴ, ߄ా, 2012, 3.
Ȇ‫ٳ‬ന᥽໹, ࿐ఆ‫ྶם‬, ‫׿‬൥ġ ‫ڒ‬ȇఉอ۴ෟនȂᦃෟនฺ̹ͬ̽ȂCrohnພࠫಸᦃឝ͈1႕.
ల48ٝ඾ུໜ໐‫ڠ֓ݢݣ‬ٛ௙ٛ, ါབ‫׵‬ఴ, ߄ా, 2012, 3.
Ȇളᰧġ ੗, ఱന࣓ဇ, ള༏֚ܵ, നಎཆढ, ਝ५ࢼ၌, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇໜ࣌‫ܿ਀੅਀ޢ‬ਠං͈‫֗ޗ‬ΏΑΞθ͈‫ږ‬ၛͬ࿒ঐ̱̹৾ͤழ͙. ల112ٝ඾ུ‫ڠشٸ‬ٛ೰‫ܢ‬‫੅ڠ‬ਬٛ. εΑΗȜ, ൐‫ނ‬, 2012, 4.
Ȇ‫ٳ‬ന᥽໹, ള༏֚ܵ, ࡼయഛռ, ൥֔ୃ֚, ኈॄ৽୕, ളᰧġ ੗, ఱന࣓ဇ, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇࠫಸֲ฼୨ੰ੅̤̫ͥͅໜ࣌ඤΡτȜϋ͈ຈါ଻ͅ‫࠿̳ͥ۾‬൦. ల112ٝ඾ུ‫ٸ‬‫ڠش‬ٛ೰‫੅ڠܢ‬ਬٛ, εΑΗȜ, ୷ဩ, 2012, 4.
Ȇࣞ୼ġ ၮ, ‫׿‬൥୷༠, ୼࢛ఱ༟, २఺ࡊఊ჊, չ൥૥ࢁ, ઀ୌၦ࣐, ධġ ဉఊ, ଼֚֔ၦ,େന౶ࢨ, ໛ോ಑౳, ࿆‫ੇٗڈ‬, ஐ֔ਜ୹, ಿཱġ ߰ȇཛྷ੕ཻଜͬဥ྄̞̹͈ٜཎͬփে
̱̹ΰσΣͺਘ໘੅͈ΠτȜΣϋΈ༹. ల10ٝ඾ུΰσΣͺ‫ڠ‬ٛ, ΩΥσΟͻΑ΃Λ
Ώοϋ, ྴࡣ‫ؚ‬, 2012, 4.
Ȇେന౶ࢨ, ࿆‫ੇٗڈ‬, ઀ୌၦ࣐, չ൥૥ࢁ, ࣞ୼ġ ၮ, ධġ ဉఊ, ଼֚֔ၦ, ໛ോ಑౳, ஐ֔ਜ୹, ೋ‫ࢨ׆‬ຳ, ಿཱġ ߰ȇಠྶ̈́ࣸ඲ࣸ໦‫ฺ̹̽ͬا‬඿ஏ‫ۼ‬ৗරਆ͈֚႕. ల20ٝ඾ུ඿‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ, εΑΗȜ, ߧུ, 2012, 6.
Ȇධġ ဉఊ, ஐ֔ਜ୹, २఺ࡊఊ჊, ୼࢛ఱ༟, չ൥૥ࢁ, ઀ୌၦ࣐, ࣞ୼ġ ၮ, ଼֚֔ၦ,େന౶ࢨ, ໛ോ಑౳, ࿆‫ੇٗڈ‬, ಿཱġ ߰ȇᦙ൮਱ඵঐಸ୨ੰ·ςΣ΃σΩΑ͈ခဥ଻.
ల24ٝ඾ུ۴౨ᦙ‫ڠشٸ‬ٛ‫੅ڠ‬ਬٛ. εΑΗȜ, ఱि, 2012, 6.
Ȇ઀ୌၦ࣐, ஐ֔ਜ୹, ఱୌġ ಐ, ୷ဩġ ஻, ༱‫܅‬ဉ௬, ୼ࡓġ ૯, ࣞ‫ޘ‬ೄ࣐, ୼࢛ఱ༟, २㧙137㧙఺ࡊఊ჊, չ൥૥ࢁ, ࣞ୼ġ ၮ, ධġ ဉఊ, ଼֚֔ၦ, େന౶ࢨ, ໛ോ಑౳, ࿆‫ੇٗڈ‬, ಿཱġ ߰ȇ൚͈֭ౙࢢ৆ໜ࣌‫ئޢ‬౨ෙഊ੄੅͈࠿൦. ల24ٝ඾ུ۴౨ᦙ‫ڠشٸ‬ٛ‫੅ڠ‬ਬٛ,εΑΗȜ, ఱि, 2012, 6.
Ȇධġ ဉఊ, ஐ֔ਜ୹, २఺ࡊఊ჊, ୼࢛ఱ༟, չ൥૥ࢁ, ઀ୌၦ෗, ࣞ୼ġ ၮ, ଼֚֔ၦ,େന౶ࢨ, ໛ോ಑౳, ࿆‫ੇٗڈ‬, ಿཱġ ߰ȇᦙ൮਱ඵঐಸ୨ੰ̤̫ͥͅυΑΠΑΞϋΠᦙߗಸ໧༹ࣣ͈ခဥ଻. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ, ါབ‫׵‬ఴ, ີ५, 2012, 7.
Ȇളᰧġ ੗, ఱന࣓ဇ, ୞໐කআ, ५‫܅‬ġ ࿆, ള༏֚ܵ, ਝ५ࢼ၌, ൥֔ୃ֚, ঌ୼࿭ঃ, ಏ࿤ġ ྶ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫ͼ܈‬τ;ᾼచ̳ͥಸ‫ࡘۯ‬գ͈փ݅. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇളᰧġ ੗, ఱന࣓ဇ, ଋངဎၮ, ୞໐කআ, ള༏֚ܵ, ൥֔ୃ֚, བ࠮ࢫ‫ݛ‬, ஐ֔ਜ୹, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇఱಸ‫̫̤ͥͅ੅਀܈‬๧‫ئ‬໾ङ৆‫֨ݟ‬ΡτȜϋ͈ခဥ଻ ȡPropensity
score matchingͬဥ̞̹࠿൦ȡ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ, Ώϋεΐ;θ, ີ५,2012, 7.
Ȇࣞ୼ġ ၮ, ࿆‫ੇٗڈ‬, ධġ ဉఊ, ଼֚֔ၦ, େന౶ࢨ, ໛ോ಑౳, ஐ֔ਜ୹, ಿཱġ ߰ȇໜ࣌‫ޢ‬༞੩‫ئ‬࿽࿝௰֍୨ੰ੅̤̫ͥͅ਀੅਀͈ܿࢥຳ͂হၷ଼ୡ. ల67ٝ඾ུક‫شٸܕا‬‫ڠ‬ٛ௙ٛ, ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇ‫ٳ‬ന᥽໹, ࿐ఆ‫ྶם‬, ‫׿‬൥ġ ‫ڒ‬ȇࣞႢ৪೟ន଻ఱಸ‫੅̫̤ͥͅ׶‬৆஖఼͈࿚ఴത. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ. εΑΗȜ, ີ५, 2012, 7.
Ȇളᰧġ ੗ȇ༽ࣣະ஠ͅచ̳ͥࣉ̢༷ ĩೄಸ‫ࣣ༽͈ࢃ੅਀܈‬ະ஠͈ထཡȆহၷȡ༗ంഎহၷ̤̫ͥͅহ࿴‫ۼܢ‬ౣੀ͈և͈ΡτȜϋ஖఼ȡĪ. ల37ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ߇ਗ౷༷ٛ,࣒‫׵‬ȆρϋΙοϋ, ໛‫ؖ‬, 2012, 9.
Ȇධġ ဉఊ, ஐ֔ਜ୹, २఺ࡊఊ჊, ୼࢛ఱ༟, չ൥૥ࢁ, ઀ୌၦ෗, ࣞ୼ġ ၮ, ଼֚֔ၦ,େന౶ࢨ, ໛ോ಑౳, ࿆‫ੇٗڈ‬, ಿཱġ ߰ȇ80पոષ͈ࣞႢ৪ͅచ̳ͥᦙ൮਱ඵঐಸ୨ੰ
͈հ஠଻. ల20ٝક‫ڠشٸܕا‬ٛఱٛJDDW, εΑΗȜ, ૰࡫, 2012, 10.
Ȇളᰧġ ੗, ఱന࣓ဇ, ଋངဎၮ, ୞໐කআ, ള༏֚ܵ, നಎཆढ, ਝ५ࢼ၌, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇ੅ஜࠐ࢛‫ူו‬༞‫ݯ‬सൎဓ଼̤̫ͥͅ໦༆֍ෳᘩশ‫ܖ͈ۼ‬யഎ࠿൦.
ల20ٝક‫ڠشٸܕا‬ٛఱٛJDDW. ΩΥσΟͻΑ΃ΛΏοϋ, ૰࡫, 2012, 10ȅȆളᰧġ ੗, ‫׿‬൥୷༠, ཱ֔૝၌, ୼ࡓġ ૯, ‫ٳ‬ന᥽໹, ଋངဎၮ, ઀ୌၦ෗, չ൥૥ࢁ, ུ‫ۼ‬ဈਏ, ࣞ୼ġ ၮ, ධġ ဉఊ, େന౶ࢨ, ࿆‫ੇٗڈ‬, ஐ֔ਜ୹ȇ൚̤̫֭ͥͅౙࢢ৆ໜ࣌‫ ئޢ‬S ેࠫಸ୨ੰ੅͈਀੅਀ܿ. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. ΫΟ΂ΓΛΏοϋ, ൐‫ނ‬, 2012, 11.
Ȇളᰧġ ੗, ࿯࿤ఊ֚, བ࠮ࢫ‫ݛ‬, ࣞ‫ୃޘ‬੗, ࿆‫ੇٗڈ‬, ஐ֔ਜ୹ȇఱಸ‫̫̤ͥͅ੅਀܈‬๧‫ئ‬໾ङ৆‫֨ݟ‬ΡτȜϋ͈ခဥ଻. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ, ါབ‫׵‬ఴ, ൐‫ނ‬, 2012.
11.
㧙138㧙

Ȇളᰧġ ੗ȇೄಸ‫͈ࢃ੅਀܈‬ςȜ·ͅ๵̢ͥȡ੅ಎPits & Falls͂ࡠޫ‫୽ैا‬ȡ. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ, ࣒‫׵‬ȆρϋΙοϋ, ໛‫ؖ‬, 2012, 11.
Ȇളᰧġ ੗, ఱന࣓ဇ, ଋངဎၮ, ୞໐කআ, ള༏֚ܵ, നಎཆढ, ਝ५ࢼ၌, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇໜ࣌‫ئޢ‬೩պஜ༷୨ੰ੅̤̫ͥͅ੅ஜໜ࣌ඤডཛ࿂ୟ௶೰͈ခဥ଻.
ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ, ါབ‫׵‬ఴ, ໛‫ؖ‬, 2012, 11.
Ȇളᰧġ ੗, ఱന࣓ဇ, ଋངဎၮ, ୞໐කআ, ള༏֚ܵ, നಎཆढ, ਝ५ࢼ၌, ൥֔ୃ֚, ஐ֔ਜ୹, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇౙࢢ৆ໜ࣌‫ ئޢ‬S ેࠫಸ୨ੰ੅͈ࠧത̷͈͂࣪໚͈দ͙.
ల25ٝ඾ུඤণ‫ڠشٸޢ‬ٛ௙ٛ, ΫΟ΂ΓΛΏοϋ, ‫؍‬ຩ, 2012, 12ȅĩࡄ‫ݪ‬ٛ൝ĪȆളᰧġ ੗, ఱന࣓ဇ, ള༏֚ܵ, നಎཆढ, ਝ५ࢼ၌, ൥֔ୃ֚, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇೄಸ‫ޫ͈܈‬ਫ਼ठอ‫֦ࡏܓ‬ঊ̤͍͢ထࢃܰ೰֦ঊ̥͙̹ͣRbೄಸ‫͈܈‬ळ໦႒ͅ‫࠿̳ͥ۾‬൦.
ల76ٝఱಸ‫ݪࡄ܈‬ٛ, εΑΗȜ, ֳസ‫ݠ‬, 2012, 1.
Ȇളᰧġ ੗ȇໜ࣌‫̦੅਀ޢ‬ષ਀̹̞̈́ͤͅ૽͈̹͛ͅ. ల 3 ٝ‫؍‬ຩໜ࣌‫ݪࡄܿ਀੅਀ޢ‬ٛĩρΩυထ๵ࢷĪ, ࣒‫׵‬ȆρϋΙοϋ, ‫؍‬ຩ, 2012, 4.
Ȇධġ ဉఊ, ஐ֔ਜ୹, ‫׿‬൥୷༠, ཱ֔૝၌, ‫ٳ‬ന᥽໹, ୼ࡓġ ૯, ଋངဎၮ, չ൥૥ࢁ, ઀ୌၦ࣐, ུ‫ۼ‬ဈਏ, ࣞ୼ġ ၮ, େന౶ࢨ, ࿆‫ੇٗڈ‬, ಿཱġ ߰ȇ൚̤̫֭ͥͅᦙ൮਱ඵঐ
ಸ୨ੰ͈਀ܿ͂੅ࢃ‫ۯ‬ၑ͈ࢥຳ. ల41ٝ૰ජ୼ક‫ݪࡄشٸܕا‬ٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012,6.
Ȇධġ ဉఊ, ஐ֔ਜ୹, ‫׿‬൥୷༠, ཱ֔૝၌, ‫ٳ‬ന᥽໹, ୼ࡓġ ૯, ଋངဎၮ, չ൥૥ࢁ, ઀ୌၦ࣐, ུ‫ۼ‬ဈਏ, ࣞ୼ġ ၮ, ളᰧġ ੗, େന౶ࢨ, ࿆‫ੇٗڈ‬, ಿཱġ ߰ȇ‫ݴ‬ఱ۴ෙ༾ͅ
చ̱̀ౙࢢ৆ໜ࣌‫ئޢ‬۴ෙ༾‫ٳ‬ௗ੅ͬঔ࣐̱̹ 2 ႕. ల 7 ٝౙࢢ৆ඤণ‫ݪࡄܿ਀੅਀ޢ‬ٛ, ๊֚‫׵‬ఴ, ढ़ི, 2012, 8.
Ȇളᰧġ ੗, ‫׿‬൥୷༠, ཱ֔૝၌, ୼ࡓġ ૯, ‫ٳ‬ന᥽໹, ଋངဎၮ, ઀ୌၦ෗, չ൥૥ࢁ, ུ‫ۼ‬ဈਏ, ࣞ୼ġ ၮ, ධġ ဉఊ, େന౶ࢨ, ࿆‫ੇٗڈ‬, ஐ֔ਜ୹ȇ൚̤̫֭ͥͅౙࢢ৆ໜ࣌‫ ئޢ‬S ેࠫಸ୨ੰ੅͈਀ܿ. ల 8 ٝReduced Port Surgery Forum, ΫΟ΂ΓΛΏοϋ, ढ़
ི, 2012, 8.
Ȇࣞ୼ġ ၮ, ධġ ဉఊ, ളᰧġ ੗, େന౶ࢨ, ࿆‫ੇٗڈ‬, ஐ֔ਜ୹ȇౙࢢ৆ໜ࣌‫ئޢ‬౨ෙഊ੄੅ͬঔ࣐̱̹ਹໝ౨ෙ‫ ͈ۯ‬1 ႕. ల 8ٝReduced Port Surgery Forum, ๊֚‫׵‬ఴ, ढ़ི,2012, 8.
Ȇളᰧġ ੗, ‫׿‬൥୷༠, ཱ֔૝၌, ୼ࡓġ ૯, ‫ٳ‬ന᥽໹, ଋངဎၮ, ઀ୌၦ෗, չ൥૥ࢁ, ུ‫ۼ‬ဈਏ, ࣞ୼ġ ၮ, ධġ ဉఊ, େന౶ࢨ, ࿆‫ੇٗڈ‬, ஐ֔ਜ୹ȇLaparoSonic Coagulating
Shears ĩLCSĪġ ͈ঀ̞༷. ΫΟ΂ΓΛΏοϋ, Look and Learn, ‫؍‬ຩ, 2012, 9.
Ȇࣞ୼ġ ၮ, ‫׿‬൥୷༠, ཱ֔૝၌, ୼ࡓġ ૯, ୷ဩġ ஻, ‫ٳ‬നਘ໹, ଋངဎၮ, չ൥૥ࢁ, ઀㧙139㧙ୌၦ࣐, ུ‫ۼ‬ဈਏ, ളᰧġ ੗, ධġ ဉఊ, େന౶ࢨ, ࿆‫ੇٗڈ‬, ஐ֔ਜ୹ȇໜ࣌‫ޢ‬༞੩‫ئ‬ஜ༷ͺίυȜΙͥ͢ͅठอஹࠂΰσΣͺआহ੅. ల 3 ٝ૰ජ୼ΰσΣͺࡄ‫ݪ‬ٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 12.

Ƀ‫؍‬ຩ͙̈́͂୤਱লພ֭ɄġȆಿനੇ֚ȇΓΛΏοϋ 3. ૰ජ୼ࡇႉ઄‫ڠ֓شٸ‬ٛਬ౴ٛ, जಿȆংٛ, ‫؍‬ຩ, 2012, 2.
Ȇ‫ݛ‬༗ฎ֚, ಿനੇ֚, ࡔന૞ࢁ, ಿ๶࣠ঢ, ‫ډ‬ഞġ ‫ڠ‬, ଫࢺ೭‫ހ‬, ಿ౓୼୍ং ઀๶༿჊,Ւ໐ഓຳȇ֍͂ఱಸ̦౎੄̱̹‫ݴ‬ఱ૙ൽႨࢢΰσΣͺ͈֚႕. ల823ٝ‫شٸ‬ਬ౴ٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 2.
Ȇಿനੇ֚, ଫࢺ೭‫ހ‬, ಿ౓୼୍ং, ઀๶༿჊, Ւ໐ഓຳ, ఱന࣓ဇ, ൥֔ୃ֚, ‫׿‬൥ġ ‫ڒ‬ȇೄಸ‫ͅ܈‬చ̳ͥ೩պஜ༷୨ੰ੅ࢃ͈ޫਫ਼ठอ֦ঊ͈࠿൦. ల112ٝ඾ུ‫ڠشٸ‬ٛ௙ٛ, εΑΗȜ, ྃಫ, 2012, 4.
Ȇࡔന૯ࢁ, ଫࢺ೭‫ހ‬, ‫ݛ‬༗ฎ֚, ಿ๶࣠ঢ, ‫ډ‬ഞġ ‫ڠ‬, ಿനੇ֚, ಿ౓୼୍ং, ઀๶༿჊,Ւ໐ഓຳȇ੅ஜ૷౯̱ංֲ̹ࠫಸެ̦፪ව̱̹WinslowࢢΰσΣͺ͈ 1႕. ల48ٝ඾ུໜ໐‫ڠ֓ݢݣ‬ٛ, ๊֚‫׵‬ఴ, ୞୼, 2012, 3.
Ȇ‫ډ‬ഞġ ‫ڠ‬, ಿനੇ֚, ‫ݛ‬༗ฎ֚, ࡔന૞ࢁ, ಿ๶࣠ঢ, ଫࢺ೭‫ހ‬, ಿ౓୼୍ং, ઀๶༿჊,Ւ໐ഓຳȇ֍৊ෑഢછฺ̹ͬ̽‫྄ڞ؍‬ཌྷႨࢢΰσΣͺ͈֚႕. ల48ٝ඾ུໜ໐‫ڠ֓ݢݣ‬ٛ, ๊֚‫׵‬ఴ, ୞୼, 2012, 3.
Ȇ଩ന࢕ၦ, ષനႃຳ, ૩ၦఊ჊, ౓࢛ࢼ֚, ઐ५ၦ୆, ࿤૜გങ, ߧུܽ໲, ໌നგ‫ז‬, നಎཆढ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇMDCTͥ͢ͅᦙਆនςϋΩ୯૷౯ෝ͈࠿൦. ల112ٝ඾ུ‫ڠشٸ‬ٛ௙ٛ, εΑΗȜ, ୷ဩ, 2012, 4.
Ȇࡔന૯ࢁ, ଫࢺ೭‫ހ‬, ‫ݛ‬༗ฎ֚, ಿ๶࣠ঢ, ‫ډ‬ഞġ ‫ڠ‬, ಿനੇ֚, ಿ౓୼୍ং, ઀๶༿჊,Ւ໐ഓຳȇ‫ͬ᥻ᦏ̹̱౎ڲ‬ඤယ̱̹͂ठอఱదΰσΣͺ͈ 1 ႕. ల10ٝ඾ུΰσΣͺ‫ڠ‬ٛ, ๊֚‫׵‬ఴ, ྴࡣ‫ؚ‬, 2012, 4.
Ȇ଩ന࢕ၦ, ષനႃຳ, ౓࢛ࢼ֚, ઐ५ၦ୆, ૩ၦఊ჊, ࿤૜გങ, ߧུܽ໲, ໌നგ‫ז‬, നಎཆढ, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇह֭‫ۼܢ‬ౣੀͬ࿒ঐ̱̹ᦙ൮਱ඵঐಸ୨ੰ੅ࢃᦙߗಸ໧
ࣣ͈਀͈ܿࢥຳ. ల24ٝ඾ུ۴౨ᦙ‫ڠشٸ‬ٛ௙ٛ. εΑΗȜ, ఱि, 2012, 5.
Ȇಿനੇ֚, ‫ݛ‬༗ฎ֚, ࡔന૯ࢁ, ଫࢺ೭‫ހ‬, ಿ౓୼୍ং, ઀๶༿჊, Ւ໐ഓຳȇStageIVఱಸ‫͈܈‬૧‫ܖ‬੔ͥ͢ͅळ໦႒ͅ‫࠿̳ͥ۾‬൦. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ, ΩΥσΟͻ
Α΃ΛΏοϋ, ີ५, 2012, 7.
Ȇࡔന૯ࢁ, ಿനੇ֚, ‫ݛ‬༗ฎ֚, ଫࢺ೭‫ހ‬, ಿ౓୼୍ং, ઀๶༿჊, Ւ໐ഓຳȇ಼ࣞႢ৪ఱಸ‫͈܈‬হၷ଼ୡ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ, εΑΗȜ, ີ५, 2012, 7.
Ȇ‫ݛ‬༗ฎ֚, ಿനੇ֚, ࡔന૯ࢁ, ଫࢺ೭‫ހ‬, ಿ౓୼୍ং, ઀๶༿჊, Ւ໐ഓຳȇೄಸ‫ͅ܈‬చ̳ͥ೩պஜ༷୨ੰ੅ࢃ͈༽ࣣະ஠อછ႕͈࠿൦. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ௙ٛ, ີ㧙140㧙

५, 2012, 7.
Ȇಿ౓୼୍ং, ֞‫ڈ‬ၖ৩, ‫܃‬५ġ ࣞ, ઀‫ࢫࡔڦ‬ຳ, ୄକఱ༟, ଩ന࢕ၦ, ಿനੇ֚, ઀๶༿჊, Ւ໐ഓຳȇໜ༃ഢ֊Ȃໜ྄෥ਅͬြ̹̱̹ࢃͅஹࠂςϋΩ୯ഢ֊ͬ୆̲̹൳শ଻ఉ
อ଻ࠫಸ‫͈֚܈‬႕. ల50ٝ඾ུ‫܈‬হၷ‫ڠ‬ٛ‫੅ڠ‬ਬٛ, εΑΗȜ, ‫؍‬ຩ, 2012, 10.
Ȇಿനੇ֚, ଩ന࢕ၦ, ಿ౓୼୍ং, ઀๶༿჊, Ւ໐ഓຳȇTNMȽStageIVBఱಸ‫ͅ܈‬చ̳ͥ
3rd lineո͈ࣛ‫ڠا‬ၷ༹͈ခဥ଻ͅ‫࠿̳ͥ۾‬൦. ల50ٝ඾ུ‫܈‬হၷ‫ڠ‬ٛ‫੅ڠ‬ਬٛ, εΑΗȜ, ‫؍‬ຩ, 2012, 10.
Ȇಿനੇ֚, ઀‫ࢫࡔڦ‬ຳ, ઀๶༿჊, Ւ໐ഓຳȇTNMల 7 ๅ̥͙̹ͣStageIVఱಸ‫͈܈‬হၷ༷ૻ଼͂ୡ. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ, ๊֚‫׵‬ఴ, ໛‫ؖ‬, 2012, 11.
Ȇಿനੇ֚, ֞‫ڈ‬ၖक, ‫܃‬५ġ ࣞ, ઀‫ࢫࡔڦ‬ຳ, ୄକఱ༟, ଩ന࢕ၦ, ಿ౓୼୍ং, ઀๶༿჊, Ւ໐ഓຳȇఱಸ‫܈‬෹ഢ֊છ႕͈হၷ଼ୡ. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ, ါབ‫׵‬ఴ,൐‫ނ‬, 2012, 11.
Ȇಿനੇ֚ȇఱಸ‫܈‬۴Ȇ෹ഢ֊হၷ͈૧ജ‫ ٳ‬2. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ, जಿȆংٛ, ൐‫ނ‬, 2012, 11.
Ȇ઀‫ࢫࡔڦ‬ຳ, ಿനੇ֚, ֞‫ڈ‬ၖ৩, ‫܃‬५ġ ࣞ, ୄକఱ༟, ଩ന࢕ၦ, ಿ౓୼୍ং, ઀๶༿჊, Ւ໐ഓຳȇఱಸ̦ͭ૷ၷ̤̫ͥͅພ૷Ⴒࠈ͈࡛ે. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ, ါབ‫׵‬ఴ, ૧਽, 2012, 11.
Ȇ֞‫ڈ‬ၖक, ಿനੇ֚, ‫܃‬५ġ ࣞ, ઀‫ࢫࡔڦ‬ຳ, ୄକఱ༟, ଩ന࢕ၦ, ಿ౓୼୍ং, ઀๶༿჊, Ւ໐ഓຳȇఱಸஊࢢછ႕͈ςΑ·֦ঊ̥͙̹ͣ੅৆஖఼. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ, ါབ‫׵‬ఴ, ൐‫ނ‬, 2012, 11.
Ȇ‫܃‬५ġ ࣞ, ಿനੇ֚, ֞‫ڈ‬ၖक, ઀‫ࢫࡔڦ‬ຳ, ୄକఱ༟, ଩ന࢕ၦ, ಿ౓୼୍ং, ઀๶༿჊, Ւ໐ഓຳȇ‫଻ݢ‬ಖ଒‫੅਀׶‬છ႕̤̫ٟͥͅក଻Ȇஊࢢ଻ಖ଒‫͈׶‬ထ௶֦ঊ͈࠿൦.
඾ུႉ઄‫ڠشٸ‬ٛ, ါབ‫׵‬ఴ, ൐‫ނ‬, 2012, 11.
Ȇ५࢛გढ, ಿനੇ֚, ֞‫ڈ‬ၖक, ‫܃‬५ġ ࣞ, ઀‫ࢫࡔڦ‬ຳ, ୄକఱ༟, ଩ന࢕ၦ, ಿ౓୼୍ং, ઀๶༿჊, Ւ໐ഓຳȇ੅ಎඤণ‫૷́ޢ‬౯̦‫ږ‬೰̱̹Ȃ‫ͥࣸ͢ͅݿ‬਱ඵঐಸల 4໐ࠆ৒ஊࢢ͈֚႕. ‫شٸ‬ਬ౴ٛ, ๊֚‫׵‬ఴ, ൐‫ނ‬, 2012, 12.
Ȇ‫ؖ‬ോġ ဉ, ઀‫ࢫࡔڦ‬ຳ, ֞‫ڈ‬ၖक, ‫܃‬५ġ ࣞ, ୄକఱ༟, ଩ന࢕ၦ, ಿനੇ֚, ಿ౓୼୍ং,઀๶༿჊, Ւ໐ഓຳȇ઀ಸ૰ࠐඤ໦๥ਆន ĩNETĪ ஊࢢͥ͢ͅ޽‫͈֚੅਀ݢ‬႕. ల135ٝ૰ජ୼ႉ઄‫ڠ֓شٸ‬ٛਬ౴ٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 12.

ĩࡄ‫ݪ‬ٛ൝ĪȆಿനੇ֚, ‫ݛ‬༗ฎ֚, ࡔന૞ࢁ, ಿ๶࣠ঢ, ‫ډ‬ഞġ ‫ڠ‬, ଫࢺ೭‫ހ‬, ಿ౓୼୍ং, ઀๶༿჊,Ւ໐ഓຳȇఱಸ‫܈‬ໜ྄෥ਅછ႕͈হၷ଼ୡ͈࠿൦. ల76ٝఱಸ‫ݪࡄ܈‬ٛ, εΑΗȜ, ඌ
࿐, 2012, 1.
㧙141㧙Ȇ࿐‫ئ‬ঃ୆, ಿനੇ֚, ֞‫ڈ‬ၖ৩, ‫܃‬५ġ ࣞ, ઀‫ࢫࡔڦ‬ຳ, ୄକఱ༟, ଩ന࢕ၦ, ಿ౓୼୍ং, ઀๶༿჊, Ւ໐ഓຳȇS ેࠫಸ‫ͅ܈‬చ̱਀੅ঔ࣐শͅȂ‫ږ‬೰૷౯ͬං̹ᦙ‫܈‬StageԈbಿ‫ܢ‬୆ం͈ 1႕. ల41ٝ૰ජ୼ક‫ݪࡄشٸܕا‬ٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 6.
Ȇಿനੇ֚, ଩ന࢕ၦ, ಿ౓୼୍ং, ઀๶༿჊, Ւ໐ഓຳȇ76पոષ͈StageIVఱಸ‫͈܈‬হၷ
଼ୡ. ఱಸ‫ݪࡄ܈‬ٛ, εΑΗȜ, ൐‫ނ‬, 2012, 7.
Ȇ୼֔നఱਏ, ଩ന࢕ၦ, ֞‫ڈ‬ၖक, ‫܃‬५ġ ࣞ, ઀‫ࢫࡔڦ‬ຳ, ୄକఱ༟, ಿനੇ֚, ಿ౓୼୍ং, ઀๶༿჊, Ւ໐ഓຳȇMeckel ࠆ৒͈ mesodiverticular band ͥ͢ͅඤΰσΣͺ́޽‫਀ݢ‬੅ͬါ̱̹֚႕. ల 4ٝ૰ජ୼ΰσΣͺࡄ‫ݪ‬ٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 12.
Ȇ઀๶༿჊, ઀‫ࢫࡔڦ‬ຳ, ‫܃‬५ġ ࣞ, ֞‫ڈ‬ၖक, ୄକఱ༟, ଩ന࢕ၦ, ಿനੇ֚, ಿ౓୼୍ং, Ւ໐ഓຳȇPྌ͉CYု଻֍‫͈܈‬୆ంၚ̥͙̹ͣ੅৆͈࠿൦. ల43ٝ૰ජ୼֍‫܈‬হၷࡄ‫ݪ‬ٛ. ‫؍‬ຩ, 2012, 12.

Ƀफ୆ٛ‫؍‬ຩঌධ໐ພ֭ɄġȆḶ൥ਘহ, ౻ġ ਜ෗, ଼֚֔ၦ, ‫܃‬५ġ ࣞ, ༌५ဎٚ, ್࿤ؐ‫ݛ‬, ๳࢛ࢴ୆, ࡔനġ ࢼ, ໹୼઎໹, ಿ౓୼௛, २ᰧఱٚ, ߦനġ ഔȇޫਫ਼ૺ࣐ೄಸ‫ͅ܈‬చ̳ͥmFOLFOX6ͬಎ૤͂
̱̹੅ஜ༞੩‫ڠا‬ၷ༹. ల112ٝ඾ུ‫ڠشٸ‬ٛ, εΑΗȜ, ୷ဩ, 2012, 4.
Ȇಿ౓୼௛, ๳࢛ࢴ୆, ಎఆ୹ঊ, ໹୼઎໹. ౻ġ ਜ෗ȇ඿‫܈‬ΓϋΙΥσςϋΩ୯୆࠿ု଻
႕̤̫ͥͅᦀᡅςϋΩ୯ഢ֊͈࠿൦. ల20ٝ඾ུ඿‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ. Ώϋεΐ;θ, ߧ
ུ, 2012. 6.
ȆḶ൥ਘহ, ‫܃‬५ġ ࣞ, ༌५ဎٚ, ್࿤ؐ‫ݛ‬, ๳࢛ࢴ୆, ࡔനġ ࢼ, ಿ౓୼௛, २ᰧఱٚ, ߦനġ ഔ, ౻ġ ਜ෗ȇໜ࣌‫࣐ࠫ؍ئޢ‬ಸ୨ੰ੅̤̫ͥͅςϋΩ୯‫ڜ‬ୄ͈εͼϋΠ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ, ΫΟ΂ΓΛΏοϋ, ີ५, 2012, 7.
Ȇಿ౓୼௛, ୒࿐‫ܮ‬઎, ാ֔୷੉, २༏ఱٚ, ୔൥ਘহ, ౻ġ ਜ෗ȇ൚͈֭́ΖτΡυϋॸ
ൎဓಎ͈BRONJ͈࡛ે. ల10ٝ඾ུႉ઄ਆន‫ڠ‬ٛ‫੅ڠ‬ਬٛ, εΑΗȜ, ఱि, 2012, 7.
ȆHasegawa S, Momiyama M, Hiroshima Y, Suetsugu A, Tome Y, Mii S, Yano S, Chishima T,
Bouvet M, Endo I, Hoffman R M : Treatment of brain tumor in nude mice with intracranial UV
irradiation. ల71ٝ඾ུ‫ڠ܈‬ٛ‫੅ڠ‬௙ٛ, ๊֚‫׵‬ఴ, ढ़ི, 2012, 9.
Ȇಿ౓୼௛, ാ֔୷੉, ୒࿐‫ܮ‬઎, ๳࢛ࢴ୆, ߦനġ ഔ, ࡔനġ ࢼ, २༏ఱٚ, ୔൥ਘহ, ౻ġਜ෗, ࣽനຮຳȇ൚͈֭́BRONJ͈࡛ે. ల50ٝ඾ུ‫܈‬হၷ‫ڠ‬ٛ‫੅ڠ‬ਬٛ, εΑΗȜ, ‫؍‬ຩ, 2012, 10.
ȆḶ൥ਘহ, ౻ġ ਜ෗, ๳࢛ࢴ୆, ଩ଽජೋঊ, २Μูཱࢬ, ༌५ဎٚ, ್࿤ؐ‫ݛ‬, ࡔനġࢼ, ໹୼઎໹, ಿ౓୼௛, २ᰧఱٚ, ߦനġ ഔȇ80पոષ಼͈ࣞႢఱಸ‫ۛ܈‬৪ͅచ̳ͥহ
ၷ͈࡛ેġ Ƚໜ࣌‫ڠا͂੅਀ئޢ‬ၷ༹. ల50ٝ඾ུ‫܈‬হၷ‫ڠ‬ٛ‫੅ڠ‬ਬٛ, ါབ‫׵‬ఴ, ‫؍‬ຩ, 2012, 10.
㧙142㧙Ȇಿ౓୼௛, ๳࢛ࢴ୆, ್࿤ؐ‫ݛ‬, ໹୼઎໹, ಎ५ġ ଢ, ౻ġ ਜ෗ȇ੅ࢃ17ා࿒͈ೄಸഢ֊
ͅచ̱̀γσκϋၷ༹̦ு̱̞ࢗ̀ͥ૫੕଻઀ဩ‫ ͈܈‬1 ႕. ల 9 ٝ඾ུ඿‫ڠ܈‬ٛ‫۾‬൐౷༷ٛ, ๊֚‫׵‬ఴ, ఱ‫ݠ‬, 2012, 12.
ȆḶ൥ਘহ, ๳࢛ࢴ୆, ࡔനġ ࢼ, २ᰧఱٚ, ߦനġ ഔ, ౻ġ ਜ෗ȇ80पոષ಼͈ࣞႢ৪ͅ
చ̳ͥໜ࣌‫ئޢ‬ఱಸ‫੅਀܈‬. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ, ါབ‫׵‬ఴ, ໛‫ؖ‬, 2012,11.
ȆḶ൥ਘহȇεΑΗȜġ ᥬ࿝‫ ܈ۯ‬1. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ‫੅ڠ‬ਬٛ, जಿȆংٛ, ໛‫ؖ‬, 2012, 11.
ȆḶ൥ਘহ, ౻ġ ਜ෗, ๳࢛ࢴ୆, ଩ଽජೋঊ, २Μูཱࢬ, ༌५ဎٚ, ್࿤ؐ‫ݛ‬, ࡔനġࢼ, ໹୼઎໹, ಿ౓୼௛, २ᰧఱٚ, ߦനġ ഔȇໜ୵ࣸໜ৆ೄಸ୨౯੅̤̫ͥͅ୵ࣸௌै.
ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ௙ٛ. ါབ‫׵‬ఴ, ൐‫ނ‬, 2012, 11.
ȆḶ൥ਘহ, ๳࢛ࢴ୆, ଩ଽජೋঊ, २Μูཱࢬ, ༌५ဎٚ, ್࿤ؐ‫ݛ‬, ࡔനġ ࢼ, ໹୼઎໹, ಿ౓୼௛, २ᰧఱٚ, ߦനġ ഔ, ౻ġ ਜ෗ȇໜ࣌‫ئޢ‬೩պஜ༷୨ੰ੅̤̫ͥͅstapling
deviceঀဥͅ‫̺̭̳ͤͩͥ۾‬. ల25ٝ඾ུඤণ‫ڠشٸޢ‬ٛ௙ٛ, ါབ‫׵‬ఴ, ‫؍‬ຩ, 2012, 12.
ȆḶ൥ਘহȇ๊֚‫׵‬ఴġ ఱಸၻ଻ĩ2Ī. ల25ٝ඾ུඤণ‫ڠشٸޢ‬ٛ௙ٛ, जಿȆংٛ, ‫؍‬ຩ,2012, 12.

ĩࡄ‫ݪ‬ٛ൝ĪȆḶ൥ਘহ, ౻ġ ਜ෗, ๳࢛ࢴ୆, ଩ଽජೋঊ, २Μูཱࢬ, ༌५ဎٚ, ್࿤ؐ‫ݛ‬, ࡔനġࢼ, ໹୼઎໹, ಿ౓୼௛, २ᰧఱٚ, ߦനġ ഔȇ‫ٳ‬ໜͥ͢ͅໜ୵ࣸໜ৆ೄಸ୨౯੅̤̫ͅ
ͥ୵ࣸௌै. ૰ජ୼ఱಸᥬ࿝਀੅਀ܿࡄ‫ݪ‬ٛ ల18ٝ‫੅ڠ‬ਬٛ, ΫΟ΂ΓΛΏοϋ, ‫؍‬ຩ,2012, 5.
Ȇಿ౓୼௛ȇ൚̤̫֭ͥͅLapatinibൎဓ႕̞̾̀ͅ. Tykerb in Kanagawa, ๊֚‫׵‬ఴ, ‫؍‬ຩ,2012, 7.
ȆḶ൥ਘহ, ౻ġ ਜ෗, ๳࢛ࢴ୆, ଩ଽජೋঊ, २Μูཱࢬ, ༌५ဎٚ, ್࿤ؐ‫ݛ‬, ࡔനġࢼ, ໹୼઎໹, ಿ౓୼௛, २ᰧఱٚ, ߦനġ ഔȇࣸ๕ͅࡥ೰̯̹ͦޫਫ਼ૺ࣐ೄಸ‫ͅ܈‬చ̱̀஠૸‫ڠا‬ၷ༹ࢃͅࡔอ௏୨ੰ࣐̹ͬ̽ 7 ႕͈࠿൦. ల77ٝఱಸ‫ݪࡄ܈‬ٛ, εΑΗȜ, ൐‫ނ‬, 2012, 7.
ȆḶ൥ਘহȇ"ड૧͈ક‫͈̦ͭܕا‬ထཡ͂হၷ ఱಸ̦ͭġ Ƚ઀̯̈́΅Β̤̳́̈́". ల72ٝ඾ུક‫ܕا‬ພ‫ڠ‬ٛ‫۾‬൐঑໐ ঌྦྷ࢖‫࣒ٳ‬ज, ࣒‫׵‬ȆρϋΙοϋ, ‫؍‬ຩ, 2012, 9.
ȆḶ൥ਘহ, ๳࢛ࢴ୆, ີ‫߱ז‬؇, ଩ଽජೋঊ, २‫ؿ‬५ဢ, ್࿤ؐ‫ݛ‬, ࡔനġ ࢼ, ໹୼઎໹,ಿ౓୼௛, २ᰧఱٚ, ߦനġ ഔ, ౻ġ ਜ෗ȇ௰౤໧ࣣठ࠺ฺ̠ͬ‫ئ‬໐ೄಸਆនͅచ̳ͥໜ࣌‫ ੅਀ئޢ‬ĩISR͂prolasing༹ͬဥ̞̹DSTठ࠺Ī. ల36ٝ૰ජ୼ఱಸᥬ࿝৖ۛःდٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 10.
㧙143㧙ȆḶ൥ਘহȇ࣒‫׵‬Ԇ. ల20ٝ૰ජ୼ક‫ܕا‬ඤণ‫ݪࡄشٸޢ‬ٛ, जಿȆংٛ, ‫؍‬ຩ, 2012, 11.

Ƀ‫؍‬ຩ஑֥༗ࡏພ֭ɄġȆ५ॄ‫ף‬య, ઀ႅකຳ, ષ࢜૝ࢨ, ಎോၦࢤ, ᠟൥࠲૽, ໹࿤ġ ૺ, ಿཱġ ࿹, ࿤ᚧ઎ങȇ࿽࿝‫ޛ‬ॏͬ೮̱̹ͺηυͼΡȜΏΑ͈1႕. ల133ٝ૰ජ୼ࡇႉ઄‫ڠ֓شٸ‬ٛਬ౴ٛ, ‫؍‬ຩ,2012, 2.
Ȇಿཱġ ࿹ḙ̥͈̑ͦͣ֓ၷͬࣉ̢ͥ. ల54ٝ஠඾ུພ֭‫ڠ‬ٛ, ‫؍‬ຩ, ρϋΙοϋΓη
΢Ȝ, 2012, 9.
Ȇಿཱġ ࿹ȇల50ٝ඾ུ২ٛ༗ࡏ֓‫ڠ‬ٛ௙ٛ, जಿ, ߄ా, 2012, 11.
Ȇࣞ‫ޘ‬౺઎, ಎോၦࢤ, ઀ႅකຳ, ષ࢜૝ࢨ, ໹࿤ġ ૺ, ಿཱġ ࿹, ࿤ᚧ઎ങȇGIST̞ͬ݃࿽࿝௰֍୨ੰ੅ͬঔ࣐̱̹Inflammatory Fibroid Polyp͈ 1႕. ల50ٝ඾ུ২ٛ༗ࡏ֓‫ڠ‬ٛ௙ٛ, ߄ా, 2012, 11.

ĩࡄ‫ݪ‬ٛ൝ĪȆಎോၦࢤ, ໹࿤ġ ૺ, ષ࢜૝ࢨ, ઀ႅකຳ, ࣞ‫ޘ‬౺઎, ಿཱġ ࿹ȇ֍‫܈‬ཌྷఱ൲ྤςϋΩ୯ഢ֊ͅచ̱̀UFȚခ࢘͂ࣉ̢̹ͣͦછ႕. ల43ٝ૰ජ୼֍‫܈‬হၷࡄ‫ݪ‬ٛ. ‫؍‬ຩ, 2012,12.
Ȇࣞ‫ޘ‬౺઎, ષ࢜૝ࢨ, ಎോၦࢤ, ઀ႅකຳ, ໹࿤ġ ૺ, ಿཱġ ࿹ȇPolypropylene meshͬဥ̞̀ਘ໘̱̹ષࣴΰσΣͺ͈ 1႕. ల 4ٝ૰ජ୼ΰσΣͺࡄ‫ݪ‬ٛ, ‫؍‬ຩ, 2012, 12.

Ƀ‫؍‬ຩᒑफٛພ֭ɄġȆ࿦ᚧࠄ֚, ୷ോၦং, ଫࢺ೭‫ހ‬, ࿐ఆྔၖঊ, ঌ୼࿭ঃ, ୞୼ġ ࢣ, ‫׿‬൥ġ ‫ڒ‬ȇ੅ࢃ 5ා࿒ͅ༶ৣ஌ચৣํսඤ͈ςϋΩ୯ͅठอ̱̹ΓϋΙΥσςϋΩ୯୆࠿֮଻඿‫͈֚܈‬႕. ల825ٝ‫شٸ‬ਬ౴ٛ, ̷͈ఈ, ൐‫ނ‬, 2012, 6.

Ƀಿೋന࢚୆௙ࣣພ֭ɄġȆఱനဢ໹, ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ໌നგ‫ז‬, ષനႃຳ, ଩ന࢕ၦ, നಎཆढ, ‫׿‬൥ġ ‫ڒ‬ȇ੅ࢃಿ‫ܢ‬ထࢃ̥͙̹ͣᦙ౨‫ࣣۯ‬ၠ։ુછͅచ̳ͥ੅৆஖఼. ల67ٝ඾ུક‫ܕا‬‫ڠشٸ‬ٛ௙ٛ, ΩΥσΟͻΑ΃ΛΏοϋ, ີ५, 2012, 7.

ĩࡄ‫ݪ‬ٛ൝ĪȆఱനဢ໹, ૩ၦఊ჊, ઐ५ၦ୆, ౓࢛ࢼ֚, ໌നგ‫ז‬, ષനႃຳ, നಎཆढ, ঌ୼࿭ঃ, ‫׿‬൥ġ ‫ڒ‬ȇᦙ౨‫ࣣۯ‬ၠ։ુ̤̫ͥͅอ‫܈‬ςΑ·͈໦ঊ୆໤‫ڠ‬എ࠿൦. ల35ٝ඾ུᦙȆ౨‫ۯ‬ࣣၠ։ુࡄ‫ݪ‬ٛ. ๊֚‫׵‬ఴ, ൐‫ނ‬, 2012, 9.
㧙144㧙Ƀॅޮ֓‫ش‬ఱ‫࣭ڠ‬ष֓ၷΓϋΗȜɄġȆSuwa H, Yamaguchi S, Kato T, Kondo H, Okada I, Tashiro J, Ishii T, Miyazawa M, Koyama I,
Shinozuka N : A retrospective study of prophylactic drainage after laparoscopic colectomy.
SAGES 2012, Poster, San Diego, 2012, 3.
ȆSuwa H, Yamaguchi S, Kondo H, Tashiro J, Ishii T, Koyama I : Comparison of functional end to
end anastomosis and double stapling technique anastomosis for laparoscopic sigmoidectomy.
ల25ٝ ISUCRS, Poster, Bologna, 2012, 6.
Ȇଋངࢤგ, ५࢛࿆ਏ, ‫ح‬൥ీ࿟, ߃൥ࢤ‫ج‬, ‫ؖ‬ന֚჊, നయġ ૆, ୞֔၌ઍ, ‫ݠ‬ᚧ࢕౳, ઀५ġ ࿺, ৚೓ġ བȇໜ࣌‫ࠫئޢ‬ಸ୨ੰ੅̤̫ͥͅΡτȜϋၣ౾͈ຈါ଻͈࠿൦. ల112ٝ඾ུ‫ڠشٸ‬ٛ, εΑΗȜ, ୷ဩ, 2012, 4.
Ȇଋངࢤგ, ५࢛࿆ਏ, ߃൥ࢤ‫ج‬, ඃ‫ז‬ဉܲ, ‫ؖ‬ന֚჊, നయġ ૆, ୞֔၌ઍ, ‫ݠ‬ᚧ࢕౳, ઀५ġ ࿺ȇ൳শ଻۴ഢ֊ͬခ̳ͥఱಸ‫͈܈‬হၷ୽ၞ. ల67ٝ඾ུક‫ڠشٸܕا‬ٛ, ๊֚‫׵‬ఴ, ີ५, 2012, 7.
Ȇଋངࢤგ, ५࢛࿆ਏ, ߃൥ࢤ‫ج‬, നయġ ૆, ୞֔၌ઍ, ‫ݠ‬ᚧ࢕౳, ઀५ġ ࿺ȇ੅ஜ༶ৣ஌
‫ڠا‬ၷ༹ࢃͅIntersphincteric resectionͬঔ࣐̱̹ೄಸ‫ ܈‬6 ႕͈࠿൦. ల20ٝ඾ུક‫ܕا‬‫ڠشٸ‬ٛఱٛJDDW, εΑΗȜ, ૰࡫, 2012, 10.
Ȇଋངࢤგ, ५࢛࿆ਏ, ࡔġ ୉‫ج‬, ႝ࿐ཻྚ, ߃൥ࢤ‫ج‬, നయġ ૆, ୞֔၌ઍȇೄಸ‫ͅ܈‬చ̳ͥ೩պஜ༷୨ੰ੅̤̫ͥͅ༽ࣣະ஠‫֦ࡏܓ‬ঊ͈࠿൦. ల67ٝ඾ུఱಸᥬ࿝ພ‫ڠ‬ٛ. εΑΗȜ, ໛‫ؖ‬, 2012, 11.
Ȇଋངࢤგ, ५࢛࿆ਏ, ‫ح‬൥ీ࿟, ࡔġ ୉‫ج‬, ႝ࿐ཻྚ, ߃൥ࢤ‫ج‬, നయġ ૆, ୞֔၌ઍ, ઀५ġ ࿺ȇCT angiographyͤٝࠫ͢ͅಸȂಎࠫಸ൲୓ྤ‫ވ‬೒ۚͬ෇̹͛ໜ࣌‫ئޢ‬ٝ࿋໐୨ੰ੅͈ 1႕. ల74ٝ඾ུႉ઄‫ڠشٸ‬ٛ, ါབ‫׵‬ఴ, ૧਽, 2012, 11.
Ȇଋངࢤგ, ५࢛࿆ਏ, ‫ح‬൥ీ࿟, ࡔġ ୉‫ج‬, ႝ࿐ཻྚ, ߃൥ࢤ‫ج‬, നయġ ૆, ୞֔၌ઍ, ઀५ġ ࿺ȇ൚̤̫֭ͥͅໜ࣌‫ ئޢ‬Intersphincteric resection͈࠿൦. ల25ٝ඾ུඤণ‫شٸޢ‬‫ڠ‬ٛ, ๊֚‫׵‬ఴ, ‫؍‬ຩ, 2012, 12.

ĩࡄ‫ݪ‬ٛ൝ĪȆଋངࢤგ, ߃൥ࢤ‫ج‬, നయġ ૆, ୞֔၌ઍ, ५࢛࿆ਏȇ঑෻ࠬ‫͈ۯ‬௢࣐։ુͬ෇̹͛ໜ࣌
‫ئޢ‬ٝ࿋໐୨ੰ੅. ల 5ٝॅޮࡇໜ࣌‫ئޢ‬ఱಸ୨ੰःდٛ, ๊֚‫׵‬ఴ, ఱ‫ݠ‬, 2012, 3.

Ƀफ୆ٛ৹௜ພ֭Ʉġĩࡄ‫ݪ‬ٛ൝ĪȆ࿐ఆġ ੔, ઀࿤ਜࣞ, ઀ाၦং, ཪ࿤ဢ౶, ਝ५ࢼ၌, ঌ୼࿭ঃ, ಿൌဢহ, ໹֔ਜ֚, ఱ࿤࿆౳, ኈॄ৽୕, ‫׿‬൥ġ ‫ڒ‬ȇConditionally Replicative Adenovirus ĩCRAdĪ ͬဥ̞̹‫ڠا‬
㧙145㧙ၷ༹࢘‫ض‬฻೰͈ခဥ଻. ల21ٝ඾ུ‫܈‬ພఠহၷࡄ‫ݪ‬ٛ, ๊֚‫׵‬ఴ, ஜ‫ޘ‬, 2012, 7.

Ƀ࣭ၛ̦ͭࡄ‫ݪ‬ΓϋΗȜ൐ພ֭ġ ႉ઄‫ٳ‬อΓϋΗȜɄġȆᚧനġ ဎ, ಎ࿂ഓ࿟ȇImmunological analysis in a phase II study of the GPC3-derived
peptide vaccine as an adjuvant therapy for HCC patients. ల71ٝ඾ུ‫ڠ܈‬ٛ, ढ़ི, 2012, 9.
Ȇᚧനġ ဎ, ಎ࿂ഓ࿟ȇGPC3βίΙΡχ·ΙϋൎဓࢃȂࡐಠ̈́ࢯਆន࢘‫̧̹̱̹ͬض‬۴ळ༾‫ ͈܈‬1ཎ࠿႕. ల25ٝ඾ུΨͼ΂Γράͻ‫ڠ‬ٛ, ါབ‫׵‬ఴ, ‫ؖ‬५, 2012, 12.

㧙146㧙